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Cardiovascular disease remains the primary cause of death worldwide. Medical 
imaging plays a critical and increasing role in both its diagnosis and 
characterisation. Recent advances in hyperpolarised 13C Magnetic Resonance 
(MR) allow, for example, imaging an injected molecule and its downstream 
metabolites to uncover biochemical changes in the myocardium. On the other 
hand, radionuclide imaging using Positron Emission Tomography (PET) and 
Single Photon Emission Computed Tomography (SPECT) has significantly 
higher sensitivity than MR, but the signals from injected tracers and their 
metabolites are indistinguishable. All these imaging modalities are able to 
produce dynamic data containing information of the kinetics of their respective 
tracers. In order to relate the measured signal or activity to the underlying 
physiological or biochemical processes mathematical models have to be used. 
In this thesis, experimental protocols have been developed and semi-
quantitative and quantitative methods have been evaluated for the analysis of 
hyperpolarised 13C dynamic time-series and time-activity curves of PET tracers 
acquired ex vivo from Langendorff perfused rat hearts. A number of 
compartmental models were explored to fit in vitro and ex vivo hyperpolarised 
13C time-series acquired for pyruvate and its downstream metabolites to derive 
apparent rates of the enzymatic reactions involved in pyruvate metabolic 
pathways. Compartmental modelling was also used in combination with Monte 




in vivo in small rodents using hyperpolarised 13C spectroscopic imaging. The 
feasibility of using a model free maximum entropy/nonlinear least square 
method (MEM/NLS) for the kinetic analysis of hyperpolarised 13C dynamic data 
was explored in this thesis for the first time and validated using Monte Carlo 
simulations and experimental hyperpolarised 13C in vitro time-series. Finally, the 
feasibility of extending the analysis methods validated for in vivo PET 
experiments (spectral-based algorithm, Patlak graphical plot and the semi-
quantitative index RATIO) to the kinetic analysis of time-activity curves of PET 
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Chapter 1 : Introduction  
1.1 Aims 
This thesis aims at the development of acquisition protocols and analysis 
methods for real-time assessment of cardiac metabolism using molecular 
imaging in Langendorff perfused rat hearts. 
For many years imaging techniques such as positron emission tomography 
(PET), single-photon emission computed tomography (SPECT), magnetic 
resonance imaging (MRI) and ultrasound were almost exclusively used to 
obtain anatomical and physiological information of the heart (Saraste et al. 
2009). Since its introduction in the early 1990’s, molecular imaging has greatly 
improved our understanding of the pathogenesis of many cardiac diseases as 
well as illuminating on new treatment targets by allowing the imaging of  
biological processes that take place at cellular and subcellular levels in the 
myocardium (Massoud and Gambhir 2003;  Osborn and Jaffer 2013). 
The Langendorff perfused heart has been the model of reference in cardiac 
research for many years and greatly contributed to the understanding of cardiac 
physiology. Section 1.2 presents a comparison between this experimental 




perfused studies were carried out both in healthy and hypoxic/ischemic hearts. 
A definition of cardiac hypoxia and ischemia is presented in Section 1.3.   
In order to understand the importance of molecular imaging techniques able to 
measure cardiac metabolism in real-time for the early assessment of cardiac 
diseases, the principle metabolic pathways which contribute to the production of 
energy necessary for the contraction of the heart in physiological and 
pathophysiological conditions are described in Section 1.4.  
An overview of the most commonly used imaging modalities in cardiology is 
introduced in Section 1.5. Many imaging modalities are able to produce 
dynamic data representing the evolution of the measured variable over the time. 
In order to derive quantitative or semi-quantitative information on the 
phenomena observed dynamic data can be analysed using several different 
approaches. An overview of the most common methods used for the analysis of 
cardiac dynamic data is presented in Section 1.6.  In Section 1.7 the objectives 




1.2 Cardiac perfusion  
 
1.2.1 Physiological Perfusion 
The heart together with the complex system of arteries and veins plays a 
fundamental role in the distribution of blood and nutrients to the rest of the body. 




is delivered to the right atrium through the inferior and superior vena cava. The 
contraction of the right atrium facilitates the flow of the blood into the right 
ventricle that once filled pumps the blood into the pulmonary artery that delivers 
the blood to the lungs, where it is oxygenated. Blood returns to the left atrium by 
the pulmonary veins and enters the left ventricle by passing through the mitral 
valve. The left ventricle ejects the oxygenated blood into the aorta that delivers 
it to the rest of the body. The cardiac muscle receives the oxygen and nutrients 
necessary for its survival, through the coronary arteries which arise from the 
coronary ostia at the base of the aorta (Figure 1.1).  
 
 
Figure 1.1: Schematic representation of the physiological perfusion of the heart. 
Deoxygenated blood is delivered to right atrium through the inferior and superior vena 
cava. The contraction of the right atrium facilitates the passage of the blood to the right 
ventricle that once filled pumps the blood into the pulmonary artery that delivers the 
blood to the lungs where it is oxygenated. The blood returns to the left atrium via the 
pulmonary veins and once in the left ventricle is ejected into the aorta that delivers it to 
the rest of the body. The cardiac muscle receives the oxygen and nutrients necessary for 
its survival, through the coronary arteries which arise from the coronary ostia at the base 




1.2.2 Langendorff Perfusion 
The Langendorff perfusion method supplies nutrients to an isolated heart 
exploiting the same principles of its physiological perfusion. After removing the 
heart from the animal carefully cutting the major blood vessels, a cannula is 
inserted into the aorta and a buffer is perfused into the heart under physiological 
pressure (Figure 1.2). The pressure generated by the buffer in the aorta forces 
the aortic valve to remain closed and the myocardium is perfused through the 
coronary arteries as it would be physiologically.  
 
 
Figure 1.2: Schematic representation of a Langendorff perfusion. The isolated heart is 
perfused with a Krebs-Henseleit buffer that contains all the electrolytes and nutrients 
that the heart needs to survive. The Langendorff heart is perfused exclusively through 





The heart rate of an isolated rat heart is normally lower than that in vivo. For rat 
hearts, for example, it is 250-320beats/min rather than 350-400beats/min 
(Skrzypiec-Spring et al. 2007). Since it is empty, and not performing active 
work, the Langendorff perfused heart is a beating but not pumping heart and 
therefore it is a biologically relevant model for studying cardiac metabolism, but 
not cardiac mechanics. 
 
 
1.3 Cardiac Hypoxia and Ischemia 
Myocardial hypoxia is a pathophysiological condition defined as an imbalance 
between the myocardial oxygen demand and the amount of oxygen supplied to 
the heart.  Similarly, myocardial ischemia is characterised by a disparity 
between the amount of blood delivered to the myocardium through the coronary 
arteries and that required for an efficient contraction of the heart. Ischemia not 
only causes hypoxia but also reduces the hydrostatic pressure and nutrient 
delivery. Nevertheless the reduction in blood flow causes an accumulation of 
the wastes from the cardiac metabolism that eventually damage myocytes. 
Coronary artery disease (CAD) is the most common cause of hypoxia and/or 
ischemia. It is characterised by a reduction or cut off in the amount of blood 
normally delivered to the myocardium associated with the formation of 
atherosclerotic plaques within the wall of one or more coronary arteries. The 
prognosis associated with this type of cardiovascular disease is inversely 




tools for early detection of ischemic/hypoxic myocardium would extremely 
improve the mortality associated with CAD.  
 
 
1.4 Cardiac Metabolism 
Many if not all cardiac pathologies involve modulation or malfunction of key 
signalling pathways, leading to downstream changes in cellular metabolism and 
to physiological and mechanical dysfunction. 
The heart is the only restless muscle in the human body. Its contraction requires 
energy in the form of adenosine triphosphate (ATP) which in normal conditions 
is continuously generated by glycolysis and fatty acid metabolism. 
The production of energy in the heart can be divided in three key processes: (i) 
utilisation of a substrate such as free fatty acids and glucose from the diet, (ii) 
production of energy in the form of ATP by the mitochondrial respiratory chain 
and (iii) ATP transfer and utilisation  (Neubauer 2007).  
 
 
1.4.1 Fatty Acid Metabolism  
The unbound fatty acids that cross the membrane of cardiac myocytes via 
specific membrane proteins originate primarily from plasma fatty acids bound to 
albumin or from fatty acids stored in the form of lipoproteins. In the cytosol free 
fatty acids are transformed to long chain fatty acyl-CoA by the action of fatty 
acid synthase (FAC S). Acyl-CoA is converted by carnitine palmitoyltransferase 




acylcarnitine transported within the mitochondria by carnitine translocase (CAT) 
which exchange one molecule of acylcarnitine with one molecule of carnitine. 
Once within the mitochondrial space, acylcarnitine is transformed back to acyl-
CoA by the enzyme CPT2 located in the inner mitochondrial membrane. At this 
point the long chain acyl-CoA enters the fatty acid β-oxidation pathway where in 
a cyclic process is broken down to generate acetyl-CoA which enters the citric 
acid cycle or tricarboxylic acid cycle (TCA). The NADH and FADH2 produced 
during the fatty acid β-oxidation are transferred to the electron transport chain 




Figure 1.3: Schematic representation of the fatty acid metabolism. Adapted from 




1.4.2 Glucose Metabolism 
Glucose is transported into the cell by specific glucose transporters (GLUTs) 
where through a cascade of ten enzyme-catalysed reactions (glycolysis), which 
take place in the cytosol, it is transformed to pyruvate whose fate depends on 
the level of myocardial oxygenation. When myocardial cells receive sufficient 
oxygen, pyruvate is transported into the mitochondria where it is converted by 
pyruvate dehydrogenase (PDH) to acetyl-CoA which subsequently enters the 
TCA cycle (aerobic glycolysis). During the metabolic conversion of glucose to 
pyruvate two molecules of ATP and one of NADH are produced. NADH is 
recycled back to NAD+ by oxidation through the ETC with oxygen as the 
terminal electron acceptor (Figure 1.4).  
 
 
Figure 1.4: Schematic representation of glucose metabolism in presence of oxygen 




1.4.3 Tricarboxylic Acid Cycle 
The acetyl-CoA produced through fatty acid metabolism or aerobic glycolysis 
enters the TCA cycle where through a series of chemical reactions is used to 
produce three molecules of NADH and one molecule of FADH2 which are 
transferred to the ETC where in the presence of oxygen are used to produce 
ATP (Figure 1.5). 
 
 
Figure 1.5: Schematic representation of the tricarboxylic acid (TCA) cycle. The acetyl-
CoA produce through aerobic glycolysis and fatty acid metabolism is used through a 
series of chemical reaction to produce three molecules of NADH and one molecule of 
FADH2 which are transferred to the ETC.  
 
 
1.4.4 Electron Transport Chain 
The ETC is formed by four inner membrane-associated enzyme complexes that 




NADH produced in both aerobic glycolysis and TCA cycle and from FADH2 
derived from the TCA cycle. The transfer of electrons between one complex of 
the ETC to another generates a proton gradient that drives ATP synthase which 
converts adenosine diphosphate (ADP) and inorganic phosphate to ATP. The 
process of electron transport is entirely dependent on molecular oxygen which 




Figure 1.6: Representative scheme of the electron transport chain (ETC) where the 
electrons donated by NADH, produced during both aerobic glycolysis and fatty acid 
metabolism, and by FADH2, derived from the fatty acid metabolism, are used to produce 
a proton gradients that drives the production of ATP through ATP synthase. Adapted 






1.4.5 Creatine Kinase Energy Shuttle 
The creatine kinase energy shuttle has two main functions: (i) facilitate the 
transport of ATP produced in the mitochondria to the myofibrils where it is used 
for myocardial contraction and (ii) energy buffering. Creatine kinase (CK) is able 
to convert creatine (Cr) and ATP to phosphocreatine (PCr) and ADP. The 
creatine kinase energy shuttle therefore facilitates energy transfer by providing 
a parallel pathway to ATP diffusion. At the same time CK is able to maintain the 
cellular level of ATP constant by controlling the creatine-phosphocreatine 
exchange (Opie 1991).      
 
 
1.4.6 Myocardial Metabolism in Hypoxia/Ischemia 
In a healthy, well perfused and oxygenated heart approximately 50-70% of the 
ATP needed for the heart contraction is produced by fatty acid metabolism with 
only 30-50% of the ATP generated via glucose metabolism (Lopaschuk et al. 
2010). The aerobic glycolysis is regulated by the citrate released by the TCA 
cycle, with the majority of glucose being converted to glycogen for storage. In 
this condition, the creatinine kinase energy shuttle maintains the cellular level of 
ATP constant by controlling the creatine-phosphocreatine exchange (Opie 
1991). 
As explained in Section 1.4.4, the ETC is able to produce ATP using the 
electrons donated by NADH and FADH2 only in presence of O2 that is the 
terminal electron acceptor. In conditions in which the level of oxygen is low due, 




hypoxia or ischemia the production of ATP through the ETC is inhibited. The 
accumulation of intermediates of cardiac metabolism inhibits both aerobic 
glycolysis and fatty acid metabolism. In this condition the NADH produced 
during the conversion of glucose to pyruvate that is not transferred to the 
inactive ETC is used to convert pyruvate to lactate via lactate dehydrogenase 
(LDH) (anaerobic glycolysis)(Heather and Clarke 2011). The two molecules of 
ATP produced during the conversion of glucose to pyruvate are however not 
enough to meet the energy required to maintain cardiac contraction. In this 
condition of reduced availability of ATP, the creatinine kinase shuttle is initially 
able to maintain the level of ATP constant by converting PCr to Cr. When the 
oxygen deprivation is prolonged the reservoir of Cr are eventually depleted and 
the creatinine kinase shuttle is not longer able to maintain the level of ATP 
necessary for the contraction of the heart. The myocardial damage is therefore 
proportional to the length of the period of energy starvation.  
 
  
1.5 Cardiovascular Imaging Techniques 
 
1.5.1 Ultrasound 
Ultrasound systems exploit acoustic energy characterised by a frequency 
between 1MHz and 20 MHz in order to form two-dimensional images of the 
plane scanned. Ultrasound can be used to obtain information on the anatomy 
and perfusion of the heart. Anatomical information is usually displayed on 




of the structure detected to the source of ultrasound waves. Colour images 
(RGB, red-green-blue) are instead used to display the perfusion of the organ 
studied. Typically, positive (red) and negative (blue) values represent areas in 
which the detected structure is moving towards or away from the source of 
ultrasound waves, respectively. These two types of ultrasound images are 
called B-mode (brightness modulated) and colour Doppler images, respectively 
(Liang and Blomley 2003).  
Ultrasound has been used by cardiologists for more than 50 years as a first 
screening test for the detection of many cardiac diseases mainly due to the fact 
that it is portable and relatively cheap (Wells 2001). It is able to acquire cardiac 
information in real time with a very high temporal resolution, typically in the 
order of milliseconds. The depth of penetration of the ultrasound waves as well 
as the contrast between different anatomical structures is however often limited 
due to the energy attenuation by the body tissue.  
In order to improve contrast, in  the last ten years many studies have been 
aimed at the development of ultrasound contrast agents (e.g. microbubbles) 
usually injected intravenously and targeted to specific biological structures of 
interest (Blomley et al. 2001).To date, the use of this technique is still limited to 
research studies but the possibility of using this approach in clinical routine for 
improving tissue contrast in ultrasounds images represent a concrete possibility 






1.5.2 Nuclear Imaging Techniques  
SPECT and PET are able to image the distribution of a probe molecule labelled 
with γ-emitting or positron-emitting isotopes, respectively, in a region of interest 
(ROI) or in the whole body. A radioactive nuclide is characterised by an 
unstable nucleus that undergoes radioactive decay during which it emits γ-rays 
or subatomic particles such as protons. 
In order to form SPECT images the γ-rays emitted during the radioactive decay 
of γ-emitting isotopes attached to specific biological molecules are detected 
using a rotating gamma camera. All emitted γ-rays are counted and therefore to 
evaluate the location of the radioactive decay a parallel-hole collimator fitted to 
the γ-camera is needed.  
The radioisotopes used in PET imaging emit a positron during their radioactive 
decay. After travelling a few millimetres the emitted positron combines with a 
free electron forming a positronium. This system is unstable and the two 
particles annihilate each other to produce two gamma-ray photons which travel 
in nearly opposite direction with energy of 511 KeV each. The location of the 
photon emission in PET does not need a collimator but is performed 
electronically using pairs of collinearly aligned detectors arranged to form a ring 
and only simultaneous events are used for image reconstruction. In both 
imaging modalities angular information is used to form 2D images from which 
3D views of the ROI can be reconstructed. 
The most used γ-radionuclides in SPECT cardiac imaging are technetium 




(18F, half-life = 109.7min), carbon (11C, half-life=20.3min), nitrogen (13N, half-life 
= 9.9min) and oxygen (15O, half-life = 122.2s) are commonly exploited in PET.  
The radioisotopes used in SPECT are characterised by half-lives in general 
much longer than those of positron-emitting isotopes. This means that SPECT 
imaging does not required a cyclotron close to the scanner and that a biological 
process can be observed over many hours after the administration of the tracer 
while the time window in which it is possible to detect signal from PET 
radionuclides requires the installation of a cyclotron in the same hospital or in a 
nearby institute strongly limiting the applicability of this imaging modality.   
SPECT tracers such as 99mTc -sestamibi, 99mTc-tetrofosmin are mainly used for 
the assessment of myocardial perfusion providing both diagnostic and 
prognostic information (Plesniak 2011). PET tracers such as 18F-
fluorodeoxyglucose (FDG), an analogue of glucose, and 13N-ammonia (13NH3) 
are commonly used to assess myocardial glucose metabolism or perfusion, 
respectively.  
Due to the importance of an early detection of CAD, in the last ten-fifteen years 
many research studies have been aimed at the development of novel imaging 
agents able to identify and characterise hypoxic myocardium. Two different 
classes of molecules have been proposed: the nitroimidazoles (e.g. [18F]-
FMISO) and the copper bis (thiosemicarbazone) complexes (e.g. 64Cu-ATSM). 
These imaging agents are characterised by the common feature of being 
cleared rapidly from blood and non-target tissues and retained in hypoxic 




Previous studies have also shown that using 11C-labelled probes it is possible to 
measure a number of different metabolic pathways in the heart (Paans et al. 
1985).  
SPECT is characterised by a better spatial resolution (0.5mm – 2.0mm) than 
PET (1.0mm – 2.0mm) however due to the low geometric efficiencies (defined 
as the percentage of detected to emitted photon) of the collimator, PET is 
superior to SPECT with respect to sensitivity (two to three orders of magnitude). 
Additionally, due to the presence of a rotating γ-camera SPECT is characterised 
by a lower temporal resolution than PET (Rahmim and Zaidi 2008;  Dobrucki 
and Sinusas 2010).  
 
 
1.5.3 Magnetic Resonance Imaging and Spectroscopy  
MR is an imaging modality based on the detection of the signal of nuclei 
possessing a non-zero spin, after the application of a radiofrequency (RF) pulse 
in presence of an external magnetic field. The basic physical principles of MR 
are presented in Chapter 2 in details. 
In clinical practice MR imaging (MRI) is most often used to image the 
distribution of 1H nuclei contained in water and fat which form approximately 
60% of the human body weight. This imaging modality can provide a wide 
variety of anatomical and functional information. Cardiac CINE imaging, for 
example, is commonly used to derive functional information by assessing the 
motion of the heart in real time and detecting changes in the anatomical 




it is possible to quantitatively estimate the volume of the cardiac chambers, 
myocardial mass as well as ejection fraction which have a prognostic value for 
many cardiac diseases (Pennell et al. 2011). MRI contrast agents (e.g. 
gadolinium) are used to enhance the contrast between the different biological 
structures in the body. In late contrast enhancement (LCE) MRI the signal from 
1H is detected approximately 15min after an intravenous injection of a 
gadolinium solution (0.1mmol/kg body mass). The contrast agent is completely 
washed out from well perfused areas of the myocardium while it is retained in 
the interstitial space in fibrotic regions. Gadolinium makes the characteristic 
relaxation time of 1H nuclei shorter and therefore it allows the localisation of 
scar tissue. In order to obtain a map of myocardial perfusion dynamic contrast 
enhancement (DCE) MR is used. In this case the 1H MR signal is acquired soon 
after the injection of the gadolinium dose and complete or partial occlusions of 
the coronary artery tree can be detected.  
CINE, LCE and DCE MRI give complementary information and they are for 
example used to establish the stage of the infracted heart in patients. A reduced 
perfusion (DCE), the formation of scar tissue (LCE) and a reduction in the 
injection fraction (CINE) are the pathological signs that appear with the 
progression of heart failure. Before the formation of fibrous tissue, a reduction of 
blood and nutrients supply due, for example, to the formation of atherosclerotic 
plaques in one or more coronary arteries causes pathophysiological alteration in 
the cardiac metabolism. Information on molecular processes at the cellular and 
subcellular level can be obtained by using MR spectroscopy (MRS). The 




metabolism where Cr is phosphorylated to PCr by CK (Neubauer 2007). As 
explained in Section 1.4 many other metabolite pools participate in giving the 
heart the amount of energy it needs. Fatty acid and glucose metabolism, for 
example, play a very important rule in supplying energy to the heart. Many 
molecules involved in these metabolic pathways contain 12C nuclei and it could 
therefore be possible to enrich these molecules with 13C nuclei and detect 
cardiac metabolism in real time using MRS. From the practical point of view the 
real time assessment of cardiac metabolism using traditional 13C MR 
spectroscopic is prohibited by the low natural abundance, sensitivity and 
concentration of 13C nuclei. 
 
 
1.5.4 Hyperpolarised Magnetic Resonance 
As explained in more details in Chapter 2, for nuclei with spin I = ½ (e.g. 1H, 
13C, 15N) the MR signal is proportional to the difference in population between 
the two energy levels corresponding to the two configurations (parallel and 
antiparallel) that these nuclear spins can assume in the presence of an external 
magnetic field B0. At room temperature, the difference in population between 
the two energy states is very small and a MR signal can be detected only if the 
concentration of the nucleus assessed is high. This is the case for 1H contained 
in water but not of 13C nuclei.  
In order to increase the detectable MR signal of low natural abundance and 
concentration nuclei, such as 13C, a number of different approaches able to 




that the spins can occupy in the presence of an external magnetic field have 
been proposed. Spin exchange optical pumping, para-hydrogen induced 
polarisation (PHIP) and dynamic nuclear polarisation (DNP) are able to 
enhance the characteristic polarisation of a specific nucleus by transferring the 
polarisation from the high polarised electrons or parahydrogen to the nucleus of 
interest. Spin exchange optical pumping has been used for enhancing the 
signal from noble gases such as 3He and 129Xe for the real time assessment of 
lung ventilation and perfusion (Fain et al. 2007). PHIP and DNP have both been 
used to enhance the MRS signal of nuclei such as 15N and 13C within 
metabolically relevant molecules by the order of tens of thousands (Ardenkjaer-
Larsen et al. 2003) to facilitate the measurement of the kinetics of cardiac 
metabolic processes in healthy or diseased tissue previously inaccessible to 
MR.  
Previous studies have shown that using hyperpolarised [1-13C1] pyruvate allows 
measurement of the activity of PDH ex vivo in the perfused rat heart (Merritt et 
al. 2007;  Merritt et al. 2008) and in vivo under pathophysiological conditions 
such as diabetes and hypertrophy (Schroeder et al. 2008;  Atherton et al. 2011). 
The TCA cycle has been assessed using hyperpolarised [2-13C1] pyruvate and a 
decrease of its intermediates, such as 13C citrate and 13C glutamate, has been 
detected in response to myocardial ischemia (Schroeder et al. 2010). PDH 
activity and TCA cycle have been also assessed simultaneously using 
hyperpolarised [1,2-13C2] pyruvate (Chen et al. 2012). Fatty acid metabolism 
has also been probed through the buffering of hyperpolarised [1-13C1] acetate 




al. 2009) or through the addition of water soluble fatty acids such as octanoate 
(Merritt et al. 2007).  
While information from non-selective MRS is sufficient for estimating metabolic 
changes and pathologies with global effects, spatially resolved spectroscopy is 
needed to study local effects in the heart. MR spectroscopic imaging (MRSI) 
potentially provides the capacity to study local effects in the heart, allowing the 
characterisation of heterogeneous metabolic changes and pathologies such as 
found in ischemic heart disease (Southworth et al. 2002;  Golman et al. 2008;  
Arai 2011). Experiments in both rodents and pigs have demonstrated that it is 
possible to image metabolic maps of the spatial distribution of H13CO3
-, [1-13C1] 
lactate and [1-13C1] alanine produced from the metabolic conversion of 
hyperpolarised [1-13C1] pyruvate via PDH, LDH and alanine transaminase 
(ALT), respectively (Rider and Tyler 2013). 
MRSI of hyperpolarised probes poses additional challenges compared to that of 
more traditional thermally polarised 1H MRSI. The rapidly decaying nature of 
hyperpolarisation to thermal equilibrium and the metabolic conversion by 
enzymatic reactions require fast spectroscopic imaging techniques. The 
hyperpolarised magnetisation needs to be traded between individual images 
and the number of dynamics in the imaging series. To preserve the 
magnetisation for all dynamics, a low number of signal excitations in 
combination with small flip angles are desired. At the same time sufficient SNR 
needs to be assured. A number of fast pulse sequences able to preserve the 








1.6 Analysis Methods for Dynamic Data 
The dynamic data acquired using SPECT, PET and hyperpolarised MR have 
the common feature of containing information of the interaction between a 
detected probe and the biological system of interest. Quantitative and semi-
quantitative parameters which describe biological phenomena can be derived 
using several analysis methods. A detailed description of the analysis methods 
exploited in this thesis is presented in Chapter 4. 
The most common approach to the quantitative analysis of dynamic data is 
compartmental modelling (Godfrey 1982). Using this method the interaction of 
the injected probes with the tissue of interest is described with a number of 
compartments that interconvert at characteristic rates. Compartmental 
modelling has been, used to describe the dynamics of the PET tracer [18F]-FDG 
in the human heart (Bertoldo et al. 1998), to quantify myocardial perfusion and 
capillary permeability after the injection of a bolus of gadolinium using DCE-MRI 
(Sourbron and Buckley 2012) as well as to characterise cardiac metabolism 
using hyperpolarised 13C MR (Menichetti et al. 2012). Compartmental modelling 
requires a priori knowledge of the number of compartments involved in probe 
uptake and redistribution, and for this reason it is inadequate when new 
radiotracers or metabolic pathways are studied. In PET, linear and nonlinear 




al. 1994;  Bertoldo et al. 1998) are commonly used to derive the kinetic 
components which describe the dynamic data with only few a priori assumption 
on the type of interaction between the tracer and the biological system studied. 
Quantitative information is also derived from dynamic PET data using graphical 
methods (Sokoloff et al. 1977;  Logan et al. 1990). This approach is easy to 
implement and does not require any a priori assumption on the number of 
compartments involved in the tracer uptake and redistribution. Only the nature 
of the tracer retention (reversible or irreversible) has to be known. Using 
graphical methods however it is not possible to fully describe the tracer kinetics 
as only one macroparameter (e.g. the tracer net trapping uptake for Patlak and 
the tracer distribution volume for Logan) is estimated. An alternative approach is 
represented by semi-quantitative analysis methods. In PET the Standard 
Uptake Value (SUV) and the tissue-to-plasma ratio (RATIO) are commonly 
used to characterise the tracer uptake (Kubota et al. 1985;  Lehtio et al. 2003;  
Mitkovski et al. 2005). The most used semi-quantitative index in MR is the area 
under the signal intensity vs. time curve (AUC). In DCE-MRI the AUC is 
commonly exploited as a semi-quantitative measurement of myocardial 
perfusion (Jerosch-Herold 2010) whereas the ratio of AUC of the injected 
hyperpolarised probe (e.g. [1-13C1] pyruvate) and product metabolite (e.g. [1-
13C1] lactate) has been shown to be proportional to the rate of the enzymatic 






1.7 Objectives of the Research 
The research presented in this thesis aimed to develop new approaches for the 
assessment of cardiac metabolism using molecular imaging techniques 
combined with quantitative and semi-quantitative analysis methods. An 
experimental protocol for the polarisation of metabolically active 13C probes was 
developed using DNP. To this end, different 13C molecules have been 
hyperpolarised and the polarisation enhancement as well as the longitudinal 
time constant of these molecules was measured in solution. An MR acquisition 
protocol was developed for the real-time assessment of the conversion of 
hyperpolarised [1-13C1] pyruvate to its downstream metabolites in vitro in whole 
blood cells and ex vivo in Langendorff perfused rat hearts. Global information 
on the metabolic state of isolated hearts was obtained using 13C MRS whereas 
the spatial distributions of these 13C metabolite signals was measured using 13C 
MRSI. A number of analysis methods were developed in order to derive 
quantitative and semi-quantitative parameters representing the metabolic state 
of the heart. They were applied to hyperpolarised 13C MR dynamic data to 
quantify the rates of metabolic conversion of hyperpolarised [1-13C1] pyruvate to 
its downstream metabolites in vitro in whole blood cells and ex vivo in 
Langendorff perfused hearts. Analysis methods were also used to derive kinetic 
information from time-activity curves of two PET tracers, [18F]-FDG and [18F]-
FMISO, acquired from Langendorff perfused rat hearts in physiological and 






1.8 Structure of the Thesis 
 
The Chapters of this thesis are organised as follow: 
 
Chapter 1 introduces the Langendorff perfusion and the main metabolic 
pathways through which the energy required for the contraction of the heart is 
produced both in physiological and pathophysiological conditions. This chapter 
also presents an overview on the most used imaging modalities for the 
characterisation of the anatomy, physiology and metabolism of the heart as well 
as the approaches commonly exploited for the quantitative and semi-
quantitative analysis of dynamic cardiac data.  
 
Chapter 2 presents the physical principles of MRI and MRS as well as of 
hyperpolarised MR. 
 
Chapter 3 describes the experimental protocols developed and validated in this 
thesis. A number of metabolically active 13C molecules were hyperpolarised 
using DNP and their relaxivity properties as well polarisation enhancement were 
measured in solution. An experimental protocol was developed for detecting the 
conversion of [1-13C1] pyruvate to its downstream metabolites in vitro in whole 
blood cells as well as ex vivo in Langendorff perfused rat hearts.  Isolated 
hearts were also used to characterise the kinetics of two PET tracers, namely 





Chapter 4 introduces the quantitative and semi-quantitative approaches used in 
this thesis for the analysis of cardiac dynamic data acquired using 
hyperpolarised 13C MR probes and PET tracers. 
 
Chapter 5 presents the dynamic data acquired in vitro in whole blood cells and 
ex vivo in Langendorff perfused rat hearts using hyperpolarised 13C MRS and 
the results obtained from their quantitative and semi-quantitative analysis. 
 
Chapter 6 presents the dynamic data acquired ex vivo in Langendorff perfused 
rat hearts using two PET tracers, namely [18F]-FDG and [18F]-FMISO, and the 
results obtained from their quantitative and semi-quantitative analysis. 
 
Chapter 7 presents the dynamic data acquired ex vivo in Langendorff perfused 
rat hearts using hyperpolarised 13C MRSI. Monte Carlo simulations aimed at 
exploring the detection limits of cardiac ischemia using dynamic MRSI of 
hyperpolarised 13C pyruvate combined with compartmental modelling in vivo in 
small rodents are also presented. 
 
Chapter 8 summarises the main findings of this thesis, its final conclusions and 









Chapter 2 : Magnetic Resonance  
MR is a physical phenomenon according to which in presence of an external 
magnetic field (B0) atomic nuclei are able to absorb and re-emit the 
electromagnetic (EM) energy following the application of a radiofrequency (RF) 
pulse. This property of nuclei with non-zero spin was first observed in molecular 
beams in 1938 by Isidor Isaac Rabi who received the Nobel Prize in Physics in 
1944 “for his resonance method for recording the magnetic resonance of atomic 
nuclei” (Rabi et al. 1938). In 1946 Felix Bloch and Edward Mills Purcell 
independently extended the work of Rabi to liquid and solid, respectively. They 
were jointly awarded the Nobel Prize in Physics in 1952 “for their development 
of new ways and methods for nuclear magnetic precision measurements” 
(Bloch 1946;  Purcell et al. 1946). The possibility of using the MR principle to 
form images using magnetic field gradients was proposed by Peter Mansfield 
and Paul Lauterbur (Lauterbur 2003;  Mansfield 2003) who were jointly awarded 
the Nobel Prize in Physiology or Medicine in 2003 “for their discoveries 
concerning magnetic resonance imaging”.  
For around 20 years since its discovery the phenomena of MR was exclusively 
developed and used for physical and molecular analysis, largely in chemistry. 




was provided in 1971 by Raymond Vahan Damadian who demonstrated that 
the characteristic time with which atomic nuclei re-emit the EM energy absorbed 
after the application of a RF pulse in a malignant lesion differs from that of 
nuclei in healthy tissues (Damadian 1971). He showed for the first time the 
possibility of discerning tumours from healthy tissues based on their MR 
properties. After this extraordinary discovery numerous studies were focused at 
the development of new technologies able to produce an image exploiting the 
MR phenomenon. The first MR image was obtained from a tube filled with water 
in 1973 and only in 1977 the first full human body image was acquired 
(Damadian et al. 1977).  
Compared to other imaging modalities, MR offers high soft-tissue contrast with 
the capability of investigating both anatomic and functional parameters and has 
the advantage to not requiring ionising radiation. 




This Chapter presents the basic physical principles behind MR imaging and 
spectroscopy as well as hyperpolarised MR. 
MR is based on the detection of an EM sinusoidal signal generated by a nuclear 
spin-system placed in an external magnetic field after its perturbation. This 
physical phenomenon is macroscopically described by the Bloch equations 
presented in Section 2.2. After its perturbation, the system of nuclear spins 




relaxation introduced in Section 2.3. The methods used in this thesis to 
measure the relaxation processes are presented in Section 2.4. In Section 2.5 
the basic principles used in MRI to produce images of the ROI are introduced. 
The intensity of the MR signal detected depends on the concentration, natural 
isotope abundance and electromagnetic properties of the nucleus assessed. 
For nuclei characterised by high natural abundance and high concentration in 
the biological tissues such as 1H in H2O, the intensity of the MR signal 
generated is adequate to detect and image real-time changes in the biological 
system assessed. However, for atomic nuclei characterised by low natural 
abundance and concentration such as 13C new technologies have been 
developed to artificially enhanced their detectable MR signal. A brief 
introduction of the DNP technique used in this thesis to enhance the 
polarisation of 13C nuclei within metabolically active molecules is presented in 
Section 2.7.  
 
 
2.2 Basic Principles of Magnetic Resonance 
Some atomic nuclei possess an intrinsic physical property called spin. The spin 
angular momentum is a vector that is related to the spin quantum number     of a 
nucleus as follows: 
 





where   is the reduced Planck constant. The amplitude L and direction m of the 
spin angular momentum     are given by Equations 2.3 and 2.4, respectively. 
 
            2.2 
 
 
                   2.3 
 
In absence of an external magnetic field 2I+1 energy levels are degenerate  
The characteristic magnetic moment generated by the rotation of the nuclear 
spin angular momentum vector is given by: 
 
             2.4 
 
where γ is the gyromagnetic ratio, a proportionality constant intrinsic of each 
nucleus. The net magnetisation is given by the sum of the magnetic moments of 
the nuclei that form the sample (Equation 2.5). 
 
           2.5 
 
In absence of an external magnetic field, the magnetic moments are randomly 






2.2.1 Zeeman Effect 
When an external magnetic field (B0) is applied, the magnetic moments of the 
nuclei within the sample align parallel or antiparallel to B0 generating a non-zero 
net magnetisation (Figure 2.1 A). In this condition the degenerate spin-states 
are split into 2I+1 levels characterised by different energies. For example, for an 
atomic nucleus with spin ½ two different energy levels are generated (Figure 
2.1 B). This phenomenon is called Zeeman Effect. 
 
 
Figure 2.1: (A) The magnetic moments of atomic nuclei with spin 1/2 align parallel or 
antiparallel to the external magnetic field applied (B0). The magnetic moments are not 
perfectly aligned with B0 but they precess about the external magnetic field B0. (B) 
Possible energy levels for a nucleus with spin 1/2.  
 
 
The energy associated with each level depends on the magnetic moment     and 
external magnetic field B0 as presented in Equation 2.6. 
 





The spins with the magnetic moments aligned parallel to B0 occupy the lowest 
energy level (m = +1/2) also named α, whereas spins with magnetic moment 
aligned antiparallel to B0 are located in the higher energy level (m = -1/2) also 
named β (Figure 2.1 B). The number of nuclei in each spin-state is given by the 






    
2.7 
 
where Nα and Nβ represent the population of nuclei in the α and β energy level, 
respectively. ΔE is the difference in energy between α and β, T is the 
temperature of the system and kB is the Boltzmann constant.  
The magnetic moments of the atomic nuclei do not orient exactly parallel (or 
anti-parallel) with the direction of the applied field B0 but precess around this 
field at a characteristic angular velocity ω0 named Larmor frequency (Equation 
2.8) (Figure 2.1 A). 
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2.2.2 Bloch Equations 
In MR the external magnetic field B0 is conventionally directed along the z-axis 
and therefore after the insertion of the sample into the field, the net magnetic 
moment of the nuclei will be aligned along +z or –z direction. In order to 




pulse at the Larmor frequency of the type of nuclei studied. The RF pulse 
generates an electric current in the transmit coil that produces a magnetic field 
B1 perpendicular to B0 that tilts the net magnetisation vector from the z-axis to 
the x-y plane. The flip angle θ is proportional to B1, γ and to the length of the RF 
pulse (tp) as follow: 
         2.9 
 
When the RF pulse is switched off, the magnetization along the z-axis (Mz) 
recovers its initial value (M0) according to a time constant T1 (longitudinal 
relaxation time), whereas the magnetization in the x-y plane (Mxy) precesses 
about the z-axis with characteristic frequency equal to ω0 and decays to zero 
with a time constant T2 (transversal relaxation time). Relaxation processes will 
be described in more details in Section 2.3. 
The motion of the net magnetisation M in these conditions is macroscopically 
described by the Bloch equations which can be written in the “laboratory frame” 
as follows: 
 
    
  
                          





    
  
                          





    
  
                          









In the “laboratory frame” the magnetisation in the x-y plane rotates at the 
Larmor frequency about the z-axis. In many applications it is more convenient to 
deal with a stationary Mxy and this can be obtained by using a “rotating frame” in 
which the x-y plane rotates about the z-axis at the frequency -ω0. Equations 
2.10-2.12 can be written in the “rotating frame” by considering each Bz = B0 =- 
ω0/γ (derived from Equation 2.8). The Bloch equations in the “rotating frame” 
are: 
 
    
  
                  
     





    
  
         
             





    
  
          
            
      






where     
  indicates the magnetic field in the “rotating frame”. The longitudinal 
component of the magnetisation is Mz, whereas the transverse component is 
equal to: 
            2.16 
 
 
2.2.3  Magnetic Resonance Spectrum  
The magnetisation on the x-y axis precesses about the z-axis and decays to 




coil that oscillates at the Larmor frequency ω0 called free induction decay (FID) 
(Figure 2.2).  
This decaying oscillating signal is described mathematically as: 
 
 









The time constant T2* depends on the relaxation rate of the tissue T2 and the 
magnetic field inhomogeneity of B0.  
The Fourier transform of the FID gives the frequency domain signal or spectrum 
which is composed by a real and an imaginary part representing the absorption 





Figure 2.2: (A) Precession of the transverse component of the magnetisation Mxy about 
the z-axis after the application of a RF pulse. This precession generates an electric 
current in the receiver coil producing a complex MR signal named free induction decay 





Figure 2.3: Representative FID and MR spectrum obtained by Fourier transforming the 
FID. The real and the imaginary part of the MR spectrum represent the absorption and 
dispersion of the nuclear spin-system at the characteristic frequency ω0, respectively. 
Adapted from reference (www.keeler.ch.cam.ac.uk/) 
 
 
2.2.4 Chemical Shift 
The electrons surrounding a nucleus also possess angular momentum and 
generate a magnetic field Be opposed to B0. The local magnetic field 
experienced by the atomic nuclei is given by: 
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The nuclei therefore precess about the z-axis at characterised by a Larmor 
frequency equal to: 
 




This shift in the Larmor frequency of the nuclei depends on the type of nucleus 
and on the electrons motion in the nearby atoms within a molecule and is 
named chemical shift. The chemical shift is usually expressed in parts per 
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where ωN and ωR are the resonance frequencies of the nucleus observed and 
that of a reference, respectively. νS represents the operating frequency of the 
spectrometer.  
For nuclei such as 1H and 13C trimethylsilyl propionate (TSP) is commonly used 
as standard reference, whereas 85% phosphoric acid is preferred for 31P. 
Even if the Larmor frequency of a nucleus depends on the strength of the 
magnetic field in which the nucleus is placed, the chemical shift in ppm is 




Relaxation consists of a series of processes that operates simultaneously by 
which the system of nuclear spins returns to its equilibrium after being perturbed 






2.3.1  Spin-Lattice Relaxation 
The spin-lattice relaxation is the mechanism by which the component of the 
magnetisation along the z-axis (Mz) returns to its thermal equilibrium value (M0). 
In this process nuclear spins dissipate the energy acquired after the application 
of a RF pulse by transferring energy to the neighbouring molecules (lattice). The 
spin-lattice relaxation can be described by the simplified Bloch equation 
(Equation 2.21).  
 
    
  
 





The recovery of the magnetisation along the z-axis after the application of a RF 
pulse is therefore described by a mono-exponential function with the 
characteristic time constant T1 (Equation 2.22).  
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The spin-lattice (or longitudinal) relaxation time constant T1 represents the 
length of time required for the perturbed system to return 63% of the way 
toward thermal equilibrium. It depends on the gyromagnetic ratio of the nucleus 






2.3.2  Spin-Spin Relaxation 
The spin-spin relaxation is the mechanism by which the component of the 
magnetisation in the x-y plane returns to its equilibrium value of zero after a 
perturbation. In this type of relaxation the energy the nuclear spins acquired 
after the application of an RF pulse is not exchanged with the lattice but 
between neighbouring spins. The spin-spin relaxation can be described by the 
simply Bloch equation for the transverse magnetisation as follow: 
 
     
  
  





The relaxation of the transverse component of the magnetisation is therefore 
described by a mono-exponential decay with the characteristic time constant T2 
(Equation 2.24).  
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where Mxy(0) is the value of the transverse magnetisation at the time point in 
which the spin-spin relaxation starts that corresponds to the time point in which 
the RF pulse is switched off. 
As mentioned in Section 2.2.3 the linewidth of the real part of the MR spectrum 
is given by the transverse relaxation time constant T2 and the magnetic field 
inhomogeneity. The latter makes T2 shorter and T2




effective transverse relaxation time that is related to the linewidth of the MR 
spectrum as follows: 
 
 
      
 








2.3.3  Dipole-Dipole Interaction 
The relaxation processes described in Sections 2.3.1 and 2.3.2 occur mainly by 
interaction of the nuclear spins with the magnetic fields produced by the 
molecular motion of the neighbouring nuclei (spin-spin relaxation) or of nuclei 
located in the lattice (spin-lattice relaxation). The relationship between the 
relaxation time constants and the molecular motion is presented in Equations 




        
  






            
  




      is the mean-square average of the local magnetic fields and is a measure of 




magnetic fields.    is the correlation time which is a quantitative measure of the 
rate of a molecular motion or rotation. As shown in Figure 2.4 both relaxation 
rates are related to the operating frequency of the spectrometer νs and therefore 
the T1 and T2 of a sample depend on the strength of the external magnetic field 
B0. 
The magnetic field created by an unpaired electron is much larger than that of a 
nucleus. An unpaired electron is half a million times more effective in promoting 
relaxation than a proton at the same distance from a relaxing nucleus. This is 
the essential basis for development of paramagnetic contrast agents such as 




Figure 2.4: The relaxation rates 1/T1 and 1/T2 are plotted as function of the correlation 






2.4  Measurement of Relaxation Time Constants 
In this Section the methodologies used in this thesis for the measurement of the 
T1 of 
13C nuclei are presented. The T2 estimation was not addressed in this 
thesis. 
The T1 of samples at thermal equilibrium were measured using an inversion 
recovery method, whereas the T1 of hyperpolarised samples were measured by 
fitting the experimental curves obtained by plotting the area under the 13C 
hyperpolarised MR spectrum (real part) (Figure 2.3 B) as function of time with 
Equation 2.28. 
 




   
2.28 
 
θ is the small flip angle used for the acquisition of the hyperpolarised spectra 
and n is the number of RF pulses applied 
 
 
2.4.1 Inversion Recovery Method 
Inversion recovery is a method commonly used in MR for measuring the spin-
lattice relaxation time constant T1 of different types of nuclei. The sequence 
used in this type of experiment is presented in Figure 2.5.  
A 180º RF pulse is applied at the Larmor frequency characteristic of the type of 
nuclei of which the T1 is to be measured. Before the application of the RF pulse 
the magnetisation is aligned with the external magnetic field B0 along +z-axis 




Following the application of the RF pulse the longitudinal and the transverse 
magnetisation are: 
 
               2.29 
               2.30 
 
where θinv is the flip angle chosen for the RF pulse. 
 
 
Figure 2.5: Inversion recovery pulse sequence. A 180º RF pulse is applied to invert the 
net magnetisation from z to –z axis. After a time τ < T1 a 90º RF pulse is applied and the 
FID produced by the magnetisation in the x-y plane recorded. The transverse component 
of the net magnetisation is measured at different time point during its relaxation by 
repeating for a certain number of times the inversion recovery sequence. The time delay 
τ between the application of the two RF pulses is increased each time. 
 
 
At this point the longitudinal magnetisation Mz starts to relax back towards its 




2.21. Using Equation 2.29 as initial condition the time-dependent longitudinal 
magnetisation is equal to: 
 
 
                        
 
 
   
2.31 
 
After a short amount of time (τ < T1) a 90
º RF pulse is applied. The net 
magnetisation is tilted on the x-y plane, a FID is generated and the value of the 
area under the MR spectrum measured (Figure 2.6).  
 
 





 pulses. The MR signal corresponding to the real part of the Fourier transform of 






This sequence of RF pulses is repeated after a period of time long enough to 
allow the magnetisation along the z-axis to fully recover its thermal equilibrium 
value M0. At each repetition the delay time τ is increased (τ1 < τ2 < ... < τn) and the 
values of Mz is measured at different relaxation time points (Figure 2.7).  
By fitting the experimental data representing the area under the MR spectrum 
acquired at different point of the spin-lattice relaxation plotted as function of τ 
using Equation 2.31 (with t = τ and θinv = 180º) it is possible to derive the 
characteristic T1 of the nucleus assessed. Due to the dipole-dipole interaction 
the same nucleus is characterised by different T1 depending on the surrounding 
chemical environment. 
When the T1 of 





Figure 2.7: Representative inversion recovery measurement. The longitudinal 
magnetisation is sampled at different time points and the experimental data are fitted 






2.5 Basic principles of Magnetic Resonance Imaging 
As introduced in Section 2.2, after the application of a RF pulse the transverse 
component of the net magnetisation creates a current in the receiver coil that 
oscillates at the Larmor frequency ω0 that represent the MR signal named FID. 
In order to form an image the system must locate the signal spatially in three 
dimensions. In MRI the localisation of the region in the body from which the 
signal was emitted is performed using linear magnetic gradients. Commonly the 
signal is first located within a slice (slice selection) and subsequently along both 
axes of the selected slice (phase and frequency encoding).  
In the MR scan the external magnetic field B0 is always present, whereas the 
magnetic field gradients are switched on and off during the image acquisition. 
The application of a linear magnetic field gradient modifies the magnitude B0. In 
particular, the local magnetic field experienced by the nuclear spins will be 
bigger or smaller than B0 depending on their location. Spins located in regions 
in which the local magnetic field is smaller than B0 precess at a frequency 
slower than the Larmor frequency, whereas those nuclei located in regions in 
which the local magnetic field is bigger than B0 precess at a frequency faster 
than ω0 (Figure 2.8). The spins precessing at different frequency produces FIDs 
which are characterised by different frequencies and therefore the application of 
linear magnetic gradients can be used to localise the region from which the 









Figure 2.8: (A) In presence of a constant magnetic field B0 all nuclear spins in the ROI 
process at the Larmor frequency. (B) The application of a linear magnetic gradient 
modifies the magnitude of B0. Spins located in regions in which the local magnetic field 
is smaller than B0 precess at a frequency slower than the Larmor frequency, whereas 
those nuclei located in regions in which the local magnetic field is bigger than B0 
precess at a frequency faster than ω0. In this example the magnetic gradient is applied 
along the x-axis but magnetic gradients can be applied in any direction or orientation. 
Adapted from reference (McRobbie D. W. 2006). 
 
 
2.5.1 Slice Selection  
In order to localise the MR signal within a slice the appropriate gradient coil is 
switched on. As seen in the previous section, the presence of gradient field will 
induce the nuclear spin to process at different frequencies depending on their 




the nuclei that precess at the frequencies within the bandwidth of the RF pulse 
are excited and produce a detectable MR signal. The range of frequencies 
contained in the RF pulse is called bandwidth. The selected slice is always 
perpendicular to the direction of the magnetic gradients applied. 
In Figure 2.9 the gradient for the slice selection is applied along the z-axis and 
therefore an axial slice is selected. The position of the selected slice can be 
change, for example, by changing the central frequency (carrier frequency) of 
the RF pulse and maintaining the same magnetic gradients. The thickness of 
the slice can be adjusted by changing the RF bandwidth or changing the slope 
of the magnetic gradient applied.         
Once an image slice is selected the MR signals coming from it must be spatially 
located (encoded) along both axes of the image. This is performed using phase 







Figure 2.9: In the slice selection precess a linear magnetic gradient is used in order to 
change the precession frequency of the nuclear spins depending on their position. A RF 
pulse is applied at the same time and only the nuclei characterised by the range of 
frequencies contained in the RF pulse (bandwidth) are excited and therefore produce a 
detectable MR signal. Adapted from reference (McRobbie D. W. 2006). 
 
 
2.5.2 Phase Encoding 
Phase encoding is usually performed by applying a linear magnetic gradient 
along the short axis of the anatomy. The presence of a gradient modifies the 
frequency of precession as well as the accumulated phase of the nuclear spins 




the magnetic field strength returns to B0 and the precessional frequency of all 
the nuclei returns to the Larmor frequency. However the phase difference 
between nuclei remains. This difference in phase between the nuclei is used to 
determine their position along the axis of the phase encoding gradient.   
 
 
2.5.3 Frequency Encoding 
Frequency encoding is usually performed by applying a linear magnetic gradient 
along the long axis of the anatomy. The precessional frequency of signal along 
the axis is therefore altered in a linear fashion and the signal can be located 
along the axis of the gradient according to its frequency. The frequency 




In order to form a MR images the slice selection, phase and frequency encoding 
have to be repeated a number of times. The time between one acquisition and 
another is called repetition time (TR). During this acquisition process the MR 
signals acquired are digitalised and stored in temporary image space named k-
space (Figure 2.10). In order to fill out different lines of the k-space, the slope of 
the phase encoding gradient must be altered after each TR. Once filled the k-
space, the data stored in it are converted into an image mathematically using 





Figure 2.10: Schematic representation of k-space. In order to fill every line the slope of 
the phase encoding gradient has to be changed after each TR. Once filled the k-space, 
the MR signals store in the k-space in their digitalised form are converted to an image 
using the Fourier transform. 
 
 
2.6  MR Sensitivity 
As mentioned in Section 2.2.1, for nuclei with spin ½ (e.g. 1H, 13C, 15N) the MR 
signal is proportional to the difference in population between the two energy 
levels in the presence of an external magnetic field    (Figure 2.11 A).  
 
 
Figure 2.11: Schematic representation of the (A) thermal equilibrium and (B) 






The detectable MR signal S is proportional to the spin-system polarisation 
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where T is temperature of the sample. At body temperature, the difference in 
population between the two spin-states is very low (e.g. P = 9.88*10-6 for 1H and 
P = 2.48 * 10-6 for 13C at 9.4T and 310K). It is therefore possible to detect a 
significant signal only if the nucleus of interest is characterised by a very high 
natural abundance and concentration. This is the case for hydrogen 1H in water 
(100% natural abundance and molar concentrations), but not for nuclei such as 
13C and 15N which have a millimolar (mM) endogenous concentration and 
natural abundance equal to 1.1% and 0.3% natural abundance, respectively.   
According to Equation 2.32, the polarisation of a spin-system can be enhanced 
by increasing the strength of the external magnetic field, decreasing the 
temperature or both. Since these two possibilities are physically limited, other 
non-equilibrium techniques able to artificially increase the difference in 
population of the two spin states, creating a so called “hyperpolarised” 
configuration, have been developed (Figure 2.11 B).  
As mention in Section 1.5.4 different methodologies such as spin exchange 
optical pumping, PHIP and DNP have been developed to enhance the 




principles of hyperpolarisation by DNP used in this thesis for increasing the 
detectable MR signal from 13C nuclei are presented. 
 
 
2.7  Basic Principles of Dynamic Nuclear Polarisation  
DNP is able to enhance the MR signal of a variety of nuclei such as 13C, 15N 
and 1H by greater than a factor 10,000 times (Ardenkjar-Larsen et al. 2003) 
such that metabolites previously invisible to MR can be quantified and imaged.  
At very low temperature free electrons are almost completely polarised while 
atoms such as 1H, 13C and 15N are characterised by a low polarisation (<10%) 
(Figure 2.12). The dominant mechanism of solid state DNP can be described by 
the solid effect through which the high polarisation of unpaired electrons is 
transferred to the nuclei of interest.   
In this thesis the only 13C was hyperpolarised, for this reason in this Section the 
basic principles of DNP are presented with particular reference to this nucleus.  
In DNP experiments a sample containing 13C  nuclei of which the polarisation is 
to be enhancing is doped with free electrons in the form of free radicals.  In 
presence of an external magnetic field the degenerate ground state of the two-
spin-system are spitted in four possible energy states due to the Zeeman Effect 













H atomic nuclei plotted as 
function of temperature at 9.4T calculated from the Equation 2.32. 
 
 
Figure 2.13: Solid effect in a two-spin-system, electron/
13
C (zero-quantum transition). (A) 
Schematic thermal equilibrium Boltzmann distribution for the electron-
13
C coupled spin-
system. ωe is the electron-spin resonance (ESR) frequency while ωC is the 
13
C Larmor 
frequency. (B) The application of a microwave pulse at ωe-ωC (zero-quantum transition) 
equalises the population between αeβC and βeαC energy states. Electron relaxation at the 
frequency ωe is showed by wavy lines. (C) Terminated the electron relaxation, the 





At thermal equilibrium, the difference in population between the two carbon 
transitions, α α  α β  and β α  β β   is very small, while the difference in 
population between the two electrons transitions α α  β α  and α β  
β β  is large at low temperature. The thermal equilibrium population can be 
artificially changed by applying a microwave field with frequency equal to 
ω  ω  (zero-quantum transition) or ω  ω  (double-quantum transition) 
(Figure 2.13 and Figure 2.14). 
The irradiation of the zero-quantum transition equalises the population between 
α β  and β α  energy states (Figure 2.13 B). This new distribution is unstable 
and both electrons and 13C nuclei relax back to their thermal equilibrium 
configuration. At the operating temperature of DNP (~ 1.4K) the relaxation rate 
of electrons is fast (103 s-1) whilst that of 13C is very slow (10-3 s
-1). As result of 
the electron relaxation from β α  to α α  , the difference in population between 
the energy states α α  and α β  is greatly enhanced generating a positive 
polarisation (Figure 2.13 C).  
The difference in polarisation of the two-spin-system can also be enhanced by 
applying a microwave pulse with frequency ω  ω  (double-quantum 
transition) (Figure 2.14 B). In this case the difference in population between 
α α  and α β  is enhanced and a negative polarization is generated (Figure 







Figure 2.14: Solid effect in a two-spin-system, electron/
13
C (double-quantum transition). 
(A) Schematic thermal equilibrium Boltzmann distribution for the electron-
13
C coupled 
spin-system. ωe is the electron-spin resonance (ESR) frequency while ωC is the 
13
C 
Larmor frequency. (B) The application of a microwave pulse at ωe+ωC (double-quantum 
transition) equalises the population between αeαC and βeβC energy states. Electron 
relaxation at the frequency ωe is showed by wavy lines. (C) Terminated the electron 
relaxation, the difference in population between αeαC and αeβC is greatly enhanced 
generating a negative polarisation. 
 
 
The hyperpolarised population distribution in the solid state is retained at low 
temperature through a continuous microwave irradiation of the sample. In this 
condition the spin-lattice relaxation constant T1 of 
13C nuclei is much slower of 
that of electrons and the hyperpolarised configuration is maintained. However in 
the absence the microwave field or during the sample dissolution (Section 3.2) 
the relaxation of 13C prevails and the system returns to its thermal equilibrium 









Chapter 3 : Experimental Methodology 
3.1 Aims 
The experimental aim of this thesis was to detect cardiac metabolism in the 
perfused rat heart using hyperpolarised 13C MR probes and PET tracers. The 
first step consisted in installing (autumn 2010) the HyperSense DNP polariser 
(Oxford Instruments®) in the pre-clinical laboratory of the Imaging Chemistry 
and Biology Department at St. Thomas’s hospital in London. The performance 
of HyperSense was validated by hyperpolarising several 13C molecules and 
measuring the polarisation enhancement achieved as well as the longitudinal 
relaxation time constants of the hyperpolarised molecules in the liquid state 
(Section 3.2). Further validation of the DNP methodology was performed in vitro 
mixing hyperpolarised 13C pyruvate with whole blood cells in order to determine 
whether the signal enhancement achieved was adequate to detect the 
conversion of pyruvate into its metabolites in a cell system in real-time (Section 
3.3). MR spectroscopic protocols for in vitro experiments were developed and 
optimised at the same time. Finally, a system for the Langendorff perfused rat 
heart was developed and validated in order to allow detecting cardiac 





3.2 Hyperpolarised 13C Magnetic Resonance 
 
3.2.1 HyperSense DNP Polariser 
To hyperpolarise 13C labelled molecules a HyperSense DNP polariser was used 
in this thesis. All experiments were carried out at St. Thomas’ Hospital in 
London where the polariser is placed next to a vertical wide bore Bruker 9.4T 




Figure 3.1: Experimental set up at St. Thomas’ Hospital in London. The HyperSense DNP 




The DNP polariser is composed by a DNP insert allocated in the centre of a 
3.35T superconductive magnet (Figure 3.2). The DNP insert includes a 
cryogenic chamber, also named Variable Temperature Insert (VTI), positioned 
in a liquid helium bath whose temperature is maintained below 4K by an 
external vacuum pump that modulates the temperature by controlling the 




Figure 3.2: Scheme of the HyperSense
 
DNP polariser.  Adapted from reference (Frydman 




During the polarisation of the sample the temperature inside the VTI is normally 
lowered and maintained at 1.4K. The VTI is connected to a microwave 
generator through a microwave guide tube that irradiates the sample at 94GHz. 
The sample is surrounded by a saddle coil tuned to the 13C frequency and able 
to measure the MR signal in the solid-state. Once the sample is fully polarised, 
a dissolution process is performed by an automatic pneumatic system that 
heats an aqueous buffered solution to at high temperature and pressure. The 
dissolved hyperpolarised solution is ejected from the machine, collected in a 
plastic tube and immediately placed into a 5mm MR tube for in vitro 




3.2.2 Sample Preparation 
The samples are normally prepared by dissolving a polarising agent into a 
solution containing the molecule to be polarised. Previous studies have shown 
that the polarisation of molecules that form a glass when frozen yields to a 
much higher DNP signal enhancement than that of molecules characterised by 
a frozen crystal structure (Barnes et al. 2008). For this reason, the latter are 
mixed with a co-solvent (DMSO or glycerol) before inserting the sample in the 
DNP polariser to enable the formation of a glass at low temperature.  






 [1-13C1] pyruvic acid 
 [2-13C1] pyruvic acid 
 [1,4-13C2] fumaric acid 
 




Figure 3.3: Scheme of the chemical structure of (A) pyruvic acid, (B) fumaric acid. The 
number in red indicates the carbon atoms that were labelled with 
13
C and hyperpolarised. 
 
 
Pyruvic acid is composed by three carbon atoms each of which can be labelled 
with 13C. Different metabolic pathways can be studied in real-time depending on 
the carbon atom labelled. [1-13C1] pyruvic acid, for example, has been used to 
investigate the metabolic conversion of pyruvate to lactate (via LDH), to alanine 
(via ALT) or to CO2 and bicarbonate (via PDH) (Merritt et al. 2007;  Schroeder 
et al. 2008). On the other hand [2-13C1] pyruvic acid has been previously 
exploited to assess the TCA cycle metabolism (Schroeder et al. 2009). Pyruvic 




simultaneous investigation of LDH, ALT, PDH activity and TCA cycle 
metabolism (Chen et al. 2012). The characteristic T1 of [3-
13C1] pyruvic acid is 
very short, due to the presence of the methyl protons, which makes this 
molecule isotope position not particularly attractive for ex vivo and in vivo 
experiments (Rider and Tyler 2013). In this thesis [1,2-13C2] pyruvic acid as well 
as [3-13C1] pyruvic acid were not hyperpolarised. 
Fumaric acid is a symmetric molecule formed by four carbon atoms each of 
which can be labelled with a 13C atom. In this thesis only [1,4-13C2] fumaric acid 
was hyperpolarised. The signal obtained by hyperpolarising [1,4-13C2] fumaric 
acid therefore arises from two 13C labels. Fumarase (FUM) converts [1,4-13C2] 
fumarate to [1,4-13C2] malate that is characterised by two non-equivalent 
carbons. [1,4-13C] fumaric acid has been used in previous studies as an imaging 
agent of tumour cell death  (Shan 2004). 
The standard samples of [1-13C1] pyruvate, [2-
13C1] pyruvate and [1,4-
13C2] 
fumarate used in all the experiments reported in this Section to validate the 
performance of the HyperSense polariser were prepared as described below. 
The same standard sample of [1-13C1] pyruvate was also used to assess the 
conversion of hyperpolarised pyruvate to its metabolites in vitro in whole blood 
cells (Section 3.3) and ex vivo in perfused rat hearts (Section 3.4). 
The hydrophilic trityl free-radical OX63 (MW = 1427g/mol) (Oxford 
Instruments®,UK) was used as a polarising agent for  the hyperpolarisation of 
[1-13C1] pyruvate, [2-
13C1] pyruvate and [1,4-
13C2] fumarate.  
Regardless of the carbon atom labelled with 13C, pyruvic acid (MW = 




was therefore polarised directly without the need of a co-solvent. The standard 
sample (14µl) used in this thesis contained 14M of [1-13C1] or [2-
13C1] pyruvic 
acid and 15mM free-radical. Where specified, a low concentration of gadolinium 
paramagnetic metal ions was added in the form of Dotarem (~1.5mM).  
Fumaric acid (MW = 118.06g/mol) is solid at room temperature and was 
therefore dissolved in a glassing mixture with addition of a co-solvent (DMSO 
and water) containing the free-radicals. The final concentration of the standard 
sample (80µl) to polarise was approximately 2.5M [1,4-13C2] fumaric acid, 15mM 
free-radical and 1.5mM gadolinium.  
 
 
3.2.3 Solid-State MR Spectrum 
The sample was placed in a small plastic cup and inserted into the cryogenic 
chamber of the VTI using a stainless steel stick. In this position the sample cup 
is surrounded by a saddle coil tuned at the 13C frequency (35MHz) that enables 
the measurement of the MR signal in the solid-state. This measurement is used 
mainly for calibrating the optimal microwave frequency for the sample irradiation 
and for monitoring the build-up of the polarisation. In Figure 3.4 a representative 
solid-state 13C MR spectrum is shown for the pyruvic acid (labelled in C1 or C2 






3.2.4 Microwave Sweep 
In order to maximise the polarisation transfer from the free electrons to the 13C 
atoms, it is necessary to induce either zero-quantum or double-quantum 
transition of the couple electron-nuclear system by applying a microwave pulse, 
as described in Section 2.7. The optimal frequency is chosen by carrying out a 
microwave sweep where the sample is sequentially irradiated with microwave 
pulses over a range of frequencies for 2min. A solid-state 13C MR spectrum is 
acquired at the end of each irradiation by applying a 90º pulse. After the 
acquisition of the 13C signal and before the next irradiation the residual 







Figure 3.4: Representative solid-state 
13
C MR spectrum measured using a pair of saddle 
coils placed around the sample cup in the VTI. (A) 14M [1-
13
C1] pyruvic acid and 15 mM 
free-radicals sample. (B) 14M [1-
13
C1] pyruvic acid, 15 mM free-radicals and 1.5 mM 
gadolinium sample. (C) 14M [2-
13
C1] pyruvic acid, 15mM free-radicals and 1.5mM 
gadolinium sample. (D) 2.5M [1,4-
13
C2] fumaric acid, 15mM free-radicals and 1.5mM 
gadolinium sample. The y-axis represents the 
13
C signal intensity (a.u.). All spectra are 
plotted on the same scale intensity. 
 
A representative microwave sweep is shown in Figure 3.5 where the 
concentration of the sample polarised was 14M [1-13C1] pyruvic acid, 15mM 
OX63 free-radical and 1.5mM gadolinium. Two peaks were found at Ω = ωe – 
ωC = 94.102GHz and Ω




frequency that induces zero-quantum or double-quantum transition, 
respectively. The microwave sweep was repeated periodically to account for 





Figure 3.5: A representative microwave sweep for a 14M [1-
13
C1] pyruvic acid, 15mM 
OX63 free-radical and 1.5mM gadolinium sample. A solid-state 
13
C MR spectrum was 
measured using a 90
º
 flip-angle after irradiating the sample with a microwave pulse over 
a range of frequencies. The increment in frequency used is 2MHz. 
  
 
3.2.5  Polarisation Build up 
Once the irradiation frequency was optimised the sample was polarised using a 
microwave pulse with a characteristic frequency Ω = ωe – ωC or Ω




The build-up of the polarisation was monitored in the solid-state by acquiring a 
13C MR spectrum with a small flip-angle θ applied every 5min. It is possible to 
quantify the time constant of the solid-state build-up Tss by fitting the signal 
intensity curve to the mono-exponential build-up in Equation 3.1 
 
 
             
 
 
           
3.1 
 
M(t) is the magnetisation as a function of time . M ( ) is the magnetisation at 
saturation (maximum polarisation achievable) and Tss depends on sample 
conditions such as the type of molecule, free-radical concentration, microwave 
frequency, concentration of the paramagnetic agent and temperature. Figure 
3.6 shows the characteristic build-up of a 14M [1-13C1] pyruvic acid, 15mM 
OX63 free-radicals sample irradiated at Ω = ωe – ωC and Ω
’ = ωe + ωC. The 
maximum polarisation achieved using a microwave pulse at Ω = ωe – ωC is 
higher than that obtained when the same sample is irradiated at Ω’ = ωe + ωC in 






Figure 3.6: A representative polarisation build-up of a sample 14M [1-
13
C1] pyruvic acid, 
15mM OX63 free-radicals without gadolinium. The maximum polarisation level was 
higher when the sample was irradiated at Ω = ωe – ωC  than at Ω’ = ωe + ωC. 
 
 
Figure 3.7 shows a representative polarisation build-up in the solid-state for a 
14M [1-13C1] pyruvic acid, 15mM OX63 free-radical solution with and without 
1.5mM gadolinium irradiated at Ω = ωe – ωC. The maximum polarisation 
achieved for [1-13C1] pyruvic acid sample with gadolinium is higher than that 
obtained when the same sample without the paramagnetic agent is polarised. 
Previous studies have suggested that the ability of gadolinium of shorten the T1 







Figure 3.7: Representative solid-state polarisation built-up for a 14M [1-
13
C1] pyruvic acid, 
15mM OX63 free-radical solution with and without 1 mM gadolinium.   
 
 
The build-up time constant and the maximum polarisation depend also on the 
type of molecule. In Figure 3.8 an example of solid-state build-up is presented 
for three different samples: 14M [1-13C1] pyruvic acid, 14M [2-
13C1] pyruvic acid 
and 2.5M [1,4-13C2] fumaric acid. All solution are characterised by the same 







Figure 3.8: A representative solid-state build up for three different samples:  14M [1-
13
C1] 
pyruvic acid, 14M [2-
13
C1] pyruvic acid and 2.5M [1,4-
13
C2] fumaric acid. All three samples 




In Table 3.1 the values reported for M( ) and Tss fitting the solid-state build-up 
curves shown in Figure 3.6, Figure 3.7 and Figure 3.8 to Equation 3.1. 
 
Table 3.1: Values reported for M( ) and Tss for the samples whose solid-state build-up is 













C1] pyruvic acid 15  0 Ω
’
 = ωe + ωC 4130 14 
14M [1-
13
C1] pyruvic acid 15  0 Ω = ωe - ωC. 7758 13 
14M [1-
13
C1] pyruvic acid 15  1.5 Ω = ωe - ωC. 11266 18 
14M [2-
13
C1] pyruvic acid 15  1.5 Ω = ωe - ωC. 7781 25 
2.5M [1,4-
13




3.2.6 Hyperpolarised Solution-State MR Spectrum 
Once the maximum polarisation was achieved, the samples were dissolved 
using 4ml of 40mM TRIS buffer and 1mM EDTA.  The buffer was inserted at the 
top of the HyperSense and heated to a high temperature (180°C or equivalently 
453.15K) and high pressure (10bar). It is then injected into the sample 
positioned within the cryostat via an automatic pneumatic system.  Both pyruvic 
acid and fumaric acid were neutralised by adding to the collection vessel a 
number of moles of NaOH equal to that of the acid contained in the sample. 
After dissolution the pyruvate solution was 50mM 13C pyruvate (labelled in C1 or 
C2 position), 52µM OX63 free-radical and 5.2µM gadolinium when present.  
The concentration of the fumarate sample was 50mM [1,4-13C2] fumarate, 
0.3mM OX63 free-radical and 30µM gadolinium.  
600µl of the resulting hyperpolarised solutions were placed in a 5mm MR tube 
and quickly inserted within the 9.4T Bruker scanner next to the HyperSense 
where a series of 13C-MRS spectra was acquired for each molecule 
hyperpolarised using a small flip-angle.  
Figure 3.9 A shows a series of hyperpolarised 13C spectra (number of spectra, 
ns = 128) of a 50mM [1-13C1] pyruvate, 52µM OX63 free-radical solution 
acquired with θ = 10º and TR = 2s (total experimental time 4.26min). Figure 3.9 
B shows the thermal equilibrium 13C MR spectrum of the solution used in the 
hyperpolarised experiment and acquired using the same acquisition parameters 
(θ, TR, etc.) exploited for the hyperpolarised signal sampling. This 13C MR 
spectrum was obtained by adding 32 spectra (total experimental time = 





Figure 3.9: (A) Representative series of hyperpolarised 
13
C spectra from a sample of 
50mM [1-
13
C1] pyruvate, 52µM OX63 free-radical acquired with θ = 10
º
 and TR = 2s. (B) 
Equilibrium 
13
C MR spectrum of the same sample used in (A) obtained by adding 32 
scans and using the acquisition parameters exploited in (A).  
 
 
In Figure 3.10 A a series of hyperpolarised 13C spectra (ns = 256) of 50mM [1,4-
13C2] fumarate, 0.3mM OX63 free-radical and 30µM gadolinium solution 
acquired with θ = 1º and TR = 1s (total experimental time = 4.26min) is shown. 
In Figure 3.10 B shows the thermal equilibrium 13C MR signal of the solution 
used in the hyperpolarised experiment and acquired using the same acquisition 
parameters (θ, TR, etc.) exploited for the hyperpolarised signal sampling. This 
13C MR spectrum was obtained by adding 128 spectra (total experimental time 







Figure 3.10: (A) Representative series of hyperpolarised 
13
C spectra from a sample of 
50mM [1,4-
13
C2] pyruvate, 0.3mM OX63 free-radical and 30µM gadolinium acquired with a 
θ = 1º and TR = 1s. (B) Equilibrium 
13
C MR spectrum of the same sample in (A) obtained 
by adding 128 scans and using the same acquisition parameters used in (A).  
 
 
3.2.7 Polarisation Measurement 
In this thesis the enhancement factor ξ was calculated as the ratio of the 
maximum intensity of the hyperpolarised signal and the signal at thermal 
equilibrium acquired with the same sample and experimental protocol (e.g. θ, 
TR, etc). The polarisation P of the hyperpolarised solution was calculated by 
multiplying the enhancement factor ξ by the polarisation at thermal equilibrium 
calculated for the same nucleus, B0 and T. The values of ξ and P obtained for 




Table 3.2: Values of signal enhancement ξ and polarisation P obtained for the 
13
C 













C1] pyruvic acid 15  -- Ω
’
 = ωe + ωC 6947 6.7 
14M [1-
13
C1] pyruvic acid 15  -- Ω = ωe - ωC. 7619 10.4 
14M [1-
13
C1] pyruvic acid 15  1.5 Ω = ωe - ωC. 27839 22 
14M [2-
13
C1] pyruvic acid 15  1.5 Ω = ωe - ωC. 11429 9.3 
2.5M [1,4-
13
C2] fumarate 15  1.5 Ω = ωe - ωC. 4324 3.5 
 
 
3.2.8 Measurement T1 of Hyperpolarised Molecules in Solution 
The hyperpolarised signal relaxes to the equilibrium signal with a characteristic 
decay time T1 that depends on the type of 
13C molecule, sample concentration, 
θ, T, B0. T1 can be quantified in solution fitting a time-series given by the peak 
area of the dynamic 13C MR spectra of each molecule as a function of time to 
Equation 2.28.         in Equation 2.28 is a correction factor for the loss of 
magnetisation due to the application of n RF pulse. When θ < 5º,           
and the correction factor can be omitted. In Figure 3.11 the characteristic 
relaxation curves of the hyperpolarised signal of a 50mM [1-13C1] pyruvate, 
52mM OX63 free-radical and 50mM [1,4-13C2] fumarate, 0.3mM OX63 free-
radical and 30µM gadolinium solutions acquired using θ = 1°, TR = 1s and ns = 
256 (total experimental time = 4.26min) are plotted with overlaid fits as function 
of time. Table 3.3: presents the values of T1 reported for all molecules 
hyperpolarised in this thesis estimated without taking in account the loss of 
magnetisation due to the application on n RF pulse as the flip-angles used were 





Figure 3.11: Time-series with fit overlaid of two hyperpolarised 
13
C solutions: 50mM [1-
13
C1] pyruvate, 52µM OX63 free-radical and 50mM [1,4-
13
C2] fumarate, 0.3mM OX63 free-
radical and 30µM gadolinium. The 
13
C MR spectra of both molecules from which was 
derived the time-series curves were acquired θ = 1
º
 and TR = 1s.  
 
 
Table 3.3: Values of the relaxation time constant T1 estimated without taking in account 











C1] pyruvic acid 15  -- Ω
’
 = ωe + ωC 49.2 
14M [1-
13
C1] pyruvic acid 15  -- Ω = ωe - ωC. 52.7 
14M [1-
13
C1] pyruvic acid 15  1.5 Ω = ωe - ωC. 25 
14M [2-
13
C1] pyruvic acid 15  1.5 Ω = ωe - ωC. 38 
2.5M [1,4-
13





3.3 In vitro MR Experimental Protocol 
After demonstrating that it was possible to enhance the 13C MR signal of 
metabolically active molecules, such as pyruvate and fumarate, further in vitro 
experiments were carried out in order to determine whether the polarisation 
achieved after dissolution was adequate to detect the conversion of pyruvate to 
its downstream metabolites in a biological system in real-time. This involved the 




3.3.1 Whole Blood Cell Preparation 
All procedures involving animals were carried out in accordance with the Home 
Office Guidance on the Operation of Animals (Scientific Procedures) Act 1986, 
HMSO (London).  
Blood samples from male Wistar rats were collected in heparinised MR tubes 
from male Wistar rats (250-300g, n = 4) under terminal anaesthesia at the same 
time of the excision of the heart for a separate experiment. 100µl of a 
hyperpolarised 50mM [1-13C1] pyruvate, 52µM OX63 free-radical and 5.2µM 
gadolinium solution was vigorously mixed with 500µl of whole blood in a 5mm 
MR tube before being inserted into the bore of the Bruker 9.4T Avance III 
spectrometer. For this type of experiment it was assumed an instantaneous 






3.3.2  MR Protocol 
Choosing the flip-angle θ of the RF pulse is a crucial point in the optimisation of 
the acquisition protocol for hyperpolarised MR signals. As mentioned in Section 
3.2.8, small flip-angles are preferable to reduce the loss of signal associated 
with the application of a series of RF pulses (Equation 2.28). It is therefore a 
good experimental practice to regularly calibrate the RF pulse to account for 
any drift in the magnetic field of the spectrometer. 
The flip-angle θ is proportional to the length of the RF pulse t1 as shown in 
Equation 2.9. The calibration of the RF pulse is performed by applying RF 
pulses over a range of durations and measuring the generated magnetisation 
on the x-y axis by measuring the spectrum at each pulse. In Figure 3.12 shows 
a representative RF pulse calibration performed for the Broad Band Observe 
(BBO) coil used for the in vitro experiments presented in this Section. 
The sample used for the calibration was 0.5M H13C  
 , 1mM EDTA and 3.5mM 
gadolinium. The gadolinium was added to shorten the T1 of H
13C  
  and make 
the acquisition process faster. The length of the first RF pulse and the 
increment were both chosen equal to 0.5µs and the pulse power was set to 
0dB. A signal intensity equal to zero is generated by a 180º RF pulse that tips 
the magnetisation on the –z-axis. In the example presented in Figure 3.12 the 
length reported for a 180º pulse was 19.5µs from which it is possible to calculate 






Figure 3.12: Representative calibration of the RF pulse for a BBO coil. For the acquisition 
of a 0.5M H
13
C  
 , 1mM EDTA and 3.5mM gadolinium solution was used. 
 
 
The relationship between the signal-loss due to the application of an RF pulse 
and the chosen flip-angle θ is clearly shown in Figure 3.13 A where the 
characteristic relaxation curves of the hyperpolarised signal of a 50mM [1-13C1] 
pyruvate, 52mM OX63 free-radical solution acquired using five different flip-
angle θ (θ = 1°, 5°, 10°, 20°, 30°), TR = 2s and ns = 128 (total experimental 
time = 4.26min) are plotted as function of time. The larger the flip-angle, the 
greater the signal loss.  
In agreement with the Bloch equations, the decay of the hyperpolarised signal 
should be mono-exponential with time constant T1. However, Figure 3.13 B 
shows that only for very small values of flip-angle the decay of [1-13C1] pyruvate 









Figure 3.13: (A) Characteristic relaxation curves of the hyperpolarised signal of a 50mM 
[1-
13
C1] pyruvate, 52mM OX63 free-radical solution acquired for five different flip-angle θ. 
(B) The relaxation curves presented in (A) are plotted on logarithmic scale. 
 
 
This is due to the presence of B1 that tends to flip the magnetisation back 
towards the +z-axis acting against B0. This phenomenon is commonly named 
“radiation damping”. The greater the flip-angle, the greater the magnitude of the 
magnetisation and the stronger is the strength of the induced magnetic field B1 
in the receiver coil. The radiation damping effect depends also on the 
concentration of the hyperpolarised solution. In Figure 3.14 A the decay of the 




solution acquired using five different flip-angle θ (θ = 1°, 5°, 10°, 20°, 30°), TR = 
2s and ns= 128 (total experimental time = 4.26min) is plotted as function of 




Figure 3.14: (A) Characteristic relaxation curves of the hyperpolarised signal of a 5mM [1-
13
C1] pyruvate, 52mM OX63 free-radical solution acquired for five different flip-angle θ. (B) 
The relaxation curves presented in (A) are plotted on logarithmic scale. 
 
 
The diluted sample is characterised by a slower relaxation time constant T1 and 
the radiation damping effect is less pronounced than in 50mM [1-13C] pyruvate 
sample (Figure 3.14 B). 
In order to minimise the “radiation damping” effect just described, 13C MR 
dynamic spectra of the hyperpolarised 50mM [1-13C1] pyruvate, 52µM OX63 








3.4 Ex vivo MR Experimental Protocol 
The ultimate experimental challenge consisted in detecting cardiac metabolism 
in real-time ex vivo in perfused rat hearts using hyperpolarised 13C MR. In order 
to achieve this aim an ex vivo MR protocol was designed and validated for 
perfused rat hearts. Due to the necessity of designing and optimising an MR 
protocol from scratch, different acquisition parameters were chosen at different 
stages of this thesis. 
 
 
3.4.1 Langendorff Perfused Rat Heart Protocol 
Male Wistar rats (250-300g) underwent terminal anaesthesia by intraperitoneal 
injection of sodium pentobarbitone (100mg/kg) and heparin (200IU) to avoid the 
formation of blood clots during the excision of the heart. After checking the 
absence of any reflex in the animal, a transabdominal incision was made, 
cutting through the diaphragm and ribs, in order to expose the thoracic cavity. 
The heart was gently held between fingers and the major vessels were cut 
taking care that sufficient length of aorta was retained. The isolated heart was 
temporarily arrested in cold Krebs-Henseleit buffer in order to minimise 




A plastic cannula (ø = 3mm) was inserted into the aorta and the heart was 
perfused, using a peristaltic pump, with Krebs-Henseleit buffer at a constant 
flow of 14ml/min to achieve a perfusion pressure of 76mmHg at the coronary 
arteries comparable to the arterial pressure in vivo (Bessho and Chambers 
2001). The standard composition of the Krebs-Henseleit buffer used in this 
thesis was:  NaCl 118mM, NaHCO3 25mM, MgSO4 1.2mM, KCl 5.9mM, 
Na2EDTA 0.6mM, CaCl2 2.5mM and glucose 11.1mM. When specified 2.5mM 
of unlabeled sodium pyruvate was added to the standard buffer. These two 
buffers were chosen because both commonly used in perfused rat hearts 
experiments (Garlick et al. 2000;  Schroeder et al. 2009). The final buffer pH 
was adjusted to 7.4 at 37 °C. The temperature of the buffer was regulated using 
a thermostatically controlled water-jacketed system in which the perfusate glass 
reservoir and the delivery lines are surrounded by recirculating hot water 
(Sutherland and Hearse 2000). Finally to assure a good oxygenation of the 




3.4.2 Cardiac Function Measurement 
Assessing the contractile function of Langendorff hearts is crucial in order to 
assess the consistency of the perfusion protocol as well as to confirm the 
contractile impairment induced by hypoxia or ischemia. 
In the experiments carried out in the early stages of this thesis cardiac function 




cardiac function of a perfused heart within the magnet. In the later stages of this 
project, a MR compatible system able to monitor the contractile function of the 
perfused heart inside the magnet was developed and validated. 
The pressure in the left ventricle was monitored with a water-filled balloon 
inserted into the left ventricular lumen connected to a pressure transducer and 
recording apparatus. Perfusion pressure was measured by a further pressure 
transducer inserted into the arterial line. Figure 3.15 shows the experimental set 
up developed for the hyperpolarised 13C MR experiments carried out in this 
thesis.  
Another crucial point in the development of a consistent and efficient 
Langendorff heart is electronic pacing. The number of full myocardial 
contraction per minutes decreases with the time of the perfusion because the 
quality of the preparation declines with time. The ability of the perfused heart to 
contract is also challenged by the induction of pathophysiological conditions 
such as hypoxia or ischemia induced during the experimental protocol. This is 
due to the attempt of the perfused heart to save fuel in an unfavourable 
energetic condition.  In vivo, the cardiac impairment induced by the presence of 
hypoxia or ischemia is initially compensated by the neurohumoral system that 
maintains the heart rate constant straining the cardiac muscle. In order to 
replicate the in vivo situation a MR compatible pacing system was developed 







Figure 3.15: Experimental setup developed and validated at St. Thomas’ hospital for 
hyperpolarised 
13
C MR Langendorff perfused rat hearts experiments. (A) The perfused rat 
heart is cannulated, placed in a glass tube and perfused with Krebs-Henseleit buffer. 
Once stabilised the cardiac function the tube containing the perfused heart is inserted 
within the MR coil placed in the MR probe. (B) The MR probe is subsequently inserted 
into the 9.4T MR Bruker scanner, from the bottom, placed next to the DNP polariser. 
Once the hyperpolarised solution is ready it is expelled by the DNP polariser and quickly 
injected into the perfusion line of the perfused rat heart though the injection port shown 







This system consists of a signal generator (DC) and a pair of silver wires used 
to deliver the electric current to the perfused heart while at the same time 
minimising induced currents within the MR scanner that would degrade the 
quality of the MR signal. The beats/min of the Langendorff perfused rat hearts 




3.4.3  MR Protocol 
All experiments were carried out on a vertical wide bore Bruker 9.4T Avance III 
spectrometer with the bore maintained 37 °C at St. Thomas’ Hospital. The 
perfused heart was inserted in a glass tube (ø = 15mm, sealed with a silicone 
bung) filled with Krebs-Henseleit buffer. Coronary perfusate was aspirated from 
the top by a gravity-fed siphon. 
 
 
3.4.4 31P MR Spectroscopy  
The experimental protocol presented in this section was developed with the 
help of Dr. Rodolfo Medina. 
In order to validate the system used to monitor the cardiac contractility the 
relationship between the cardiac energy level and cardiac function was 
assessed using 31P MRS. The detection of 31P is commonly used to 
characterise the creatine-kinase energy shuttle described in Section 1.4.5 




ADP. Under high-energy demand, PCr is rapidly re-converted to Cr and ATP is 
released.  
In this experiment Langendorff hearts were initially perfused with a well 
oxygenated buffer for a period long enough to ensure their stabilisation (12min). 
In order to assess if the system developed for the measurement of the cardiac 
function was sensitive enough to detect changes associated with an external 
insult perfused hearts were made ischemic by stopping the flow of Krebs-
Henseileit buffer (12min) and then reperfused (16min). Cardiac contractility was 
monitored throughout the experiment and 31P MR spectra were acquired to 
obtain information of the metabolic state of the heart.  Perfused hearts were 
paced at a constant frequency of 300beats/min.  
31P spectra were acquired using a dual-tuned 1H/31P birdcage coil (ø=15mm), 
flip-angle θ = 60º, TR = 3.8s and 64 scans to give a total experiment time of 
4min per spectrum. In normoxia and ischemia ns = 3 (total experimental time = 
12min), whereas in during the reperfusion of the isolated heart ns = 4 (total 
experimental time = 16min). 
In Figure 3.16 the series of 31P spectra acquired following the protocol 







Figure 3.16: A series of 
31
P spectra acquired from a perfused rat heart in normoxia, 
ischemia and during repefusion.  
 
 
The perfusion pressure, heart rate, left ventricular developed pressure (LVDP) 
and end diastolic pressure (LVDEP) measured during the acquisition of the 31P 
MR spectra shown in Figure 3.16 are presented in Figure 3.17.  
The 31P spectrum of a normoxic perfused heart yields one peak corresponding 
to PCr (~ -3.5ppm) and one to inorganic phosphate (Pi) (~ 1.5ppm) as well as to 
three peaks characteristic of the phosphates in the ATP molecule (γ-ATP, α-
ATP and β-ATP).  During normoxia the perfusion pressure, heart rate, LVDP 
and LVEP are stable (Figure 3.17).  After stopping the flow of oxygenated buffer 
to the heart the perfusion pressure drops and the heart becomes arrhythmic 
(Figure 3.17 B) resulting in a significant reduction of the LVDP and LVEDP 
(Figure 3.17 A, C and D). In this condition, the intensity of the PCr peak in the 
31P spectrum diminishes together with the ATP peaks, while the Pi peak 
intensity increases. This is justified by the fact that during ischemia the total 
amount of ATP available diminishes and CK converts PCr to Cr in order to 




hydrolysis leads to the production of Pi. This reaction is pH dependent and the 
characteristic resonance frequency of the Pi peak during ischemia is shifted 
towards lower frequencies (Stewart et al. 1986;  Raftos et al. 1990). After 
reperfusion the total amount of ATP available increased as well as the PCr 
produced by the conversion of ATP via CK, while Pi decreased. The heart 
quickly recovers the rate of pacing (300beats/min), while both LVDP and 






Figure 3.17: Parameters measured to monitor the cardiac contractility during the 
acquisition of the 
31
P spectra presented in Figure 3.16 are presented as a function of 






3.4.5 13C MR Spectroscopy  
In the early stages of this thesis, the tube containing the perfused heart was 
placed within the isocenter of a custom-built 23Na/13C saddle coil (ø=15mm), 
and inserted into the spectrometer. Shimming was carried out using the 23Na 
signal (FWHM 13Hz), and then re-tuned to 13C. In studies carried out at a later 
point a 1H/13C birdcage coil (ø = 15mm) was used for the acquisition of the13C 
MR spectra. Shimming was performed on the water signal using the 1H channel 
of the coil (FWHM 35Hz). Although characterised by the same internal 
diameter, the two coils have a different geometry. Additionally the shimming 
was performed using the signal from two different nuclei characterised by a 
different concentration within the tube containing the perfused heart and its 
perfusion solution. The sensitivity of the two coils was not measured in this 
thesis and therefore it is not possible to exclude a priori that the 23Na/13C saddle 
coil and the 1H/13C birdcage coil are characterised by a different sensitivity. This 
factor has to be taken into account when the acquired hyperpolarised 13C MR 
spectra are interpreted. 
Regardless the type of coil used the acquisition of the MR data was 
commenced at the end of the dissolution. In all the experiments presented in 
this Section a 50mM [1-13C1] pyruvate, 52µM OX63 free-radical and 5.2µM 
gadolinium hyperpolarised solution was injected into the perfused heart through 
an injection pump. A time-series of 13C-MR spectra (ns = 128) was acquired 
using a single acquisition per spectrum, θ = 10°, TR = 2s (total experimental 




(Bruker). All spectra were baseline corrected and integrals of each peak 
extracted as a function of time.  
Two groups of Langendorff hearts (n=5 for each group) were used. The first 
group was perfused with the standard Krebs-Henseleit buffer containing 
11.1mM glucose while the buffer used to perfuse the second group contained 
11.1mM glucose and 2.5 mM sodium pyruvate. Details on the type of 
experimental protocol used for the acquisition of the dynamic 13C spectra for 
each heart are reported in Table 3.4. 
 
Table 3.4: Experimental protocol used to acquire hyperpolarised 
13
C MR time-series from 
Langendorff rat hearts.  
 Buffer Cardiac 
Function 
Pacing Coil 




















































3.4.6 Metabolite Peak Assignment 
Natural abundance 13C MR spectra of a range of metabolites were acquired to 
assign relevant metabolite peaks detected in the hyperpolarised spectra. Each 
sample was prepared by mixing 600 l of PBS, 60 l of deuterium and the 
metabolite (150mM, pH = 7.4). 128 spectra were acquired for each compound 
using a flip-angle θ = 30°, TR = 21s (total experimental time = 45min) and then 




compared with the 13C hyperpolarised spectrum acquired for each heart and 
matches were found.  
 
 
3.4.7 13C MR Spectroscopic Imaging 
All the images presented in this Section were acquired in collaboration with Dr. 
Kilian Weiss (PhD student at the Institute for Biomedical Engineering at the 
University and ETH, Zurich).  
In the MRSI experiments the tube containing the Langendorff heart (n=2, 
perfused with Krebs- Henseleit buffer containing 11.1mM glucose only) was 
placed within the isocenter of a dual-tuned 1H/13C birdcage coil with (ø =  
20mm). A hyperpolarised 50mM [1-13C1] pyruvate, 52µM OX63 free-radical and 
5.2µM gadolinium solution was injected in both hearts. Shimming was 
performed on the water signal using the 1H channel of the coil (FWHM 35Hz). 
Cardiac contractility was not recorded in these experiments and perfused hearts 
were left beating spontaneously. 
In order to check the position of the heart within the coil, standard 1H cine 
images were acquired in short axis and four chamber view using a self-gated 
gradient echo sequence (Heijman et al. 2007) with the following parameters; 
TE: 2.9ms, TR: 8ms, acquisition matrix: 128 x 128, field of view: 32 x 32 mm2, 
spatial resolution: 250 x 250 µm2, slice thickness: 5mm, θ = 20°, 10 cardiac 
frames. 
Hyperpolarised 13C spectroscopic images of [1-13C1] pyruvate and its 
metabolites [1-13C1] lactate and H
13CO3




spectroscopic imaging (EPSI) sequence as shown in Figure 3.18. The 
acquisition parameters were as follows; TE: 1.315ms, TR: 89ms, time between 
dynamic images Δt = 5s, acquisition matrix: 16 x 16, field of view: 32 x 32 mm2, 
θ = 20°, spatial resolution: 2 x 2 mm2, slice thickness: 5mm, spectral bandwidth 
during acquisition: 6250Hz, spectral resolution 12.2Hz. For each experiment 64 
images were acquired in a total time of 320s starting with the dissolution of the 
sample. MRSI data were reconstructed using Matlab (Mathworks Inc., Natick, 
MA). To avoid spectral N/2 ghosts, even and odd echoes of the echo planar 
readout were combined after linear phase correction of the even echoes, 




Figure 3.18: Schematic diagram of the echo planar spectroscopic imaging (EPSI) 
sequence. Slice selective excitation is followed by phase encoding. The signal is 
acquired during an alternating gradient train. Adapted from reference (Weiss and Mariotti 





3.5 Ex vivo PET Experimental Protocol 
All the experiments presented in this Section were carried out by Dr. Richard 
Southworth and Dr. Rodolfo Medina in order to quantify the uptake of two PET 
tracers [18F]-FDG and [18F]-FMISO in normoxic and hypoxic perfused rat hearts.  
 [18F]-FDG was provided by the clinical PET Centre, St. Thomas’ Hospital, 
whereas [18F]-FMISO was prepared following a previously reported method (Oh 
et al. 2005).  
Langendorff rat hearts (n = 4 for [18F]-FDG and n=3 for [18F]-FMISO) were 
perfused with a Krebs-Henseleit buffer containing 11.1mM glucose only. 
Cardiac contractile function was monitored with a water-filled balloon inserted 
into the left ventricular lumen as explained in Section 3.4.2. A bolus of each 
radiotracer (1MBq in 100µl KHB) was administered via an in-line injection port, 
and its transit through the perfusion apparatus was monitored by NaI detectors 
(i) in the arterial line above the heart cannula, and (ii) directly opposite the heart 
(to quantify the tracer accumulation in the heart) connected to a GinaSTAR TM 
ITLC unit (Figure 3.19). All datasets were acquired with a time resolution Δt = 
0.0033min. 
After a stabilisation period, where KHB perfusate was gassed with 95% O2-5% 
CO2, the first bolus of either [
18F]-FDG or [18F]-FMISO was injected into the 
perfusion line, and their passage through the system under “normoxic” 
conditions was recorded.  After 5 min, hypoxia was induced by switching to a 
second reservoir (KHB gassed with 95% N2 - 5% CO2). Further boli of each 
tracer were injected into the system after 5min and 15min of hypoxic buffer 











was injected through the injection port and its passage through the perfusion line was 
recorded using two NaI γ-detectors able to measure the input (detector 1) and the tissue 

















Chapter 4 : Kinetic Modelling 
4.1 Introduction 
Imaging modalities are able to detect the distribution of endogenous probes. 
While MRI informs on structure, function and perfusion, MRS and 
hyperpolarised technologies allow the distinction and imaging of an injected 
molecule from its downstream metabolites to uncover biochemical changes in 
the myocardium. PET and SPECT are characterised by a significantly higher 
sensitivity than MR, but the signals from injected tracers and their metabolites 
are indistinguishable. 1D dynamic time-series containing information on the 
interaction between the injected imaging agent and the underlying biological 
system are directly acquired in vitro or ex vivo, or can be obtained from 2D or 
3D in vivo images by plotting the signal over the time for either a ROI, or pixel 
by pixel. Regardless the technique used the dynamics of the imaging agents is 
typically described by differential equations whose solution to an impulse input 
is multi-exponential. Kinetic information on the observed phenomenon can be 
derived by fitting the time-series with mathematical models.  








The gold standard quantitative analysis technique is represented by 
compartmental modelling (Godfrey 1982). This approach allows a complete 
characterisation of the imaging agent kinetics by deriving micro (e.g. rates of 
conversion) and macro (net uptake) parameters. It however requires a priori 
assumptions of the number of compartments involved in the tracer kinetics, 
information not always available especially when new biological systems or 
imaging agents are studied. The hybrid Maximum Entropy/Nonlinear Least 
Squares method (MEM/NLS) (Steinbach et al. 2002) and Spectral-based 
Algorithms (SA) (Cunningham and Jones 1993;  Bertoldo et al. 1998) are 
quantitative analysis techniques that allow the full characterisation of the tracers 
dynamics and require little a priori knowledge of the system studied. They 
therefore represent a valid alternative to compartmental modelling when there is 
a certain degree of uncertainty on the metabolic pathway or on the system 
assessed.  An alternative approach is represented by graphical methods (Patlak 
et al. 1983) that allow estimating macro parameters from the dynamic curves, 
but do not fully describe the tracer kinetics. Together with the quantitative 
analysis techniques mentioned above, semi-quantitative indices are routinely 
used in the characterisation of tracer kinetics (Huang 2000;  Lehtio et al. 2003;  
Hill et al. 2013). They are simple to apply, but less informative and more 






This Chapter introduces the quantitative and semi-quantitative techniques used 
in this thesis for the analysis of time-activity curves of PET tracers acquired ex 
vivo from perfused rat hearts and hyperpolarised MR dynamic data whose 
acquisition is presented in Chapter 3.  
Compartmental modelling is the gold standard analysis methods for both PET 
and hyperpolarised MR dynamic data. In Section 4.3.1 the most commonly 
used compartmental models in PET are presented with particular reference to 
the irreversible radiotracers used in this thesis: [18F]-FDG and [18F]-FMISO. The 
application of this analysis technique to the kinetic analysis of hyperpolarised 
data is described in Section 4.3.2.  
The biological systems studied using hyperpolarised MR probes or PET tracers 
are not always well characterised. In this case analysis methods that require a 
minimum a priori knowledge of the biological mechanisms involved in the 
dynamics observed are desirable.  A general introduction on the implementation 
of the MEM/NLS algorithm is presented in Sections 4.4 with particular reference 
to hyperpolarised time-series acquired in vitro (Section 4.4.1). Spectral-based 
algorithms and graphical methods applied to ex vivo PET data are introduced in 
Section 4.5 and 4.6, respectively. Section 4.7 introduces the semi-quantitative 
techniques exploited for the analysis of ex vivo PET time-activity curves and 
hyperpolarised dynamic data. Finally, the Monte Carlo method used in this 
thesis to assess the accuracy and reproducibility of the proposed analysis 





4.3 Compartmental Modelling 
In compartmental modelling, a system is approximated by a number of 
compartments that interact with each other at characteristic rates. This 
approach requires some general assumptions such as an instantaneous mixing 
of the imaging agent within each compartment and that the amount of tracer 
added does not perturb the system under study (Gunn et al. 2001). Depending 
on the type of imaging technique used, different compartmental models are 
used in order to account for the characteristic interaction of the imaging agent 
with the underlying biological system and the experimental protocol.  
 
 
4.3.1 PET Dynamic Data 
 A three compartment, three rates model (3K model) (Figure 4.1) (Sokoloff et al. 
1977) is the most commonly used compartmental model for the kinetic analysis 
of time-activity curves of irreversible tracers such as [18F]-FDG and [18F]-FMISO 
(Bertoldo et al. 1998;  Wang et al. 2009). According to this model, the 
radiotracers can move back and forward between the plasma/blood (Cp) and a 
reversible tissue compartment (Ce), but once it enters the irreversible 






Figure 4.1: Block diagram for a 3K compartmental model used for PET tracer that are 







The evolution in time of the tissue compartments in Figure 4.1 is described by a 
system of linear differential equations as follow: 
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where k1 and k2 are unknown kinetic rates that characterise the movement of 
the tracers from the blood stream to the tissue (influx) and vice versa (efflux), 
while k3 is the rate at which the tracer moves from the reversible to the 
irreversible tissue compartment. In PET experiments Cp(t), which represents the 
delivery of the radiotracer to the tissue of interest, is assumed to be known and 
can be measured through blood sampling in vivo or using a γ-detector coupled 
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where   indicates the mathematical operator convolution. The total amount of 
signal in the ROI (e.g. voxel or field of view of the detector) that includes the 
tissue and the vascular space is given by: 
 
                                      4.7 
 
Vb and Cp representing the fraction of vascular space in the tissue of interest 
and the tracer concentration in whole blood, respectively (Lammertsma et al. 
1992).  By fitting the experimental data to Equation 4.7 the unknown parameters 
k1, k2, k3 and Vb can be derived.  
Approximating the delivery input function Cp(t) by a sum of exponentials and 
assuming that the whole blood curve is approximated by the plasma curve 
Equation 4.7 can be re-written as follow: 
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For     the reversible component decreases, while the irreversible 
component increases. The net uptake rate for this type of model is given by: 
 
 
   
    




For example for [18F]-FDG this index can be used in vivo to calculate glucose 
metabolic rate (MRgluc) as the product of Ki and the steady-state concentration 
of glucose (Cgluc) in the blood (Equation 4.13). 
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The “lumped constant” (LC) in Equation 4.13 is used to relate the measured 
uptake of [18F]-FDG to that of glucose. This correction factor assumes that the 
transport and the phosphorylation rates of glucose and its tracer do not change 
with respect to each other (Sokoloff et al. 1977). Langendorff hearts are usually 
perfused with a constant glucose concentration (11.1 mM) and therefore MRgluc 
should be directly proportional to Ki. However, previous studies have identified a 
mismatch between glucose and [18F]-FDG uptakes under a number of 
pathophysiological conditions such as ischemia (Southworth 2009). In these 
conditions the LC is not constant and the accuracy of the estimation of the 
glucose uptake using [18F]-FDG is limited.  




The approach just introduced assumes that each compartment is homogenous. 
When time-series reflect the distribution of the tracers within heterogeneous 
systems, the most appropriate approach is given by the compartmental model 
shown in Figure 4.2 A. It considers one compartment for the plasma and n 3K 
models representing the heterogeneity of the tissue studied. This is equivalent 
to a 3K model shown in Figure 4.2 B and is described by the following system of 
differential equations: 
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Using the exponential approximation for k2(t) and k3(t) (Equations 4.18 and 
4.19) the number of unknown parameters to estimate by fitting the experimental 
data is five:   
   is the rate constant of the influx of the tracer from the plasma to 
the heterogeneous tissue,   
  and   
  the mass-weighted rate constants for efflux 
of the tracer from the heterogeneous tissue to the plasma and for the transport 
in the irreversible compartment, respectively. C1 and C2 are parameters that 
describe the time varying nature of k2(t) and k3(t) (Schmidt et al. 1991).  
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Figure 4.2: (A) Block diagram for a heterogeneous system where n 3K compartmental 
models are considered to represent the heterogeneity of the tissue. (B) Simplification of 
the system shown in (A).   
  is the rate constant of the influx of the tracer from the 
plasma to the heterogeneous tissue. k2(t) and k3(t) are given by Equations 4.3 and 4.4. 
 
 
4.3.2  Hyperpolarised Dynamic Data 
Hyperpolarised MR allows the metabolically active molecule injected into the 




window given by approximately 5*T1, with T1 indicating the longitudinal 
relaxation time of the hyperpolarised signal. The evolution in time of this type of 
system is described by the Bloch-McConnell equations obtained combining the 
traditional Bloch equations with those describing the chemical reaction as 
explained below. 
The chemical exchange between two molecules A and B can be modelled with 




Figure 4.3: Block diagram for the chemical exchange of two molecules. 
 
 
kAB and kBA are the characteristic rates of conversion between A and B. This 
system is described by a system of linear differential equations as follows: 
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The Bloch equations that describe the evolution of the net magnetisation of a 
spin-system in the presence of an external magnetic field and relaxation 






     
     











    




   
    








     
     






where ω0 is the Larmor frequency of the nucleus observed and M0 represents 
the steady-state nuclear longitudinal magnetisation (Section 2.2.2).  
The evolution in time of longitudinal component of the net magnetisation of 
nuclear spin-systems in chemical exchange is described by the Bloch-
McConnell equations obtained by combining Equation 4.23 with the Bloch 
equations (Equation 4.24) as follows: 
 
 




      







     
   
       
   
     
   







      





where Mz,(A,B) and M0,(A,B) are the longitudinal and the steady-state nuclear 




described by Equation 4.25 is presented in Figure 4.4 where         
   and 
        
   are the relaxation rates of the hyperpolarised signal of compartment 




Figure 4.4: Block diagram for the chemical exchange between the hyperpolarised 
molecules A and B 
 
 
The hyperpolarised magnetisation is several orders of magnitude more intense 
than that at thermal equilibrium (Mz >> M0). For this reason in this case it is 
possible to consider     . Under this assumption the kinetics of Mz(t) of the 
two chemical species A and B is obtained by solving System 4.25 with M0,A = C 
and M0,B = 0 (Equations 4.26- 4.28). 
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The term           θ  takes in account the loss of hyperpolarised signal due to 
the application of a RF excitation pulse characterised by a flip angle θ.  
Depending on the experimental protocol, it may be necessary to consider the 




Figure 4.5 : Bloch diagram that describe the conversion of a hyperpolarised molecule A 
into to its metabolic product B through a single first order enzymatic conversion. 
 
 
In this thesis the delivery of the hyperpolarised solution to the assessed system 
Cp(t) (input function) was not detected experimentally. Cp(t) was approximated 
to a delta function for in vitro experiments where the mixing of the 
hyperpolarised probe with the cell solution is considered instantaneous (Section 
5.2.1), while for ex vivo perfused rat hearts experiments Cp(t) was modelled as 




The equations that describe Mz of A and B as a function of time are given by the 
convolution of Equations 4.26 and 4.27 with Cp(t): 
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where      is presented in Equation 4.28. The unknown parameters to estimate 
are C, kAB, kBA, r1a and r1b. They can be derived by fitting the experimental data 
to the mathematical function that describe the kinetics of the longitudinal 
magnetisation Mz(t) of the two metabolites. All the equations derived above are 
valid if the two metabolites A and B are exchangeable. If the enzymatic reaction 
is unidirectional all the equations introduced above are still valid assuming kBA = 
0. 
Enzymatic conversions of metabolites depend on the availability of one or more 
cofactors (e.g. ATP is the cofactor for the conversion of Cr to PCr via CK).  
Hyperpolarised probes are injected into the system at super physiological 
concentrations, potentially inducing a rapid depletion of the cofactors involved in 
the enzymatic reaction studied. In systems able to rapidly regenerate the 
cofactor through other metabolic pathways the conversion of metabolite A into B 
can be considered independent from the availability of the cofactors and 
modelled as explained above. When the system is not able to compensate for 
the loss of cofactor, the enzymatic reaction observed after the injection of the 




follows a second order kinetics. In this condition, the chemical conversion of 
molecule A to molecule B can be modelled using a three-compartment second-




Figure 4.6: Block diagram for a second-order chemical conversion of molecule A to 
molecule B including the depletion of the cofactor Co.  
 
 
Co rappresents the cofactor compartment. This system is described by a 






    
    
     
   
           
          
           
  
    
    






The Bloch-McConnell equations that the described the evolution in time of the 
longitudinal component of the net magnetisation of the system shown in Figure 
4.6 are obtained by combining Equation 4.30 with the Bloch equation (Equation 









      
      
       
   
     
        
    
           
     
            
  
      
     





r1CO is the relaxation rate of the hyperpolarised magnetisation associated with 
Co and r1A and r1B are described by Equation 4.29. 
Depending on the experimental protocol, it may be necessary to consider the 





Figure 4.7: Bloch diagram that describe the conversion of a hyperpolarised molecule A 
into to its metabolic product B through a single second order enzymatic conversion. 
 
 






      
      
       
   
     
        
    
           
     
            
  
      
     
       








By fitting the data to the solution of Equations 4.34, assuming for example 
             and            , it is possible to derive the values of the 
unknown parameters C0, kAB, kBA, r1A and r1B. 
The measurement of the optimal input function for hyperpolarised in vivo and ex 
vivo experiments is still an unsolved problem. The dynamics of the injected 
hyperpolarised molecule does not represent the input function because this not 
only contains information on the delivery of the injected probe but also on its 
metabolic conversion. Recent studies have proposed methods to obtain an 
accurate measure of the in vivo input function directly by measuring the 
hyperpolarised metabolite signal in the arterial blood or indirectly by detecting 
the hyperpolarised signal of urea, a non metabolically active compound, 
injected into the system at the same time of the molecule of interest (von Morze 
et al. 2012;  Kazan et al. 2013). Alternatively, the delivery of the hyperpolarised 
probe to the tissue of interest can be modelled as a sum of exponentials 
(Menichetti et al. 2012). In vitro it is reasonable to assume that the mixing 
between the hyperpolarised solution and the cells suspension or enzyme is 






4.4 Maximum Entropy/Nonlinear Least Squares Method  
In order to derive kinetic information on the underlying physiological or 
biochemical processes, multi-exponential time-series can be fitted to a function 
given by the discrete sum of exponentials as follows: 
 
 
                 
  




where Ai is the characteristic amplitude of the rate ri and nc is the total number 
of kinetic components contained in the data. The problem of finding the optimal 
value for the unknown parameters Ai, ri and nc is often formulated as an 
optimisation problem and a nonlinear least squares (NLS) algorithm is 
commonly used.  
This approach requires a priori knowledge of the nature of the tracer kinetics 
and it is likely to be hampered by the “multiple minimum problem”. NLS, through 
an iterative process, choose the optimal value for the unknown parameters by 
minimising the sum of squares of the vertical distances of the fitting curve and 
the data (Motulsky and Christopoulos 2004). This corresponds to find the global 
minimum of the surface formed by the curves generated by all possible 
combinations of values of the unknown parameters. When the number of kinetic 
rates to derive is high, this surface is characterised by multiple minima and in 
this condition it is likely that the NLS fails in discerning the global minimum from 
the surrounding local minima which do not minimise the sum of square. The 




depends on the initial values of the unknown parameters chosen that 
correspond to the point on the multidimensional curve where the algorithm 
starts to find the global minimum.  
Experimental time-series can alternatively be fitted to a continuous function 
defined in Equation 4.36. 
 
 







This formulation corresponds to the Laplace transform where the integral over 
the rate constant       is replaced by an integral over     . Experimental 
dynamic curves can be characterised by kinetic rates that differ by several 
orders of magnitude and therefore a logarithmic space is more appropriate for 
their derivation than a linear one. The distributions that best describe the data 
are obtained by applying the inverse Laplace transform to x(t) without any 
assumption on the nature of the metabolic conversion. The Laplace inversion of 
experimental data characterised by random noise is an ill-posed problem (e.g. 
an infinite number of solutions is available) and a regularisation strategy is 
required to find the optimal distribution         . The maximum entropy method 
(MEM) finds the unique optimum distribution         maximising the following 
function (Mohammad-Djafari et al. 2002): 
 





where the S is the entropy term and    is the normalised mean square error 
given by Equations 4.38 and 4.39 respectively (Steinbach et al. 2002).  
 
 
                                      
  
  
      
 




















where M in Equation 4.38 is the number of points in which the fitting function is 
estimated, whereas N in Equation 4.39 is the number of point in which the 
experimental measure is available.    is a vector containing the values of the 
MEM distribution that best approximates the experimental data at each time 
point.     is used during the optimisation process to filter artefacts from     
(Steinbach et al. 2002). This approach guarantees a unique solution 
independent on the initial guess of the model parameters. MEM, however, 
intrinsically forces    to follow     leading to biased results and non-random 
residuals (Steinbach et al. 2002).  
Steinbach and colleagues have proposed a new analysis method based on a 
hybrid Maximum Entropy/Nonlinear Least Squares method (MEM/NLS) that 
allows combining the advantages of NLS with those of MEM. Using MEM/NLS, 
the distribution of rates that best describes the experimental data is derived 
without any a priori assumption of the number of the kinetic processes 




The MEM/NLS algorithm is based on an iterative process that exploits a 
continuous distribution derived from the experimental data through MEM to 
insert one exponential at time in the NLS fit.  
In more details, as the first iteration of the MEM optimisation starts    is set equal 
to    . A Newton-Raphson optimisation of Q at fixed values of λ is followed by 
automatic adjustments of this Lagrange multiplier. During the optimisation of Q, 
S and Χ2 are progressively adapted to maximise Q. When the value of Χ2 stops 
changing appreciably (<1%) the optimisation of Q is terminated. At this point, 
the first NLS fit is performed with a number of exponentials equal to the total 
number of peaks in the MEM distribution. The initial values for the amplitude 
and the initial values of the discrete rates are set equal to the area under the 
curve and the mean of the peaks in the continuous solutions, respectively. The 
large and well resolved peaks in    are include in     unchanged, while the smaller 
and less resolved features are blurred before being added to    . Once the new     
is defined, the optimisation of Q is started afresh with       . Every time the 
MEM algorithm converges the number of peaks n in the continuous distribution 
is characterised and the NLS fit is performed with one exponential more than 
those used at the previous iteration. If the number of peaks in the continuous 
distribution is increased by more than one from the previous iteration, only the 
n+1 peaks with the largest AUC are considered for the NLS fit in an iterative 
process until all the peaks that appear in the continuous distribution are 
accounted for in the discrete fit. The MEM optimisation is terminated when the 




distributions are chosen according to the values of Χ2 and the correlation length 
of the residuals       given by the sum of the autocorrelation function |Cj| 
(Equation 4.40) over the first three quarters of the time interval: 
 
 
   
                   





    indicates the mean over i.       is a measure of the systematic deviation of 
the derived distribution from the data and therefore this index is very helpful in 
deciding which is the optimal fit among all those generated.  
The chosen optimal MEM distribution is the last one for which both Χ2 and       
have decreased by more than 1% from the previous MEM optimisation. While 
the chosen optimal NLS fit will be that characterised by the maximum number of 
exponentials, n, for which both Χ2 and       have decreased by more than 1% 




4.4.1 Hyperpolarised Dynamic Data 
As previously mentioned, hyperpolarised time-series of the injected molecule 
and its metabolites are characterised by a multi-exponential dynamics and 
therefore the MEM/NLS algorithm can be used to extract kinetic information of 




Assuming to have as input to the MEM/NLS algorithm two time-series 
corresponding to the evolution in time of the MR signal of the hyperpolarised 
molecule A and its metabolite B observed in vitro (impulse input function) then a 
possible MEM/NLS solution is:  
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where Ai and Bi are amplitudes and λij are kinetic rates.  
After deriving the number of kinetic rates that characterised the dynamic of 
hyperpolarised time-series, it is possible to associate a compartmental model to 
the metabolic pathway under certain hypotheses. It is however not possible to 
unequivocally associate a model to the data. A compartmental model that is 
compatible with this the MEM/NLS solution in Equations 4.41 and 4.42 is that 
shown in Figure 4.5 with Cp ≈ delta function. Under this hypothesis the 
amplitudes and the rates in Equations 4.41 and 4.42, derived without any 
assumption on the system studied, are related to the characteristic rates and 
amplitudes of a two-compartment, bidirectional kinetic model described by 
Equations 4.30 and 4.31 as follows: 
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Another possible solution that can be obtained by fitting the two time-series 
corresponding to the hyperpolarised molecule A and its metabolite B with the 
MEM/NLS algorithm is: 
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In this case a two-compartment, unidirectional (kAB = 0) compartmental model is 
compatible with the MEM/NLS solution. The relationship between the rates and 
the amplitudes derived with MEM/NLS and those characteristics of a two 
compartment, one-way reaction system (Equations 4.30 and 4.31 with kBA = 0) 
is: 
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By solving the system of linear algebraic equations (Equations 4.43-4.48 and 
4.51-4.56), it is possible to derive the unknown parameters C, r1A, r1B,     and 
   . 
 
 
4.5 Spectral-based Algorithm 
A different approach to derive information on the kinetic process contains in 
dynamic data is represented by SA (Cunningham and Jones 1993), originally 
proposed for the analysis of clinical PET data. This method does not need a 
priori assumptions about the structure of the system but it is applicable only to 
single input/output noncyclic systems (Schmidt 1999). In SA the concentration 
of the activity at time t, Ctiss(t), is modelled as a convolution of the plasma time-




                   
    
 
   




where αj and βj are assumed to be real and non-negative. The upper limit, M, 
represents the maximum numbers of terms to be included in the model and is 




predetermined and fixed in order to cover a range of all possible kinetic 
components measurable from the data. Commonly, the grid of values of the 
rates βj (β1< β2<…< βM) is defined as a logarithmic distribution with lower limit β1 
= 1/(3Tend), where Tend is the end time of the experiment, and upper limit βM = 
3/Tin (DiStefano 1981). Tin is the duration of the first time frame of the 
experiment. A component for β = 0 is included in the model corresponding to a 
fully trapped component. The M+1 values of αj are estimated using non-
negative least square (NNLS) estimator and normally only few components with 
αj > 0 are detected.  
It is possible that the value of βj that gives the best fit to the experimental data is 
not present in the predefined discrete grid. In this case the algorithm will choose 
two consecutive values of β that include the optimal value. Under the 
hypothesis that consecutive components in the SA solution are due to the effect 
just described, the components j and j+1 are replaced with a single new 
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Using this approach the kinetic processes contained in the experimental data 
are derived without any a priori knowledge of the system studied. A 




possible to determine an unequivocal correspondence between the spectrum of 
kinetic components derived through SA and a compartmental model (Gunn et 
al. 2001). When the purpose of SA is to find the number of kinetic components 
of the system, an alternative approach is to estimate the number of 
exponentials (M in Equation 4.57) necessary for the SA model to give a good fit 
to the data by using models of increasing order. This approach firstly presented 
by Bertoldo and colleagues (Bertoldo et al. 1998) is also called NLSA. 
For the implementation of NLSA, it is not necessary to specify a grid of values 
of βj and the M+1 unknown values of βj and αj are estimated through nonlinear 
fitting. The standard model parsimony criteria techniques, such as the Akaike 
information criterion (AIC) (Akaike 1971) or the Bayesian information criterion 
(BIC) (Schwarz 1978), can be used to choose the best model. The AIC or BIC 
index for a given model is written in the form: 
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where L is the likelihood function, P is the number of unknown parameters in 
the model, and k is 2 for AIC and log(np) for BIC, with np number of points in the 
dataset. BIC therefore penalises a model characterised by a larger number of 






4.6 Graphical Method: Patlak Plot 
Time-series describing the distribution of a given imaging agent can be 
alternatively fitted using graphical analysis techniques. This approach does not 
require any a priori assumption of the number of compartments involved in the 
distribution and uptake of the tracer but only the reversible or irreversible nature 
of the tracer. Graphical methods are based on the assumption that after a 
certain time from the intravenous injection into the system the movement of the 
tracer from and to the reversible compartment reaches equilibrium. Based  on 
this hypothesis it is possible to calculate the tracer distribution volume 
(reversible tracers) or the tracer uptake (irreversible tracers) using Logan 
(Logan et al. 1990) or Patlak (Patlak et al. 1983) graphical methods, 
respectively.  
This type of analysis, however, does not allow the complete characterisation of 
the tracer kinetics and only macro-parameters can be derived.  
In this thesis only time-activity of irreversible PET tracers such as [18F]-FDG and 
[18F]-FMISO were analysed and therefore the graphical method of choice was 
Patlak.   
Patlak and colleagues showed that the evolution in time of the amount of tracer 
in the region of tissue of interest, Ctiss(t), is given by: 
 
 
                   
 
 







Ki represents the net uptake rate of the tracer, V0 and Vb are the distribution 
volume in the reversible compartment and the fractional blood volume, 
respectively. Dividing Equation 4.61 by Cp(t): 
 
         
     
   
         
 
 
     




For tracers characterised by an irreversible trapping, the Patlak plot will result in 
a straight line, after sufficient equilibration time, with slope Ki and intercept V = 
V0 + Vb . The unknown macro-parameters Ki and V are obtained by linear 
regression from a graph of                against               
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4.7 Semi-quantitative Indices  
Semi-quantitative indices are common alternatives to the quantitative analysis 
methods introduced in the previous sections. They are easy and fast to 
calculate, but very sensitive to the experimental conditions. 
 
 
4.7.1 PET Dynamic Data 
SUV is a semi-quantitative analysis routinely used for the analysis of clinical 




ratio of tissue radioactivity concentration (        , MBq/Kg) at a specific time 
and the injected dose (e.g. MBq) divided by the body weight (e.g. Kg). 
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In ex vivo experiments the input function is delivered as an impulse with no re-
circulation and therefore the plasma radioactivity rapidly decays to zero. 
Additionally, the experimental set up used for the acquisition of time-activity 
curves of PET tracers (Section 3.5) ex vivo does not allow relating directly the 
measured activity to the concentration of the radioactive tracer injected. This is 
due to the fact that the time-activity curves are acquired from the arterial line 
above the heart cannula (input function) and from the heart using two different 
γ-detectors. As explained in Section 3.5, one γ-detector is placed perpendicular 
to the inflow line (input function), while the other is positioned in front of the 
Langendorff perfused rat heart (Figure 3.19). Due to this geometry, the amount 
of radioactivity detected by the due γ-detectors may differ and a unique 
calibration between the two is not guaranteed. For this reasons when ex vivo 
data are analysed the semi-quantitative index SUV cannot be computed as 
defined for in vivo experiments.  
In this thesis the normalised activity (NA) was defined as a surrogate of the 
traditional SUV. NA was calculated as a ratio of the mean tissue activity 
(        ) (CPS) over a small interval at the end of the experiment and the 
maximum value of Ctiss(t) (CPS) that replaced the normalised injected dose of 






    
                               
              




4.7.2 Hyperpolarised Dynamic Data 
Different semi-quantitative approaches have been proposed for deriving 
information on the enzymatic conversion of a molecule A to its metabolite B 
from hyperpolarised 13C MR spectra. The conversion of hyperpolarised pyruvate 
to bicarbonate was, for example, estimated using the ratio of the maximum 
intensity of the bicarbonate time-series to that of pyruvate in rat hearts 
(Schroeder et al. 2008) . This approach was shown to be sensitive enough to 
detect changed in the enzymatic activity. It is however not possible to relate 
mathematically this semi-quantitative index to the rate of enzymatic conversion 
kAB. In this thesis the ratio between AUC of metabolite A and B was used as 
semi-quantitative index for the characterisation of the enzymatic conversion of a 
molecule A into its metabolite B. This index was chosen not only because it was 
shown to be sensitive to changes in the rate of metabolic conversion but also 
because it is possible to mathematically relate this index to the forward rate of 
enzymatic conversion kAB (Hill et al. 2013). The relation between the AUC ratio 
and kAB can be derived from the Bloch-McConnell equations that describe the 
system studied. For example for the system shown in Figure 4.5 the Bloch-
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The Laplace transform of Equation 4.66 is: 
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By re-arranging the member in Equation 4.67 becomes: 
 
       
      
 
   





The general definition of Laplace transform for function X(t) is given by: 
 
 












Since the hyperpolarised signal of both metabolite A and B decays to the 
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The ratio between the area under the curve of metabolite B and A can be 
therefore used as a semi-quantitative index of the rate of forward conversion 
kAB. This method is easy to apply and does not require any knowledge of the 
delivery input function Cp(t). 
 
 
4.8 Monte Carlo Method 
The Monte Carlo method was firstly introduced in 1946 by Stanislaw Ulam a 
Polish-American mathematician who worked on the nuclear weapons project 
during the World War II. This approach includes a large number of 
computational algorithms which rely on running simulations many times in order 
to obtain the distribution of an unknown probabilistic entity.  
Monte Carlo simulations are especially useful for simulating phenomena 
characterised by a large uncertainty in inputs and system with many degrees of 
freedom. This method is commonly used in many different fields such as 
computational biology, computer graphics, applied statistics, finance and 
business.  
In this thesis Monte Carlo simulations were used to assess the performance of 
the analysis methods proposed. In particular, simulations were carried out in 
order to investigate the effect of the presence of the random noise normally 




algorithm, SA, NLSA in the estimation of the number of the kinetic processes 







































In this Chapter the results obtained from the hyperpolarised 13C dynamic 
experiments described in Chapter 3 are presented with particular reference to 
the [1-13C1] pyruvate-lactate exchange detected in vitro in whole blood cells 
(Section 5.2) and to the metabolic conversion of [1-13C1] pyruvate to its 
downstream metabolites observed ex vivo in perfused rat hearts (Section 5.3). 
The characteristic rates of the 13C pyruvate-lactate exchange were derived 
using three different approaches: (i) compartmental modelling (Section 5.2.1), 
(ii) MEM/NLS algorithm (Section 5.2.2) and (iii) semi-quantitative index AUC 
(Section 5.2.3). Compartmental modelling and AUC were also used to measure 
the rate of conversion of [1-13C1] pyruvate to H
13CO3
-
 via PDH ex vivo in 





5.2  In vitro Systems: Hyperpolarised [1-13C1] Pyruvate-Lactate 
Exchange in Whole Blood Cells 
The datasets presented in this Section were acquired as described in Section 
3.3 using a flip-angle θ = 10° to avoid the radiation damping effect described in 
Section 3.3.2. Figure 5.1 A shows a representative hyperpolarised MR 13C time-
series of three molecules, namely [1-13C1] pyruvate (~170.5ppm), [1-
13C1] 
pyruvate hydrate (~179ppm) and [1-13C1] lactate (~183ppm), detected in whole 
blood cells at 9.4T. [1-13C1] pyruvate hydrate is a not metabolically active 
molecule formed when [1-13C1] pyruvate is placed in an aqueous solution, 
whereas [1-13C1] lactate is produced from [1-
13C1] pyruvate through LDH. In 
Figure 5.1 B a detail of the evolution in time of the [1-13C1] lactate 
hyperpolarised peak is shown. Two factors contribute to the dynamics of the 
hyperpolarised signal of [1-13C1] pyruvate: (i) the loss of signal due to metabolic 
conversion of pyruvate to lactate and (ii) the relaxation of the hyperpolarised 
pyruvate signal to thermal equilibrium. Similarly, the build up of the [1-13C1] 
lactate hyperpolarised signal is due to the production of the molecule from [1-
13C1] pyruvate, while the decay is due to the relaxation of the hyperpolarised 







Figure 5.1: (A) Hyperpolarised 
13
C MR time-series of [1-
13
C1] pyruvate (~170.5ppm), [1-
13
C1] pyruvate hydrate (~179ppm) and [1-
13
C1] lactate (~183ppm) acquired in real time in 
whole blood cells. (B) Details of the [1-
13
C1] lactate hyperpolarised peak.  
 
 
5.2.1 Compartmental Modelling 
The metabolic conversion of hyperpolarised [1-13C1] pyruvate to [1-
13C1] lactate 
in vitro is an exchange reaction that is close to equilibrium and therefore it 
commonly approximated by a two-compartment, first-order, bidirectional model 
shown in Figure 4.4 where pyruvate and lactate are represented by 
compartment A and B, respectively. The input function Cp(t) is usually not 
considered in the modelling of this type of experiments as the hyperpolarised 
solution in mixed with the cell suspension before the sample is inserted into the 




type of model is described by a system of differential equations whose solution 
is presented in Equations 4.26 and 4.27. The characteristic rates of the 
exchange (kAB and kBA) as well as the effective relaxation rates of the 
hyperpolarised signal of the two molecules (r1A and r1B) can be derive by fitting 
the experimental data with Equations 4.26 and 4.27. In Figure 5.2 A the 
representative peak integrals of pyruvate (blue) and lactate (black) with overlaid 
fits (red) are plotted as function of time. In this thesis all residuals obtained from 
different fits are plotted normalised to the pyruvate peak value in agreement 
with previous hyperpolarised studies(Hill et al. 2013). Residuals obtained from 
the compartmental fit are presented in Figure 5.2 B in blue for pyruvate and in 
black for lactate. Their values were found to be in agreement with previous in 
vitro studies. The values obtained for the unknown parameters obtained by 
fitting the experimental datasets (n = 4) with a two-compartment, bidirectional 
kinetic model were: C = 1.01 ± 0.025 (a.u.), r1A = 0.028s
-1 ± 0.005s-1, r1B = 
0.034s-1 ± 0.011s-1, kAB = 0.006s
-1 ± 0.002s-1. The algorithm failed in estimating 
the values of kBA always returning the value of the lowest boundary condition 
set.  The coefficient of variation in percentage (%CVp) was estimated as index 
of the accuracy in the estimation of the unknown parameter p. The values 
reported were: %CVC = 0.45% ± 0.15%, %CVr1A = 2.61% ± 1.35%, %CV r1B = 
12.15% ± 9.51%, %CVKAB = 7.32% ± 3.4%.  
The quality of the fit did not change appreciably when the experimental datasets 
were fitted with a two-compartment, first-order, unidirectional model (Figure 4.4  
with kBA = 0). The values estimated for the four unknown parameters were 




1.01 ± 0.025 (a.u.), r1A = 0.027s
-1 ± 0.004s-1, r1B = 0.038s
-1 ± 0.0051s-1, kAB = 
0.006s-1 ± 0.002s-1. The %CV calculated for each parameter was: %CVC = 
0.37% ± 0.12%, %CVr1A = 1.8% ± 0.97%, %CVr1A= 6.46% ± 2.94%, %CVKAB = 








pyruvate (blue) and [1-
13
C1] lactate (black) with 
overlaid fits plotted as a function of time. (B) Residuals normalised to the peak value of 




5.2.2 MEM/NLS Method 
The MEM/NLS method, presented in Section 4.4, was originally proposed by 
Steinbach and colleagues for the analysis of protein folding (Steinbach et al. 
2002). In this thesis the feasibility of using this approach for the kinetic analysis 




simulations over a range of known kinetics. After its validation the MEM/NLS 
algorithm was applied to the characteristic time-series of hyperpolarised 13C 
pyruvate-lactate exchange acquired in vitro in whole blood cells.  
 
 
5.2.2.1 Monte Carlo Simulations  
Two groups of Monte Carlo simulations were used in this thesis to assess the 
accuracy and reproducibility of the hybrid MEM/NLS algorithm for the kinetic 
characterisation of in vitro hyperpolarised data. Time-series representing the 
hyperpolarised peak integrals of uni- and bi-directional in vitro systems were 
simulated using  the solution of the Bloch-McConnell equations written for a 
two-compartment, first-order system (Equations 4.30 and 4.31, Figure 4.5Figure 
4.4). In this thesis the mixing of the hyperpolarized solution and the in vitro 
system was considered to be instantaneous and therefore Cp(t) was modelled 
as a delta function. 
 
In the first group of Monte Carlo simulations in vitro systems were simulated for 
four different values of kAB (kAB = 0.002s
-1
, kAB = 0.004s
-1
, kAB = 0.006s
-1
 and kAB 
= 0.008s-1), while the rates of decay of the hyperpolarised signals of 
compartment A and B were maintained constant in all systems simulated (r1A = 
0.0267s-1 and r1B = 0.045s
-1). Bidirectional systems were simulated considering 





The values of kAB and kBA used in the second group of Monte Carlo simulations 
are reported in Table 5.1. In this case, r1A and  r1B were randomly generated 
within a chosen interval ( 0.022s-1 < r1A < 0.04s
-1 and  0.03s-1 <  r1B < 0.05s
-1) for 
both uni- and bi-directional systems.  
 
 
Table 5.1: Values chosen for the rates of conversion kAB and kBA in the second group of 
Monte Carlo simulations where r1A and r1B were randomly generated within a chosen 
interval ( 0.022s
-1
 < r1A < 0.04s
-1
 and  0.03s
-1
 <  r1B < 0.05s
-1
). 
 Bidirectional Unidirectional 
 kAB kBA kAB kBA 
system 1 0.02 0.002 0.002 0 
system 2 0.04 0.004 0.004 0 
system 3 0.06 0.006 0.006 0 
system 4 0.08 0.008 0.008 0 




The rate values used in both groups of simulations were chosen within a 
physiological range characteristic of the in vitro conversion of pyruvate to lactate 
and in agreement with previous studies (Harris et al. 2009;  Hill et al. 2013;  Hill 
et al. 2013). In each dataset the time-series of both compartments were 
normalised to the maximum value of the time-series of compartment A and 
therefore the unknown parameter C in Equations 4.30 and 4.31 was always 
equal to 1. To assess the influence of random noise in the data, each dataset 
was simulated for a low and a high signal-to-noise ratio (SNR) (SNR = 20 and 
SNR=90) in the range of those found in our experimental data. Usually the 
lowest SNR detected in vitro is associated with the hyperpolarised time-series 




compartment B. In this study the SNR was calculated as the ratio between the 
maximum value of the time-signal intensity curve of compartment B and the 
standard deviation of the thermal equilibrium signal (noise) of the same curve 
(SNRB) (Santarelli et al. 2012). Datasets were simulated with Δt = 2s equal to 
the experimental TR used for the in vitro hyperpolarised experiments carried out 
in this thesis and repeated N = 100 times at each set of parameters.  
The ability of the MEM/NLS algorithm to derive the correct number of known 
kinetic components in the simulated data was firstly assessed. The values of C, 
r1A, r1B, kAB and kBA were subsequently derived by associating a compatible 
compartmental model to the MEM/NLS solution and solving the system of 
algebraic equations shown in Equations 4.43-4.48 and Equations 4.51-4.56 for 
bi- and uni-directional systems, respectively. These values were compared to 
the simulated reference values as well as to the estimates derived using 
conventional compartmental modelling. The percent bias (%BIAS) for the kinetic 
rates kAB and kBA was calculated as a performance index: 
 
 
            
          
     
 
 







where pj and pTRUE are the estimated and true value of the indices p.  
Monte Carlo simulations and the fit using compartmental models were 
performed using a custom-made Matlab (MathWorks®) code, whereas the fitting 
was performed with MeMExp software available online  




The results from Monte Carlo simulations showed that the hybrid MEM/NLS 
algorithm is able to discern between uni- and bi-directional in vitro systems by 
identifying the number of exponentials that describe the data. Figure 5.3 A and 
B show a representative simulated time-series for compartment A (blue) and B 
(black) with overlaid the MEM/NLS fits (red) for bi- and uni-directional systems, 
respectively. The random residuals obtained from the data fit, normalised to the 
peak value of the pyruvate time-series are shown in Figure 5.3 C and D in blue 
for compartment A and black for compartment B. Values were found in 
agreement with previous hyperpolarised in vitro studies. In both group of Monte 
Carlo simulations, the hybrid algorithm was able to derive two rates for 
compartment B from the time-series of both systems (black lines in Figure 5.3 E 
and F), while two and one exponentials are identified from the dynamic curve of 
compartment A of a bi- and uni-directional system, respectively (blue lines in 
Figure 5.3 E and F).  This is in agreement with the solution of the Bloch-
McConnell equations written for bi- and uni-directional in vitro systems 
(Equations 4.30 and 4.31 with Cp = delta function) in which the hyperpolarised 
time-series of compartment A is characterised by a bi- and mono-exponential 
dynamics, respectively. 
The percentage errors in identifying the number of components using the 
MEM/NLS algorithm from bi- and uni-directional systems are presented in Table 






Figure 5.3: Representative results from the hybrid MEM/NLS fit for bidirectional reaction 
kinetics, left panel, and unidirectional reaction kinetics systems, right panel.  ) and (B) 
show simulated datasets (coloured dots) and overlaid fits (coloured lines) plotted for 
compartments A (blue) and B (black). (C) and (D) Residuals, normalised to the peak value 
of the pyruvate time-series, from the fits shown in (A) and (B) are plotted in blue and 
black for compartment A and B, respectively. (E) and (F) show the kinetic rates resulted 
from the MEM/NLS analysis of the datasets shown in (A) and (B), respectively. Solid and 







The ability of the hybrid method in deriving the correct number of rates from the 
time-series of compartment A in general does not dependent on the SNRB in 
the range of noise values simulated as well as on the simulated value of kAB and 
kBA. For both groups of simulations and regardless the type (uni- or bi-
directional) system simulated, the percentage of correctness (CE) is > 90%, 
with the only exception of the bidirectional system in the second group of 
simulations simulated with the smallest kAB and the highest noise (CE = 64%) 
(Table 5.2 and Table 5.3).Results also suggested that the capability of the 
algorithm in deriving the correct number of exponentials from compartment B 
decreases with increasing values of kAB for all simulated systems. Similarly to 
compartment A, also in compartment B, SNRB played a minor role in the correct 
identification of the simulated components. 
The values of the apparent kinetic rates kAB and kBA were derived in both groups 
of simulation by associating a compatible compartmental model to the 
MEM/NLS solution as detailed in Section 4.4.1. The values calculated for kAB 
and kBA using the MEM/NLS algorithm and those obtained by fitting the data 
with a corresponding compartmental modelling are plotted against the values 
used as input to the Monte Carlo simulations in Figure 5.4. The values of kAB 
estimated for bidirectional systems using the hybrid algorithm for both group of 
simulations are in excellent agreement with those derived through 
compartmental modelling (reference) and the real values (Figure 5.4 A-C and 
D-F) regardless the SNRB and the value of kAB. In the first group of simulation 
where kBA = kAB, the MEM/NLS algorithm was not able to derive the correct 




kBA and SNRB simulated (Figure 5.4 B).  In the second group of simulations 
results show that the MEM/NLS algorithm is less accurate than traditional 
compartmental modelling in the estimation of the rate at lower values of kBA, 
nevertheless the values of kBA reported using the hybrid method are in a linear 






Table 5.2: Performance of MEM/NLS algorithm in identifying the number of kinetic components from simulated datasets. In this set of Monte Carlo 
simulations  r1A = 0.0267s
-1




BIDIRECTIONAL  SYSTEMS 
 
 
Compartment A Compartment B 
SNRB=20 SNRB=90 SNRB=20 SNRB=90 
Simulated scenario UE OE CE UE OE CE UE OE CE UE OE CE 
kAB = 0.002/kBA=0.002 8% -- 92% 1% -- 99% 1% 2% 97% -- -- 100% 
kAB = 0.004/ kBA =0.004 6% -- 94% 1% -- 99% 3% 4% 93% -- -- 100% 
kAB = 0.006/ kBA =0.006 5% -- 95% -- -- 100% 2% 7% 91% 9% 7% 84% 




Compartment A Compartment B 
SNRB=20 SNRB=90 SNRB=20 SNRB=90 
Simulated scenario UE OE CE UE OE CE UE OE CE UE OE CE 
kAB = 0.002 -- 4% 96% -- 1% 99% 1% 4% 95% -- 4% 96% 
kAB = 0.004 -- 9% 91% -- 5% 95% -- 6% 94% -- 1% 99% 
kAB = 0.006 -- 10% 90% -- 7% 93% 3% 4% 93% -- 4% 96% 
kAB = 0.008 -- 8% 92% 2% 8% 90% 2% 8% 90% -- 2% 98% 
 
kAB and kAB indicate the apparent rates  of enzymatic conversion. Units are in s
-1
.  UE = Underestimated number of components; OE = overestimated number 




Table 5.3: Performance of MEM/NLS algorithm in identifying the number of kinetic components from simulated datasets. In this set of Monte Carlo 
simulations r1A and  r1B were randomly generated within a chosen interval ( 0.022s-1 < r1A < 0.04s-1 and  0.03s-1 <  r1B < 0.05s-1). 
 
BIDIRECTIONAL  SYSTEMS 
 
 
Compartment A Compartment B 
SNRB=20 SNRB=90 SNRB=20 SNRB=90 
Simulated scenario UE OE CE UE OE CE UE OE CE UE OE CE 
kAB = 0.02/kBA=0.002 36% -- 64% -- 2% 98% 2% 4% 94% -- 5% 95% 
kAB = 0.04/ kBA =0.004 4% -- 96% 5% -- 95% 4% 8% 88% 1% 13% 86% 
kAB = 0.06/ kBA =0.006 5% -- 95% 5% -- 95% 1% 22% 77% 1% 23% 76% 




Compartment A Compartment B 
SNRB=20 SNRB=90 SNRB=20 SNRB=90 
Simulated scenario UE OE CE UE OE CE UE OE CE UE OE CE 
kAB = 0.002 -- -- 100% -- -- 100% 1% 5% 94% -- 5% 95% 
kAB = 0.004 -- 2% 98% -- -- 100% 2% 4% 94% -- 2% 98% 
kAB = 0.006 -- -- 100% -- -- 100% 3% 4% 93% -- 2% 97% 
kAB = 0.008 -- -- 100% -- -- 100% 5% 6% 89% -- 3% 97% 
 
kAB and kAB indicate the apparent rates  of enzymatic conversion. Units are in s
-1
.  UE = Underestimated number of components; OE = overestimated number 





Figure 5.4: Bidirectional in vitro systems: (A)-(B) and (D)-(E) show the values of kAB and 
kBA, respectively, derived using the MEM/NLS algorithm plotted for SNRB = 20 (black) and 
SNRB = 90 (gray) against the real values used as input to the two groups of Monte Carlo 
simulations. The values estimated for the same rates using a conventional two-
compartment, bidirectional kinetic model are plotted in the same figure in red. 
Unidirectional in vitro systems: (C) and (F) show the relationship between the values of 
kAB estimated through the MEM/NLS method and the real values for SNRB = 20 (black) 
and SNRB = 90 (gray) for the first and the second group of Monte Carlo simulations, 
respectively. The values estimated through a two-compartment, unidirectional kinetic 





This disagreement in the results is due to the different values chosen for kAB 
and kBA in the two groups of Monte Carlo simulations. In the first group of 
simulations kAB was chosen equal to kBA. In this particular case the values of the 
simulated rates λ      and λ      are much closer that those generated in the 
second group of Monte Carlo simulations where kAB >> kBA. Nevertheless, the 
MEM/NLS algorithm was able to discern the two rates equally well in the two 
groups of simulations (Table 5.2 and Table 5.3). The accuracy in the estimation 
of the values of λ      and λ     was however effected by the proximity of the 
two unknown rates to derive. 
The maximum and the minimum values of %BiasKAB and %BiasKBA estimated 
using the MEM//NLS algorithm are reported in Table 5.4 for both groups of 
Monte Carlo simulations. 
 
In light of the results obtained from the two groups of Monte Carlo simulations it 
possible to conclude that the MEM/NLs algorithm is adequate to characterise 
the kinetic of in vitro hyperpolarised time-series by identifying the number of 
kinetic rates that best describe the data. Additionally MEM/NLS algorithm is as 
accurate as compartmental modelling in the estimation of the values of kAB 
derived by associate a compatible compartmental model to the MEM/NLS 
solution. However the ability of the proposed approach in estimating the values 






Table 5.4: Maximum and the minimum values of %BiasKAB and %BiasKBA estimated using the MEM//NLS algorithm for both groups of Monte Carlo 
simulations. 
 BIDIRECTIONAL SYSTEMS UNIDIRECTIONAL SYSTEMS 


























































5.2.2.2 Experimental Data 
The hyperpolarised time-series in whole blood of pyruvate (blue) and lactate 
(black) with overlaid MEM/NLS fits (red) are plotted as function of time in Figure 
5.5 A. Fitting residuals are presented in Figure 5.5 B for both pyruvate (blue) 
and lactate (black). Figure 5.5 C shows the results of the MEM/NLS fits to the 
hyperpolarised 13C data. One discrete rate was derived through the hybrid 
algorithm from the pyruvate curve (blue line), whereas two rates were obtained 
from the lactate time-series (black lines). This solution is compatible with a two-
compartment, first-order, unidirectional compartmental model and therefore 
Equations 4.51-4.56 were used to derive the characteristic kinetic rates of the 
pyruvate (compartment A) to lactate (compartment B) conversion.  
The linear relationship between the values estimated for kAB (kAB = 0.0058s
-1 ± 
0.0020s-1, n=4) using the MEM/NLS approach and those derived using a two-
compartment, unidirectional kinetic model (kAB = 0.0059s
-1 ± 0.0022s-1, n=4) is 
plotted in Figure 5.5 D. The values reported for r1A and r1B were equal to 0.02s
-1 
± 0.002s-1 and 0.05s-1 ± 0.01s-1, respectively. The SNRB estimated for these 











pyruvate (blue) and [1-
13
C1] lactate (black) with 
overlaid fits plotted as a function of time. (B) Residuals normalised to the peak value of 
the pyruvate time-series and plotted as a function of time for pyruvate (blue) and lactate 
(black). (C) Representative kinetic rates derived through the MEM/NLS analysis. Solid 
and dashed lines correspond to rates with positive and negative amplitude, respectively. 
(D) The values of kAB, representing the rate of conversion of pyruvate to lactate via LDH, 
derived using the MEM/NLS approach are plotted against those obtained fitting the 
experimental data with a two compartments, first-order, unidirectional kinetic model.  
 
 
5.2.3 Semi-quantitative Index: AUC 
The AUC index for the 13C pyruvate-lactate exchange datasets was calculated 
as detailed in 0. In Figure 5.6, the results are plotted against the values of kAB 
estimated by fitting the same datasets with a two-compartment, first-order, 






Figure 5.6: AUC ratio values calculated for the 
13
C time-series acquired for the pyruvate-
lactate exchange are plotted against the kAB values obtained by fitting the same datasets 
with a two-compartment, first-order, unidirectional compartmental model.     
 
 
5.3 Ex vivo Systems: Metabolism of Hyperpolarised [1-13C1] 
Pyruvate Detected in Langendorff Perfused Rat Hearts   
13C MR dynamic spectra were acquired after the injection of the injection of 
50mM [1-13C1] pyruvate and 5.2µM gadolinium into two different groups of 
Langendorff rats hearts. The first group of isolated hearts (n = 5) was perfused 
using a Krebs-Henseleit buffer containing 11.1mM glucose, whereas the second 
group (n = 5) using a Krebs-Henseleit buffer containing 11.1mM glucose and 
2.5mM unlabelled pyruvate (Section 3.4.1). Hyperpolarised 13C spectra (ns = 




and a time resolution Δt = 2s (Section 3.4.5). Details of the type of Krebs-
Henseleit buffer and of the type of coil used in each experiment are reported in 
Table 3.4. Peaks were assigned by comparing the chemical shift of the 13C 
metabolites in the hyperpolarised spectra with the natural abundance 13C MR 
spectra of several common metabolites as detailed in Section 3.4.6. Figure 5.9 
A and B show a representative 13C hyperpolarised spectrum acquired from a 
perfused rat heart and the natural abundance 13C MR spectrum of lactate, 
aspartate, alanine, pyruvate and bicarbonate obtained by adding together the 
spectra of the different amino acids (Appendix A), respectively.  
A schematic diagram of the metabolic pathways observed after the injection of 
hyperpolarised [1-13C1] pyruvate into Langendorff perfused rat hearts is shown 
in Figure 5.10. The metabolic conversion of hyperpolarised [1-13C1]
 pyruvate to 
lactate catalysed by LDH, to alanine catalysed by alanine transaminase (ALT), 
to bicarbonate catalysed by PDH, and interconversion of bicarbonate and CO2 
catalysed by carbonic anhydrase (CA) were observed for both groups of 
perfused rat hearts. The conversion of hyperpolarised [1-13C1] pyruvate to 
aspartate C1 and C4 by transamination via oxaloacetate was detected only for 
the group of Langendorff hearts perfused with a Krebs-Henseleit buffer 
containing 11.1mM glucose only. This is attributed to anaplerotic metabolism via 
the action of pyruvate carboxylase (PC). The C1 label appears from direct 
conversion of pyruvate via oxaloacetate. It has been suggested that the C4 
signal in aspartate arises from TCA cycle conversion of oxaloacetate to malate 
and fumarate where the position of the hyperpolarised signal is scrambled in 













time-series acquired after the injection of a solution of [1-
13
C1] pyruvate and gadolinium 
into Langendorff rat hearts perfused with a Krebs-Henseleit buffer containing 11.1mM 
glucose only. Lac = lactate, PyrH = pyruvate hydrate, Asp = aspartate, Ala = alanine, Pyr 













time-series acquired after the injection of a solution of [1-
13
C1] pyruvate and gadolinium 
is shown for each heart perfused with a Krebs-Henseleit buffer containing 11.1mM 
glucose and 2.5mM pyruvate. Lac = lactate, PyrH = pyruvate hydrate, Asp = aspartate, Ala 














time-series acquired after the injection of a solution of [1-
13
C1] 
pyruvate and gadolinium into Langendorff rat hearts perfused with a Krebs-Henseleit 
buffer containing 11.1mM glucose only. (B) Natural abundance 
13
C MR spectrum of 
lactate, aspartate, alanine, pyruvate and bicarbonate obtained by adding together the 
spectra of the different amino acid spectra shown in the Appendix A. Lac = lactate, PyrH 
= pyruvate hydrate, Asp = aspartate, Ala = alanine, Pyr = pyruvate, Bic = bicarbonate. 
 
The aspartate C4 signal was less intense than the aspartate C1 signal. 
However, oxaloacetate, malate or fumarate where not observed and therefore it 
was not possible to distinguish between this process and a possible direct 





Figure 5.10: Schematic representation of pyruvate metabolism with the metabolites 

















 under the 
action of LDH, ALT, PDH, respectively, was detected for both groups of hearts. The 
conversion of [1-
13
C1] to oxalocetate through
 
pyruvate carboxylase (PC) and the 
transamination of oxaloacetate to aspartate were detected only in the group of heart 
perfused with a buffer containing 11.1mM glucose. The outer box corresponds to the 
plasma membrane whilst the inner box is the mitochondrial membrane. Figure adapted 






Figure 5.11 A and B show a representative 13C time-series of pyruvate, lactate, 
alanine and H13CO3
- acquired from isolated rat hearts perfused with 11.1mM 





Figure 5.11: Representative 
13
MR time-series of [1-
13





 for Langendorff rat hearts perfused with a Krebs- Henseleit buffer containing (A) 
11.1mM glucose and (B) 11.1mM glucose plus 2.5mM pyruvate. 
 
 
The two groups of hearts mainly differed in the H13CO3
- time-series dynamics. 
In those acquired from isolated heart perfused with only glucose the build up of 
the H13CO3




9.28s before the peak value of the pyruvate curve. H13CO3
- time-series acquired 
from Langendorff hearts perfused with glucose and pyruvate were characterised 
by a slower build up reaching a maximum value at the same time or soon after 
that of the pyruvate peak value. The dynamics of the H13CO3
- curves of the two 
groups of hearts will be investigated in more details in the following Sections. 
 
 
5.3.1 Compartmental Modelling 
The metabolic pathway that has been most assessed in the heart using 
hyperpolarised 13C MR is that characterised by the conversion of pyruvate to 
Acetyl-CoA via PDH (Figure 5.12). In this reaction the mitochondrial cofactors 
NAD+ and Co-A are necessary to convert pyruvate to Acetyl-CoA. The resultant 
CO2 is rapidly converted to HCO3




Figure 5.12: Schematic representation of the metabolic conversion catalysed by PDH that 
converts [1-
13
C1] pyruvate to Acetyl-CoA utilising the mitochondrial cofactors NAD
+
 and 
CoA.  The resultant CO2 is rapidly converted to HCO3
- 





Previous studies have shown that it is possible to derive the apparent rate of the 
metabolic conversion of PDH fitting the experimental hyperpolarised time-series 
of [1-13C1]
 pyruvate and H13CO3
- (Schroeder et al. 2010;  Schroeder et al. 2011). 
It has been commonly assumed that the metabolic conversion of pyruvate to 
H13CO3
- follows first-order kinetics and therefore in order to derive the 
characteristic rates of the system experimental time-series have been fitted 
using a two-compartment, first-order, unidirectional kinetic model (Figure 4.5). 
This approach has been shown to be adequate for the analysis of data acquired 
in vivo where it is possible to assume that the enzyme cofactors are 
regenerated faster than they are consumed. The validity of first-order kinetics 
however has not been demonstrated for data acquired ex vivo where the 
metabolism of the heart and its ability to regenerate the enzyme cofactors 
greatly depends on the substrate contained in the Krebs-Henseleit buffer.  In 
the following sections the time-series of pyruvate and H13CO3
-
 acquired for the 
two groups of Langendorff perfused hearts are fitted using two different 
compartmental models and the results are compared. 
 
 
5.3.1.1 First-order Kinetics 
Experimental time-series of [1-13C1] pyruvate and H
13CO3
- acquired from the 
two groups of perfused rat hearts were fitted using a two-compartment, first-
order, unidirectional model (Figure 4.5). The input function (Cp) was modelled 






             
       
            




Where A, alpha and beta are parameters that characterised the shape of the 
input function, whereas tarrival is the time point in which the hyperpolarised signal 
of pyruvate is first detected. In this case kAB corresponds to the rate of 
conversion of hyperpolarised [1-13C1] pyruvate to H
13CO3
- via PDH. Figure 5.13 
(A) and (B) show a representative peak integrals of [1-13C1] pyruvate (blue) and 
H13CO3
- (black) with overlaid fits (red) acquired from Langendorff rat hearts 
perfused with a Krebs-Henseleit buffer containing 11.1mM glucose only and 
11.1mM glucose plus 2.5mM pyruvate, respectively.  
Regardless, the initial condition chosen for the NLS fitting, the chosen 
compartmental model was not able to fit correctly the H13CO3
-
 time-series 
characterised by a fast build up and corresponding to those acquired from 
isolated hearts perfused with glucose only (Figure 5.13 A). However, the 
H13CO3
- time-series acquired from the group of hearts perfused with glucose 
and pyruvate were well fitted using first-order, two-compartment, unidirectional 
model. The value of kAB estimated for this last group of hearts was 0.014s
-1 ± 














 (black) with overlaid 
fits (red) for the group of Langendorff hearts perfused using a Krebs-Henseleit buffer 
containing (A) 11.1mM glucose only and (B) 11.1mM glucose plus 2.5mM pyruvate. (C) 
and (D) show the residuals normalised to the peak value of the pyruvate time-series and 




 (black) to the fits in (A) and (B), respectively.  
 
 
5.3.1.2 Second-order Kinetics 
The results presented in the previous section suggested that the conversion of 
hyperpolarised [1-13C1] pyruvate to H
13CO3
- does not follow simple first-order 
kinetics in Langendorff rat hearts perfused with a Krebs-Henseleit buffer 
containing 11.1mM glucose only. As mentioned before the assumption that the 

















 (black) with overlaid 
fits (red) for the group of Langendorff hearts perfused using a Krebs-Henseleit buffer 
containing (A) 11.1mM glucose only and (B) 11.1mM glucose plus 2.5 mM pyruvate. The 
cofactor dynamics is represented in (A) and (B) in green on the same arbitrary scale.  (C) 
and (D) show the residuals normalised to the peak value of the pyruvate time-series and 




  (black) to the fits in (A) and (B), respectively.  
 
 
To investigate whether the enzymatic reaction assessed was limited by the 




unidirectional model (Figure 4.7) was used to fit the experimental data. The 
time-series of pyruvate and H13CO3
- presented in Figure 5.13 A are plotted with 
overlaid the fit derived from the second-order model in Figure 5.14 A. Residuals 
are presented in Figure 5.14 B. Using this approach the experimental curves of 
both metabolites are well fitted suggesting that the metabolic conversion 
catalysed by PDH in isolated hearts perfused with only 11.1mM glucose most 
probably follows second-order rather than first-order kinetics. The value of kAB 
derived was 0.006s-1 ± 0.0009s-1 with a corresponding %CVKAB equal to 35.2% 
±  34.9%.  
Even if well fitted with first-order compartmental model, the datasets acquired 
from the group of hearts perfused with 11.1mM glucose plus 2.5mM pyruvate 
were also analysed using a two-compartment, second-order, unidirectional 
model. The value of kAB derived in this case was 0.0015s
-1 ± 0.0002s-1. The 
value estimated for %CVKAB for the second group of hearts using second-order 
kinetics was equal to 51% ± 42.5%, significantly lower that reported for the 
same group of dataset using first-order kinetic model (p < 0.05). This result 
suggests that also the group of isolated hearts perfused with glucose plus 
pyruvate is better characterised by second-order rather that first-order kinetics. 
The values of mean ± SD reported for kAB fitting the experimental datasets 
using a two-compartment, second-order, unidirectional model are presented in 
Figure 5.15 for both groups of perfused hearts assessed. Statistical analysis 












 using a two-compartment, second-order, unidirectional kinetic 
model for isolated hearts perfused with Krebs buffer containing 11.1mM glucose only 
(red) and 11.1mM glucose plus 2.5 mM pyruvate (orange). * indicates p < 0.05. 
 
 
The values of kAB estimated for the group of Langendorff rat hearts perfused 
with only 11.1mM glucose were significantly higher than those reported for the 
group of hearts perfused with 11.1mM glucose and 2.5mM pyruvate (p < 0.05). 
 
 
5.3.2 NADH Surface Fluorescence 
The results from the kinetic analysis of experimental hyperpolarised 13C time-
series acquired from Langendorff rat hearts perfused with two different Krebs-
Henseleit buffers suggested that the metabolic conversion of hyperpolarised [1-
13C1] pyruvate to H
13CO3
- via PDH likely follows second-order rather than first-
order kinetics. In other words the PDH activity in perfused rat hearts depends 




conversion of pyruvate to acetyl-CoA using the mitochondrial cofactors NAD+ 
and CoA (Figure 5.12). In order to relate the results obtained from the kinetic 
analysis to the underlying biology a real time measurement of the enzymatic 
cofactors is desirable. In this Section a preliminary study aimed at the real time 
measurement of NAD+ cofactor concentration in perfused rat hearts during the 
injection of a 50mM pyruvate solution is presented. NAD+ accepts electrons  
during the metabolic conversion (oxidation) of pyruvate to Acetyl-CoA (Figure 
5.12). This coenzyme is, therefore, found in two forms in cells: NAD+ that 
accepts electrons from pyruvate and becomes reduced to NADH. Previous 
studies have shown the possibility of using surface fluorescence imaging to 
measure the characteristic fluorescence intensity of the cofactors that is 
proportional to fluorophore concentration. Using this imaging modality it is only 
possible to detect the signal from NADH as NAD+ does not fluoresce.  
In this thesis a preliminary NADH surface fluorescence imaging experiment of 
perfused hearts was performed by Dr. Coert Zuurbier at the University of 
Amsterdam. A Langendorff rat heart was perfused with a Krebs-Henseleit buffer 
identical to that used for the hearts perfused at St. Thomas’ hospital and 
containing 11.1mM glucose only. Fluorescence imaging of NADH was carried 
out during the injection of a 50mM pyruvate solution (to mimic the 
hyperpolarised experimental protocol) by digital video recording with a temporal 
resolution Δt = 1s. The fluorescence intensity of NADH averaged over the whole 
heart is plotted as a function of time in Figure 5.16 where t = 0 corresponds to 
the point in which the infusion of 50mM pyruvate solution was started. It is 




this coenzyme, increased throughout the experimental protocol. Assuming that 
[NAD+] + [NADH] is constant during the experimental time, the increase in 
NADH concentration corresponds to a decrease in NAD+ availability. This is in 




Figure 5.16: A representative NADH fluorescence signal acquired from a Langendorff rat 
heart perfused with a Krebs-Henseleit buffer containing 11.1mM glucose in which a bolus 
of 50mM pyruvate is injected though an injection pump. t = 0 represents the time point in 
which the infusion of the pyruvate was started. 
 
 
5.3.3 Semi-quantitative Index: AUC 
Figure 5.17 shows the AUC ratio values calculated for the conversion of 
hyperpolarised [1-13C1] pyruvate to H
13CO3
- estimated from the experimental 




Henseleit buffer containing 11.1mM glucose only (blue) and 11.1mM glucose 
plus 2.5mM pyruvate (red) plotted against kAB values obtained by fitting the 
same datasets with a two-compartment, second-order, unidirectional 
compartmental model. For this set of datasets the AUC ratio was found not to 
be proportional to the values of kAB regardless the compartmental model chosen 











 estimated from experimental time-series acquired from Langendorff 
rat hearts perfused with a Krebs-Henseleit buffer containing 11.1mM glucose only (blue) 
and 11.1mM glucose plus 2.5mM pyruvate (red) plotted against kAB values obtained by 
fitting the same datasets with a two-compartment, second-order, unidirectional 





5.4 Discussion  
The conversion of hyperpolarised [1-13C1] pyruvate to [1-
13C1] lactate and [1-
13C1] pyruvate hydrate was detected in vitro in whole blood cells. Lactate is 
produced from pyruvate via LDH, whereas the pyruvate hydrate is formed when 
pyruvate is placed in aqueous solution. In order to quantify the characteristic 
rates of pyruvate-lactate exchange the hyperpolarised 13C time-series of the two 
molecules were fitted using two quantitative and one semi-quantitative analysis 
methods. If compartmental modelling is the standard analysis method for 
hyperpolarised data, MEM/NLS algorithm has been previously proposed for the 
kinetic analysis of protein folding and has never been applied to hyperpolarised 
data. In this thesis the feasibility of using the MEM/NLS algorithm for the 
analysis of hyperpolarised data was assessed using Monte Carlo simulations. 
After its validation, the proposed method was used to derive the characteristic 
kinetic rates of the pyruvate-lactate exchange and the results were compared 
with those obtained from the analysis of the experimental data with 
compartmental modelling. The results from Monte Carlo simulations showed the 
MEM/NLS algorithm is able to discern between uni- and bi-directional systems 
by identifying a different number of rates from the hyperpolarised time-series of 
compartment A. Additionally it was shown that under certain hypothesis it is 
possible to associate a compatible compartmental model to the MEM/NLS 
solution. Solving a system of algebraic equations shown in Equations 4.43-
4.48and 4.51-4.56 for bi- and uni-directional systems, respectively, it is also 
possible to derive the value of the kinetic rates (C, r1A, r1B, kAB and kBA) 




estimating the value of kAB with the MEM/NLS algorithm was comparable with 
that of conventional compartmental modelling for both types of systems. 
However the ability of the hybrid method in estimating the values of kBA 
depends on the values of kAB and kBA. When applied to in vitro hyperpolarised 
13C time-series of pyruvate-lactate exchange in whole blood cells the MEM/NLS 
algorithm identified one rate from the pyruvate time-series, whereas two rates 
were detected from the lactate time-series. The conversion of pyruvate to 
lactate catalysed by LDH is an exchange reaction that is close to equilibrium. In 
the absence of other information, it would be therefore reasonable to fit the 
experimental data with a two compartment, bidirectional kinetic model as 
presented in Section 5.2.1. MEM/NLS however identifies only a single rate for 
the pyruvate curve suggesting that the experimental data reflect a unidirectional 
enzymatic conversion rather than exchange reaction as known from the biology. 
We speculate that in this experiment, carried out in a suspension of blood cells, 
the concentrations are compartmentalised according to the intracellular and 
extracellular volume fractions. The signal from hyperpolarised pyruvate would 
therefore be dominated by the large extracellular pool which is not in exchange 
and the decay of the hyperpolarised signal is then characterized by the T1 
relaxation time of this compartment with only the smaller cytosolic pool being in 
exchange with intracellular lactate. This information is lost when the data are 
analysed with a compartment model assuming a priori a bidirectional reaction.  
The value of kAB for the conversion of pyruvate to lactate derived using the 
MEM/NLS algorithm were found to be in very good agreement with those 




previously published (Hill et al. 2013). The semi-quantitative index AUC 
calculated for the pyruvate-lactate exchange was found to be linearly 
proportional to the values of kAB estimated using a two- compartment, 
unidirectional model (Figure 5.6) in agreement with previous studies (Hill et al. 
2013).  
Hyperpolarised 13C spectra of pyruvate and its metabolites were acquired from 
two different groups of perfused rat hearts. Peaks corresponding to [1-13C1] 
pyruvate, [1-13C1] lactate, [1-
13C1] alanine and H
13CO3
- were detected for both 
groups of hearts, whereas those attributed to aspartate C1 and C4 were 
identified in the group of Langendorff hearts perfused with a Krebs-Henseleit 
buffer containing 11.1mM glucose only but not in those perfused with 11.1mM 
glucose plus 2.5mM pyruvate. The aspartate C1 and C4 peaks observed in the 
isolated hearts perfused with only glucose were previously described in the 
liver, where AcetylCoA is produced via anaplerosis (Merritt et al. 2011) but 
never in the heart. Anaplerotic reactions are also essential in the heart to 
maintain the intermediates of the TCA cycle (e.g. oxaloacetate, malate, α-
ketoglutarate) constant under different metabolic conditions. It has previously 
been reported under similar perfusion conditions that 80% of the acetyl-CoA 
generated in the heart arises from pyruvate metabolism whilst only 8-10% is 
attributed to anaplerosis. To verify that the hearts perfused in this thesis were 
characterised by an energetic state similar to those reported in previous studies, 
the PC and PDH activity were estimated dividing the maximum intensity of the 
aspartate C1 and H13CO3
- peak, respectively, to the maximum intensity of the 




metabolism was approximately 7% the total metabolism (anaplerotic + pyruvate 
metabolism) and therefore in good agreement with that reported previously 
(Moreno et al. 2010). To date, anaplerosis has only been studied using 13C-
isotopomer analysis by MR (Malloy et al. 1988;  Chatham et al. 2003;  Merritt et 
al. 2007;  Moreno et al. 2010), but no real-time estimation of this important 
metabolic pathway has been carried out. 
The difference in the number of metabolites identified in the characteristic 
hyperpolarised 13C MR spectra acquired from the two groups of Langendorff 
perfused rat heart could also be due to the different sensitivity of the two coils 
(23Na/13C saddle coil and 1H/13C birdcage coil) used in this thesis. In the tube 
containing the perfused heart and its perfusion solution the concentration of 1H 
was higher than that of 23Na. It is therefore likely that the shimming performed 
using the signal from the first type of nucleus was more efficient than that 
performed on the second type of nucleus. The spectra acquired using the 
1H/13C birdcage coil would therefore be characterised by a narrow bandwidth 
than those acquired using the 23Na/13C saddle coil. Narrower the bandwidth, 
better metabolites characterised by adjacent frequencies of resonance can be 
discern in the hyperpolarised 13C MR spectrum. However, as detailed in Table 
3.4 most all the hyperpolarised 13C MR spectra acquired from the Langendorff 
hearts perfused with glucose plus pyruvate, and for which the aspC1 and aspC4 
peaks were not observed, were acquired with the 1H/13C birdcage coil which, for 
what mentioned above, is likely to be characterised by a higher sensitivity than 
the 23Na/13C saddle coil. Additionally, the spectra acquired from the Langendorff 




were acquired using both types of coils and the aspartate peaks were always 
detected regardless the type of coil used.      
The most widely explored application of hyperpolarised 13C MR in the heart is 
the measurement of the characteristic rate constant of PDH. Previous studies 
have shown that it is possible to derive this rate by fitting the hyperpolarised 
time-series of [1-13C1] pyruvate and H
13CO3
- with a two compartments, first-
order, unidirectional compartmental model. This assumes that the PDH activity 
is not limited by the enzyme cofactors availability and therefore that the 
cofactors are regenerated quicker than consumed. This condition may be true in 
vitro where often the coenzymes are added in stoichiometric amount or in vivo 
where the heart metabolic substrates are regenerated via a number of 
competitive metabolic pathways. Langendorff hearts for hyperpolarised 
experiments are commonly perfused with Krebs-Henseleit buffers containing 
glucose (or glucose plus pyruvate) but not fatty acids because the physiological 
long-chain fatty acids bound to albumin shortening the characteristic T1 making 
more difficult the real time detection of the hyperpolarised molecules involved in 
the metabolic pathway assessed (Moreno et al. 2010). Due to the uniqueness of 
the experimental protocol exploited for the hyperpolarised experiments in 
perfused hearts it was necessary to verify if the metabolic conversion catalysed 
by PDH does not depend on the availability of the enzyme cofactor as 
previously reported for in vitro and in vivo experiments. With this aim the 
hyperpolarised time-series of pyruvate and H13CO3
- acquired for both groups of 
perfused hearts were fitted with both a first and second-order compartmental 




perfuse the isolated hearts the conversion of pyruvate to H13CO3
- appears to 
follow second-order rather than first-order kinetics as previously suggested for 
in vivo and in vitro experiments. Two co-factors are involved in the metabolic 
conversion catalysed by PDH: NAD+ and CoA. In this thesis a study was carried 
out in collaboration with the University of Amsterdam in order to assess the 
dynamic of cofactor NAD+ in perfused rat hearts during the injection of a 50mM 
pyruvate solution using fluorescence imaging. Although at very preliminary 
stage, results showed that NAD+ is depleted during the injection of pyruvate 
suggesting the possibility that the PDH activity is limited by the availability of 
this cofactor in perfused hearts.  
The value of the apparent rate of conversion of pyruvate to H13CO3
- (kAB) 
estimated using a two-compartment, second-order, unidirectional kinetic model 
was significantly lower for the group of isolated hearts perfused with a Krebs-
Henseleit buffer containing 11.1mM glucose plus 2.5mM pyruvate than that 
reported for the group of hearts perfused with only 11.1mM glucose (Figure 
5.15). It is possible that perfusing the isolated hearts with a Krebs buffer 
containing 11.1mM glucose plus 2.5 mM pyruvate results in a baseline value of 
the cofactors NAD+ at the moment of the injection of hyperpolarised pyruvate 
significantly lower than that characteristic of isolated rat hearts perfused with 
Krebs buffer containing only 11.1mM glucose. As a result, in the pyruvate 
perfused hearts the PDH activity is significantly lower due to the reduced 
amount of NAD+ available.  It is also possible that the lack of the metabolic 
peaks corresponding to aspartate C1 and C4 in the 13C MRS spectrum of 




the lower availability of NAD+ in the mitochondria. The conversion of malate to 
oxaloacetate, part of the TCA, as well as the aspartate-malate shuttle depends 
on the availability of NAD+. Therefore, it is plausible that the production 
aspartate C1 and C4 is stopped or drastically reduced when the availability of 
the cofactor NAD+ is low. 
The semi-quantitative index AUC was also estimated for the conversion of 
hyperpolarised [1-13C1] pyruvate to H
13CO3
-. In contrast to what is reported for 
the pyruvate-lactate exchange detected in vitro in whole blood cells, AUC was 
found not to be directly proportional to the PDH enzymatic rate regardless the 
compartmental model used for the determination of kAB. This is probably due to 
the fact that the conversion of pyruvate to H13CO3
- does not follow first-order 
kinetics for which has been shown the proportionality of the AUC ratio to the 
rate of metabolic conversion kAB estimated using compartmental modelling.  
All analysis methods used in this thesis to characterise the metabolic 
conversion of hyperpolarised 13C pyruvate to its metabolites both in vitro and ex 
vivo do not account for the measurement error. In the experimental MR 
protocols used in these types of studies each point of the hyperpolarised time-
series is acquired using the same experimental time. The error associated with 
the measurement can be therefore considered equal at each time point. For this 
reason un-weighted estimators has been commonly used in previous studies for 
the analysis of hyperpolarised time-series (Menichetti et al. 2012;  Hill et al. 
2013) . 
The results presented in this Chapter show that the experimental protocol 




hyperpolarised [1-13C1] pyruvate to its downstream metabolites both in vitro in 
whole blood cells and ex vivo in Langendorff rat hearts. There are, however, 
some limitations in the methodologies used in this thesis that have to be 
considered. All experiments presented in this Chapter were carried out during 
the optimisation of the experimental protocol for the hyperpolarisation of 
metabolically active molecules, heart perfusion, and MR acquisition. The 
datasets are therefore characterised by some variability in the intensity of the 
metabolite peaks (Figure 5.7 and Figure 5.8).  Additionally, in the experiments 
carried out in the early stage of this thesis the cardiac function was not 
monitored due to the lack of an MR compatible system, meaning that it was not 
possible to assess the consistency of the heart perfusion protocol after it was 
inserted into the spectrometer. In future studies, hyperpolarised time-series of 
[1-13C1] pyruvate and its downstream metabolites will be acquired using the 
same optimised experimental protocol and cardiac contractility will be monitored 
throughout each experiment. 
The kinetic analysis of the hyperpolarised time-series of [1-13C1] pyruvate and 
H13CO3- suggested that the metabolic conversion catalysed by PDH follows 
second-order kinetics rather than first-order kinetics as speculated for in vitro 
and in vivo data. A preliminary study suggested that availability of NAD+ may be 
reduced during the injection of a 50mM pyruvate solution in Langendorff rat 
hearts perfused with a Krebs buffer containing 11.1mM glucose only. Further 
studies are however needed to confirm this hypothesis. In future studies, the 
dynamics of the cofactor NAD+ during the injection of a 50mM pyruvate solution 




hearts; one group will be perfused with a Krebs-Henseleit buffer containing only 
11.1mM glucose while the buffer used to perfuse the second group will contain 
11.1mM glucose plus 2.5mM.   
Compartmental modelling suggests that the hyperpolarised signal from the 
cofactor is characterised by sigmoidal dynamics starting to decay as soon as 
the hyperpolarised pyruvate arrives to the perfused heart and reaches a 
minimum after ten-twenty seconds (Figure 5.14). A more complete 
compartmental model that will be developed in the future will not model 
hyperpolarised signals but concentrations. In order to do so it is necessary to 
add three additional compartments representing the thermal equilibrium signal 
of pyruvate, H13CO3
- and cofactor to the compartmental model presented in 
Figure 4.7.  
In the compartmental models developed in this thesis the rate of uptake across 
the mitochondria membrane of the hyperpolarised pyruvate was not included 
assuming that the formation of the pyruvate products is limited by the rate of the 
enzymatic conversion rather than by the uptake of the hyperpolarised solution. 
Pyruvate is transported within mitochondria through specific proteins. The rates 
of uptake of this molecule can therefore limit the formation of pyruvate 
metabolites such as bicarbonate. The transport of hyperpolarised pyruvate 
across the mitochondria membrane will be included in future compartmental 
models.      
Additional details on the dependency of the PDH activity on the enzyme 
cofactor concentration may be derived using the hybrid MEM/NLS algorithm for 




shown that the MEM/NLS algorithm is an adequate tool for the kinetic analysis 
of in vitro hyperpolarised dynamic data however the extension of this analysis 
method to ex vivo data needs further considerations. In this thesis the proposed 
algorithm was tested for the sensitivity to noise of the hybrid method only for a 
range of SNRBs typical of in vitro experiments (20 < SNRB < 90).   
Hyperpolarised time-series acquired ex vivo exhibit higher noise levels than 
those detected in vitro. The performance of the MEM/NLS algorithm at lower 
SNRBs should be therefore accurately assessed before extending this method 
to the analysis of ex vivo data. Extending this method to the analysis of ex vivo 
data also requires further consideration on the input function.  The 
measurement of the optimal input function during hyperpolarised ex vivo 
experiments is still an unsolved problem. The hyperpolarised signal of the 
injected molecule cannot be used as an input function because it contains 
information on the delivery of the molecule but also on its metabolic conversion. 
Recent studies have proposed methods to obtain an accurate measure of the 
delivery input function directly by measuring the hyperpolarised signal of the 
injected molecule in the tube used to perfused the heart or indirectly by 
detecting the hyperpolarised signal of urea, a non metabolically active 
compound, injected into the system at the same time of the metabolite of 
interest (von Morze et al. 2012;  Kazan et al. 2013). With an accurate 
knowledge of the delivery input function, the hyperpolarised time-series of 






5.5 Conclusion  
This Chapter presented the results of the in vitro and ex vivo hyperpolarised 
experiments whose acquisition protocols are detailed in Chapter 3. The 
metabolic conversion of hyperpolarised [1-13C1] pyruvate to its downstream 
metabolites was detected in vitro in whole blood cells and ex vivo in 
Langendorff rat hearts.  In order to quantify the rate of the metabolic 
conversions observed using hyperpolarised 13C MR, experimental time-series  
were fitted using the analysis methods presented in Chapter 4. For in vitro data 
the results from the Monte Carlo simulations showed that the MEM/NLS 
algorithm is able to identify the number of exponentials that describe the time-
series of hyperpolarised data. It is then possible under certain hypothesis to 
associate a compatible compartmental model to the MEM/NLS solution and 
derive the characteristic kinetic rates of the system assessed. In this Chapter 
the combination of the hybrid MEM/NLS algorithm was shown to be able to 
derive information on the enzymatic conversions that would otherwise be 
ignored if the experimental data were analysed with the traditional 
compartmental models only where the type of reaction is assumed a priori.  
The extension of this approach to the analysis of ex vivo hyperpolarised data 
requires further considerations and has not been addressed in this thesis. In 
this Chapter the hyperpolarised time-series of [1-13C1] pyruvate and H
13CO3
- 
were fitted using compartmental modelling in order to derive the characteristic 
rate of the PDH activity. Preliminary results suggested that ex vivo the 
metabolic conversion of pyruvate to H13CO3
- does not follow first-order kinetics 




limited by the enzyme cofactor NAD+ availability. Further studies are needed in 
this direction but the experiments carried out in this thesis pointed out the 
possibility that the injection of a non-tracer amount (50mM) of hyperpolarised 
pyruvate solution into a perfused heart may change the biological system and 
therefore the kinetics of the enzymatic reaction assessed before measuring it. In 
light of the results presented in this thesis, a new study aimed at investigating 
the effect of different concentrations of hyperpolarised pyruvate on the kinetics 





















Chapter 6 : Analysis Methods for Time-
Activity Curves of PET Tracers Acquired 
Ex vivo from Langendorff Rat Hearts 
6.1 Introduction 
The Langendorff perfused heart has been often used for the early evaluation of 
novel radiotracer pharmacokinetics. It is a biologically relevant model, with an 
intact vasculature, which provides insight into tracer uptake and retention in a 
metabolically active beating heart, without the potential complications of 
systemic metabolism and recirculation. This experimental protocol is versatile in 
terms of allowing direct drug or tracer administration, control of perfusion, 
workload, and energy substrate supply, simple induction of hypoxia or ischemia, 
and the capacity to monitor the effects of such interventions upon cardiac 
contractile function and biochemistry (Southworth et al. 2007;  Southworth 
2009). Perfused hearts were, for example, used to assess the possibility of 
using copper bis(thiosemicarbazonato) (BTSC) complexes (Fujibayashi et al. 
1997;  Handley et al. 2014), [18F]- FMISO (Shelton et al. 1989) and [99mTc]-




In order to derive information on tracer kinetics, ex vivo time-activity curves 
have to be fitted with accurate and reliable analysis methods.  
To date there is not a gold standard analysis technique for the kinetic 
characterisation of time-activity curves of PET tracers acquired ex vivo from 
perfused hearts.  Previous studies have fitted this type of data to exponential 
functions characterized by an pre-specified number of rates and quantified the 
tracer retention by averaging the activity measured in a chosen time interval at 
the end of the acquisition window (Ng et al. 1995). This approach requires a 
priori assumption of the number of kinetic processes described in the data, 
information not always available especially when new biological systems or 
imaging agents are studied. 
A number of quantitative and semi-quantitative analysis methods that do not 
require any a priori assumption on tracer kinetics are available for the 
evaluation of PET tracer kinetics in vivo, but to date there is a lack of studies 
that investigate their performance for the kinetic characterisation of ex vivo time-
activity curves. Due to the differences between the two experimental set up it is 
not possible to assume that the techniques validated for the analysis of in vivo 
PET data are appropriate for the kinetic characterisation of ex vivo time-activity 
curves of PET tracer. The delivery of the tracer (Cp(t)) to a Langendorff 
perfused heart can be measured with a γ-detector coupled to the inflow line 
while the time-activity curve in the heart (Ctiss(t)) can be acquired using a single 
γ-detector interrogating the entire isolated perfused heart. As tracer uptake is 
heterogeneous across the myocardium (from endocardium to epicardium, for 




likely represent a more heterogeneous range of kinetics than spatially resolved 
imaging data. Ex vivo time-activity curves further differ from those acquired in 
vivo in terms of SNR and lack of recirculation leading to an input function that 




In this Chapter the possibility of using a number of methods for the kinetic 
characterisation of time-activity curves of PET tracers acquired from perfused 
rat heart was assessed using Monte Carlo simulations and experimental time-
activity curves of two hypoxia-sensitive PET tracers: [18F]-FDG and [18F]-FMISO 
acquired as described in Section 3.5. In particular this study aimed at 
investigating the performance of spectral-based algorithms (SA and NLSA), 
introduced in Chapter 4, in (1) identifying the presence of irreversible trapping, 
(2) deriving the number of kinetic components and (3) quantifying the 
irreversible trapped component (α0) from ex vivo time-activity curves. The 
accuracy and reproducibility of SA and NLSA in quantifying α0 were compared 
to those of the Patlak graphical method and the semi-quantitative index NA also 
presented in Chapter 4.  
The analysis methods used in this Chapter were chosen because they can be 
applied to homogenous as well as heterogeneous systems with only few 
hypotheses on the number of compartments necessary to describe the data. All 




made Matlab (MathWorks®) code. SA was implemented in collaboration with 
Dr. Mattia Veronese.  
 
 
6.3 Monte Carlo Simulations 
Datasets were simulated reproducing the characteristics of ex vivo time-activity 
curves from isolated hearts in normoxia and at different levels of hypoxia. Bi- 
and tri-exponential ex vivo time-activity curves with known kinetics were 
simulated using Equation 4.57. The values of βj were fixed (for tri-exponentials 
β1 = 0.5min
-1, β2 = 5min
-1 and β3 = 15min
-1, and for bi-exponentials β1 = 0.5min
-1 
and β2 = 15min
-1), whereas αj were randomly generated within a chosen interval 
(for tri-exponentials 0.011min-1 < α1 < 0.11min
-1,  0.12min-1 < α2 < 0.2min
-1, 
5min-1 < α3 < 8min
-1, and for bi-exponentials 0.011min-1 < α1 < 0.11min
-1, 5min-1 
< α2 < 8min
-1). Bi- and tri-exponential curves were simulated with and without a 
trapped component α0 (for β0 = 0). Four different values of irreversible trapping 
were simulated (α0,1 = 0.006min
-1, α0,2 = 0.06min
-1, α0,3 = 0.2min
-1 and α0,4 = 
0.6min-1) (Figure 6.1). The values used in the simulations were chosen within a 
physiological range and in agreement with previous studies (Bertoldo et al. 
1998). To obviate further sources of variability between one dataset and 
another, the same Cp(t), taken from an experimental dataset and representative 
of these experiments, was used for all simulations. Each dataset was simulated 
for a low and a high SNR (SNR = 60 and SNR = 120), consistent with the 
experimental data. N=100 and a time resolution Δt = 0.0033min were chosen. 




standard deviation and the mean value of the radioactive signal detected in the 
ROI (Dahlbom 2002). In this thesis the SNR was estimated from ex vivo time-
activity curves and not from in vivo images. To take into account the differences 
between the in vivo and the ex vivo PET experimental protocol, a new definition 
of SNR, similar to that exploited for ex vivo MR 13C time-series, was used in this 
thesis. In particular the SNR of the time-activity curves of PET data acquired ex 
vivo from Langendorff rat hearts was calculated as the ratio of the maximum 
value of the time-activity curve and the standard deviation of the signal in the 
last minute of each experiment. 
The percent bias (%BIAS) of quantitative and semi-quantitative indices (α0, 
Patlak and NA) was calculated as a performance index (Equation 6.1). 
 
 
            
          
     
 
 













Figure 6.1: Simulated datasets. (A) Representative input function used in the simulations. 
(B) Representative simulated heart time-activity curves for different values of irreversible 
trapped components (α0) (units are in min
-1
). The dynamics simulated were chosen to 
mimic the tissue time-activity curves of hypoxia sensitive tracers characterised by an 
increase in tracer uptake when the perfused heart is made hypoxic compared to that 






6.4 Experimental Ex vivo Time-Activity Curves of PET Tracers  
Time activity curves of two hypoxia sensitive PET tracers ([18F]-FDG and [18F]-
FMISO) were acquired ex vivo in Langendorff perfused rat hearts as described 
in Section 3.5. Representative [18F]-FDG input and tissue time-activity curves 
are shown in Figure 6.2 B, while the experimental protocol used for their 
acquisition in   Figure 6.2 A. 
 
 
6.5 Data Analysis 
Simulated and experimental time-activity curves were analysed using (1) 
spectral-based algorithms (SA and NLSA), (2) the Patlak graphical plot and (3) 











F]-FMISO ex vivo time-activity curves from perfused rat hearts. (B) 
Representative [
18
F]-FDG input and tissue time-activity curves acquired ex vivo using the 
protocol described in (A) (y-axis units are counts per second).  
 
 
To adjust the experimental data for residual activity due to prior injections in the 
same heart, a model prediction correction was used. The time-activity curve 
acquired in normoxia was fitted with the algorithm assessed (SA or NLSA) and 




The contribution of the activity from the first injection to the second was 
therefore calculated and subtracted. After the background correction the curve 
relative to the second injection was fitted and its contribution subtracted to the 
third injection. Statistical analysis was performed using GraphPad Prism® 
(GraphPad Software Inc, USA). All values are expressed as the mean ± SD. 
Data were analysed using a one way ANOVA with Dunnett’s test to compare 
each group of datasets acquired in hypoxia with the corresponding control 





6.6.1 Monte Carlo Simulations   
The results of simulations showed that NLSA is more accurate than SA in 
identifying the absence of irreversible trapping (α0 = 0min
-1) for the dynamics 
and SNRs considered.  For the lowest value of the trapping simulated (α0 = 
0.006min-1) with tri-exponential kinetics a similar degree of accuracy was found 
for SA and NLSA whereas for bi-exponential kinetics SA was found to be 
superior. For higher values of trapping, the accuracy in estimating the presence 




Table 6.1: Proportion of simulations that had α0 = 0 or α0 ≠ 0 identified by NLSA and SA.  
Simulated scenario 
NLSA performance SA performance 
SNR = 60 SNR = 120 SNR = 60 SNR = 120 
α0 = 0 
(%) 




α0 = 0 
(%) 
α0 ≠ 0 (%) Accuracy 
(%) 
α0 = 0 
(%) 




α0 = 0 
(%) 




Tri-exponential             
 No trapping (α0 = 0) 100 - 100 100 - 100 21 79 21 14 86 14 
 Trapping 1 (α0 = 0.006) 10 90 90 6 94 94 6 94 94 10 90 90 
 Trapping 2 (α0 = 0.06) - 100 100 - 100 100 - 100 100 - 100 100 
 Trapping 3 (α0 = 0.2) - 100 100 - 100 100 - 100 100 - 100 100 
 Trapping 4 (α0 = 0.6) - 100 100 - 100 100 - 100 100 - 100 100 
Bi-exponential             
 No trapping (α0 = 0) 100 - 100 100 - 100 14 86 14 2 98 2 
 Trapping 1 (α0 = 0.006) 23 77 77 13 87 87 4 96 96 - 100 100 
 Trapping 2 (α0 = 0.06) 6 94 94 2 98 98 - 100 100 - 100 100 
 Trapping 3 (α0 = 0.2) - 100 100 - 100 100 - 100 100 - 100 100 
 Trapping 4 (α0 = 0.6) - 100 100 - 100 100 - 100 100 - 100 100 
 α0 indicates the tracer trapping. Units are in min
−1




The values of %BIASα0 (Equation 6.1) reported with NLSA and SA for both bi- 
and tri-exponential curves and high and low SNRs are shown in Figure 6.3. For 
tri-exponential kinetics (Figure 6.3 A and C), NLSA displayed a lower bias than 
SA for the quantification of small α0 values with a %BIASα0 equal to 38.30% ± 
4.92% and 176.15% ± 114.65% at α0,1 = 0.006min
-1 and SNR = 60 for NLSA 
and SA, respectively.  For higher values of trapping (α0,3 = 0.2min
-1 and α0,4 = 
0.6min-1), SA and NLSA were of similar accuracy, with a %BIASα0 equal to  
0.17% ± 0.03% for SA and to 1.55% ± 0.34% for NLSA at α0,4 = 0.6 min
-1 and 
SNR = 120. The same trend was found for bi-exponential curves (Figure 6.3 B 
and D), where %BIASα0 was 16.41% ± 4.71% for NLSA and 228.39% ± 
117.70% for SA at α0,1 = 0.006 min
-1 and SNR = 60. The values estimated for 
%BIASα0 at higher trapping were similar to those found for tri-exponential 
kinetics. The accuracy in quantification of α0 for both NLSA and SA algorithms 
improved with increasing values of trapping and SNR. Additionally, the %BIAS 
reported for both algorithms were generally lower for bi-exponential curves than 
those estimated for tri-exponential kinetics. 
In Figure 6.4 A and B the mean and the standard deviation of the %BIAS 
reported for Patlak and NA are presented for simulated tri-exponential curves. 
In the absence of noise, Patlak returns the exact value of α0, whereas NA is a 






Figure 6.3: %Bias in estimated trapping (α0) of the NLSA and SA algorithm applied to 
simulated tri-exponential (A-B) and bi-exponential (C-D) models. α0,i indicates the 





The accuracy in quantifying the trapped component from the simulated data 
using Patlak increased with the value of trapping and SNR with a maximum 
%BIAS equal to -1662% ± 1053.8% at SNR = 60 and -507% ± 230% at SNR = 
120 and a minimum value equal to -20.2% ± 3% at SNR = 60 and -12.2% ± 
2.5% at SNR = 120. The maximum %BIAS reported for NA is 5.3% ± 10% at 




0.8% ± 12.4% at SNR = 60 and 0.6% ± 12.4% at SNR = 120. The %BIAS 
reported for both Patlak and NA estimated from bi-exponential curves were not 
significantly different from those calculated for tri-exponential curves (data not 
reported).  
Table 6.2 shows the performance of the NLSA and SA algorithm in estimating 
the number of non-trapped components from simulated bi- and tri-exponential 
curves. Results showed the percentage of datasets where the number of 
components was under estimated (UE), over estimated (OE) or correctly 
estimated (CE). For tri-exponential time-activity curves, the accuracy in 
determining the number of components was better for NLSA when α0 = 0min
-1, 
whilst SA was more accurate at all other values of α0 simulated. For bi-
exponential kinetics the accuracy in determining the number of components 
was significantly better than for tri-exponential time-activity curves. NLSA was 
more accurate when α0 = 0min
-1, whereas SA was better than NLSA for all non 

















Table 6.2: Proportion of simulations that had the number of components underestimated, overestimated or correctly estimated by NLSA and SA 
Simulated scenario 
NLSA performance SA performance 
SNR = 60 SNR = 120 SNR = 60 SNR = 120 
UE (%) OE (%) CE (%) UE (%) OE (%) CE (%) UE (%) OE (%) CE (%) UE (%)  OE (%) CE (%) 
Tri-exponential             









 Trapping 1 (α0 = 0.006) 100 - - 46 - 54 18 - 82 - - 100 
 Trapping 2 (α0 = 0.06) 100 - - 60 - 40 18 - 82 - - 100 
 Trapping 3 (α0 = 0.2) 100 - - 95 - 5 46 - 54 - - 100 
 Trapping 4 (α0 = 0.6) 100 - - 100 - - 53 - 47 1 - 99 
Bi-exponential             




 - - 100
a
 
 Trapping 1 (α0 = 0.006) 1 - 99 - - 100 17 18 65 - - 100 
 Trapping 2 (α0 = 0.06) 1 - 99 - - 100 - - 100 - - 100 
 Trapping 3 (α0 = 0.2) 11 - 89 5 - 95 - - 100 - - 100 
 Trapping 4 (α0 = 0.6) 34 - 66 32 - 68 - - 100 - - 100 
α0 indicates the tracer trapping. Units are in min
−1
; UE, underestimated number of components; OE, overestimated number of components; CE, correctly 
estimated. Results are shown only for the percentage of datasets where the presence of baseline was correctly estimated (Table 6.1). 
a
An accuracy in 





6.6.2 Experimental Datasets 
 
Two time-activity curves were acquired for each experiment: one representative 
of the delivery input function and a second reflecting the tracer accumulation in 
the heart. Both curves were included in the SA and NLSA fitting. In Figure 6.5 a 
representative normoxic dataset after decay and background correction 
(coloured dots) is shown with overlaid fits (coloured lines). The SNRs estimated 
for the [18F]-FDG time-activity curves were 165 ± 40 (a.u) in normoxia, 129 ± 35 
(a.u.) at 5min hypoxia and 103 ± 32 (a.u.) at 15min hypoxia. The SNRs 
estimated for the [18F]-FMISO time-activity curves were 253 ± 117 (a.u.) in 
normoxia, 182± 20 (a.u.) at 5min hypoxia and 151 ± 17 (a.u.) at 15min hypoxia. 
Results from the NLSA and SA quantification of [18F]-FDG datasets (n = 4) are 
shown in Table 6.3. The NLSA algorithm always identified a trapped component 
α0 (with the exception of one dataset run 4, Hypoxia1), whereas SA determined 
a null trapped component for 5 datasets out of 12. NLSA identified 4 kinetic 








Figure 6.5: (A) Experimental input function (blue dots) with overlaid fit (green).  (B-C) 
Experimental heart data (red dots) with overlaid NLSA (blue) and SA (black) fits. 
 
 
Figure 6.6 A shows the mean ± SD of the trapping quantified with NLSA and 
SA. The value of α0 estimated with NLSA significantly increased from 0.04min
-1 
± 0.02min-1 in normoxia to 0.20min-1 ± 0.11min-1 at 15min hypoxia (p < 0.05). 
The mean of the trapped component estimated with SA did not change 
significantly between normoxia and hypoxia and was associated with larger 
error. The coefficient of variation (CVα0 (%)) associated with the estimation of 
the trapped component was smaller for NLSA than SA. The CVα0 in normoxia 
was 3.4% ± 2% for NLSA and 181.2% ± 308.9% for SA. At 15min hypoxia it 




Figure 6.7 A shows the mean ± SD of Patlak and NA calculated for [18F]-FDG. 
The value of Patlak increased, but not significantly, from 0.06min-1 ± 0.02min-1 
in normoxia to 0.19min-1 ± 0.09min-1 at 15min hypoxia. NA also increased from 
0.03 ± 0.01 (a.u.) in normoxia to 0.04 ± 0.02 (a.u.) at 15min hypoxia, but not 
significantly. Table 6.4 shows the results from the NLSA and SA quantification 
for [18F]-FMISO datasets (n=3). The NLSA algorithm always identified a trapped 
component α0, whereas SA determined a null trapped component for one of the 
dataset (run 2, Normoxia). The number of kinetic components different from α0 




Figure 6.6: Mean ± SD of the trapping estimated with the NLSA (blue) and SA (green) 
algorithm in normoxia and hypoxia for (A) [
18
F]-FDG and (B) [
18
F]-FMISO experimental 







Figure 6.7: Mean ± SD of Patlak (orange) and NA (red) in normoxia and hypoxia for (A) 
[
18
F]-FDG and (B) [1
8
F]-FMISO experimental time-activity curve acquired ex vivo from 






Table 6.3: Results from the NLSA and SA quantification for [
18
F]-FDG ex vivo datasets 
 
[18F]-FDG datasets 
Normoxia Hypoxia 1 Hypoxia 2 
1 2 3 4 1 2 3 4 1 2 3 4 
α0 NLSA (min
−1
) 0.037 0.070 0.023 0.025 0.084 0.160 0.200 - 0.310 0.260 0.220 0.042 
α0 SA (min
−1
) 0.038 0.005 0.037 - 0.064 - - - - 0.130 0.050 0.060 
Patlak (min
−1
) 0.066 0.080 0.066 0.040 0.100 0.150 0.250 0.046 0.200 0.180 0.300 0.077 
NA (a.u.) 0.015 0.025 0.025 0.015 0.023 0.050 0.020 0.020 0.040 0.040 0.072 0.021 











Table 6.4: Results from the NLSA and SA quantification for [18F]-FMISO ex vivo datasets 
 
[18F]-FMISO datasets 
Normoxia Hypoxia 1 Hypoxia 2 
1 2 3 1 2 3 1 2 3 
α0 NLSA (min
−1
) 0.004 0.008 0.004 0.033 0.025 0.011 0.050 0.040 0.023 
α0 SA (min
−1
) 0.004 - 0.005 0.010 0.016 0.002 0.020 0.015 0.013 
Patlak (min
−1
) 0.005 0.007 0.004 0.015 0.018 0.054 0.450 0.025 0.024 
NA (a.u.) 0.004 0.007 0.010 0.020 0.020 0.004 0.028 0.028 0.017 




Figure 6.6 B shows the mean ± SD of the trapping quantified with NLSA and SA. The 
value of α0 estimated with NLSA significantly increased from 0.005min
-1 ± 0.002min-1 
in normoxia to 0.03min-1 ± 0.0002min-1 at 15min hypoxia (p < 0.05). The mean ± SD 
of the trapped component derived through SA also changed from 0.004min-1 ± 
0.00025min-1 in normoxia to 0.0148min-1 ± 0.0023min-1 at 15min hypoxia, but not 
significantly. As found for the [18F]-FDG time-activity curves, the CVα0 reported for 
NLSA was much smaller than that reported for SA. The CVα0 in normoxia was 4% ± 
0.6% for NLSA and 16.1% ± 18.3% for SA. At 15min hypoxia it was 1.3% ± 0.2% 
and 13.7% ± 7% for NLSA and SA, respectively. In Figure 6.7 B the mean ± SD of 
Patlak and NA calculated for [18F]-FMISO time-activity curves is reported. The value 
of Patlak increased from 0.005min-1 ± 0.001min-1 in normoxia to 0.031min-1 ± 
0.01min-1 at 15min hypoxia, but was not significant. NA increased significantly from 




The results from the Monte Carlo simulations suggest that both quantitative and 
semi-quantitative analysis methods are adequate for the kinetic characterisation of 
time-activity curves acquired ex vivo from perfused hearts. NLSA was found to be 
more accurate than SA in estimating the absence of trapping (α0 = 0min
-1) for the 
SNRs considered and for both tri- and bi-exponential kinetics. NLSA was also 
superior to SA in quantifying the trapped component at low values of α0, while for 




The difference in performance of NLSA and SA in the identification and quantification 
of the trapped component is due to the different implementation of the two 
algorithms. In SA the possible values of the exponents βj (Equation 4.57) that best 
describe the experimental data are chosen from a fixed grid of values and only the 
values of αj are estimated. The optimal number of exponents is therefore not chosen 
a priori and is given by the number of rates βj for which a non-zero αj is estimated. 
The presence of noise can significantly reduce the accuracy of SA in identifying and 
quantifying very low frequency (e.g. trapping) and high frequency components 
(Veronese et al. 2010) as well as introducing phantom kinetic components 
(Cunningham and Jones 1993;  Turkheimer et al. 1994) . For the NLSA algorithm, 
the experimental data are fitted with exponential curves of increasing order, and both 
βj and αj are derived using a non-linear least square estimator. In this case, all the 
kinetic components, specified a priori, are estimated and the model that best fits the 
experimental data is chosen a posteriori using a standard model parsimony criteria 
(Bertoldo et al. 1998). This means that the very low-frequency and high-frequency 
components are always estimated and the presence of noise can only affect the 
quantification of the value of the components, but not their identification.  
SA was more accurate than NLSA in quantifying the number of components different 
from α0, regardless the value of the trapping and SNR for tri-exponential curves. To 
determine whether the ability to estimate the correct number of kinetic components 
using the NLSA algorithm was dependent on the standard model parsimony criterion 
used, the NLSA algorithm was implemented and the optimal model was chosen 




estimating the number of kinetic components different from trapping was similar for 
both parsimony criteria used. 
The accuracy of both algorithms in determining the correct number of exponentials 
appeared significantly better for bi-exponential dynamics, with accuracy close to 
100% for all cases studied. Two or more kinetic components with close values are 
likely to be seen by SA and NLSA as a unique component. The greater the spread of 
kinetic values, the easier it is for the algorithms to discern the exponentials as 
separate components. In the simulations, the values of the kinetic components βj 
were more spaced in the bi-exponential than tri-exponential curves, meaning that it 
was easier for SA and NLSA to discern the two components as distinct βs. 
The values estimated for Patlak and NA were found to be linearly proportional to the 
simulated values of trapping, but like spectral analysis, their estimation was affected 
by the presence of the noise. The %BIAS associated with the estimation of Patlak 
was always higher than that reported for the semi-quantitative index NA, for all SNRs 
and trapping considered. Patlak is derived by calculating the ratio between tissue 
retention of the tracer and the delivery input function which decays rapidly to zero. 
Both curves exhibit noise and therefore dividing two noisy quantities amplifies the 
noise and reduces the accuracy of the method.  The mean of the %BIAS reported for 
NA becomes smaller with increasing values of trapping and SNRs, but the standard 
deviation does not change. In the Monte Carlo simulations for a given SNR the same 
amount of noise was added to the time-activity curves with different values of the 
trapped component. The standard deviation of the bias is dependent on the noise 
variance of the time-activity curve fitted and therefore it does not change with 




For experimental datasets the values reported for CVα0 suggest that the NLSA is 
more accurate than SA for the kinetic characterisation on ex vivo time-activity 
curves. NLSA identified a trapped component for the [18F]-FDG datasets 11 times 
out of 12 and consistently indicated the presence of trapping for the [18F]-FMISO 
datasets. Additionally, the trapped component quantified using NLSA significantly 
increases with the level of hypoxia for both [18F]-FDG and [18F]-FMISO in agreement 
with previous studies (Handley et al. 2011). In contrast the Patlak values estimated 
from the experimental time-activity curves of [18F]-FDG and [18F]-FMISO (Figure 6.6) 
are characterised by a large variability due to the noise exhibited by both tissue and 
input curves. An additional source of variability is associated with the nature of the ex 
vivo experiment where there is no recirculation. Bolus injection of radiotracer leads to 
a plasma activity that decays rapidly to zero leading to a input function Cp(t) mainly 
characterised by background noise at later times.  
Ex vivo time-activity curves have to be corrected for the contribution of radioactivity 
from previous injections to the residual tissue background signal in successive 
injections. For both spectral-based algorithms, the residual activity was corrected for 
by fitting the previous injection, and then subtracting the contribution of the first 
injection to the second, and the contribution of the first and second to the third. This 
approach assumes that (1) the tracer studied is irreversibly trapped or, if reversible 
has decayed entirely before the subsequent injection, (2) the concentration of 
exchangeable (reversible) tracer in the tissue is negligible before the next injection 
and (3) the trapped component in a previous injection remains trapped when the 
condition of the heart is changed. With the tracers (irreversible) used in this study 




in the heart contributing to each subsequent time-activity curve was very small, and 
was mainly represented by trapped tracer with the activity of the tracer in the 
equilibrating compartments almost zero (<3% of the total measured signal). These 
conditions are necessary to guarantee that the trapping rates quantified after the first 
injection are associated with changes in tissue metabolism rather than the presence 
of residual activity in the tissue. 
Monte Carlo simulations showed that both NLSA and SA are not able to reliably 
estimate the number of non-trapped components characterising the tracer kinetics 
especially when the number of rates is high.  As a result, the kinetic analysis of time-
activity data acquired ex vivo from perfused hearts gives reliable information 
regarding the trapped component of the tracer studied, but no information of its 
transport/diffusion through the capillary membrane or of its transport from the 
intracellular space into the cells can be gained.  
In PET in vivo studies each dynamic point in the time-activity curve, which represent 
the evolution in time of the radioactive signal point by point of within a ROI, is 
commonly acquired using different acquisition times. Each experimental point in the 
time-activity curve will be therefore characterised by a different level of noise and the 
different measurement error is usually taken into account by weighing the 
experimental data. In the ex vivo PET experiments presented in this thesis the 
radioactive signal is detected using two γ-detectors which measure all the radioactive 
decays that occur within their FOV. In this case, each point in the time-activity curve 
is acquired with the same acquisition time and is characterised by the same amount 




equal at each time point. For this reason un-weighted estimators were chosen for the 
analysis of ex vivo time-activity curves in this thesis. 
The Langendorff perfused heart has been the model of choice of cardiologist for 
years and has greatly increased our understanding of cardiac physiology. 
Nevertheless, this experimental model has a number of limitations. Ex vivo tissue 
time-activity curves are, for example, a heterogeneous measure of the tracer kinetics 
in the whole heart, as opposed to data acquired from more spatially homogeneous 
imaging studies. It is expected that the number of kinetic components returned by SA 
approaches are higher than found within a given region of tissue (Bertoldo et al. 
1998) due to heterogeneity of tracer kinetics.  While in vivo the coronary flow through 
the rat heart is 3ml/min, in the buffer-perfused Langendorff heart this increases to 
~14ml/min at the same perfusion pressure, due to the lower oxygen carrying 
capacity of Krebs buffer.  Because the flow rate defines tracer delivery to the tissue, 
this might complicate interpretation of semi-quantitative results where the bolus input 
is not accounted for. However, semi-quantitative approaches are simple to apply, 
and whilst less informative and more sensitive to experimental conditions, the use of 
NA offers a useful surrogate descriptor of tracer retention when datasets are 
acquired under identical experimental set up and protocol.  
When investigating the pharmacokinetics of metabolic tracers like [18F]-FDG, buffer 
substrate composition is also a critical consideration.  In the present study, hearts 
were perfused with glucose as a sole energy substrate. The lack of fatty acids in the 
perfusion medium, and their influence on glucose transport and or downstream 




elaborate perfusion media and the use of membrane oxygenators would be required 




Accurate quantification of radiotracer kinetics in the Langendorff perfused heart is 
highly desirable for the characterisation and development of novel radiotracers and 
for the exploitation of existing tracers to probe biological processes in greater detail.  
In this Chapter the performance of three quantitative (SA, NLSA and Patlak) and one 
semi-quantitative (NA) analysis methods for the kinetic characterisation of ex vivo 
perfused heart time-activity curves was compared. SA and NLSA algorithms were 
tested in terms of their accuracy in identifying and quantifying the trapped 
component, and in estimating the kinetics of non-trapped components. Results from 
both Monte Carlo simulations and experimental data suggest that NLSA is the 
algorithm of choice when the aim of the kinetic analysis is to assess whether the 
radiotracer injected in the perfused heart is irreversible trapped or not. Once the 
presence of a fully trapped component has been identified, it can be quantified using 
either NLSA or the semi-quantitative index NA. Neither analysis methods were 
adequate for estimating the number of non-trapped components characterising the 
kinetics of ex vivo time-activity curves probably due to the heterogeneity of the 








Chapter 7 : MR Dynamic Spectroscopic 
Imaging of Cardiac Metabolism using [1-
13
C1] Pyruvate  
7.1 Introduction 
In Chapter 5 hyperpolarised 13C pyruvate has been introduced as a potential 
valuable tool for studying changes to cardiac metabolism within the whole heart. 
However it is known that many pathophysiological changes in cardiac metabolism 
occur locally within a given region of the myocardium rather than globally across the 
entire heart. 
Hyperpolarised 13C pyruvate has been shown to be a promising tool for assessing 
alterations in cardiac metabolism during ischemia (Schroeder et al. 2010). As 
mentioned in Section 1.3, myocardial ischemia is defined as a reduction or cut-off of 
the amount of blood normally delivered to the myocardium and is typically associated 
with the formation of atherosclerotic plaques within the wall of one or more coronary 
arteries. Depending on the severity and duration of the ischemic event, myocytes 
located in the region of myocardium supplied by the occluded artery may become 
irreversibly injured and undergo necrosis. Myocyte death, also called myocardial 
infarction (MI), progresses following a transmural wave front from the 




have shown that the extent of the transmurality of the infracted region is strongly 
dependent upon the duration of the ischemic event before reperfusion (Tarantini et 
al. 2005) and therefore its early detection and accurate monitoring is essential for 
both prognosis and treatment (von Knobelsdorff-Brenkenhoff and Schulz-Menger 
2012). The response of the enzymatic complex PDH to myocardial ischemia and 
subsequent reperfusion has been extensively studied using hyperpolarised 13C 
pyruvate, labelled in C1 and/or C2 position, both in ex vivo perfused hearts and in 
vivo in small and medium size animals (Merritt et al. 2008;  Schroeder et al. 2009;  
Schroeder et al. 2010;  Lau et al. 2013). In these studies a decrease in PDH activity 
associated with the ischemic event and a switch from aerobic to anaerobic 
metabolism were observed by measuring the hyperpolarised metabolic products of 
the injected pyruvate such as H13CO3
-, lactate or glutamate (Golman et al. 2008;  
Schroeder et al. 2010). 
Global information on cardiac metabolism can be obtained using non-selective 
hyperpolarised 13C MRS, as discussed in Chapter 4, that allows the detection of the 
metabolic conversion of pyruvate to its metabolites within a volumetric region (voxel) 
covering the whole heart (Santarelli et al. 2012). Alternatively, heterogeneity of 
myocardial metabolism can be studied through dynamic spatial-spectral imaging 
techniques and ischemic regions identified (Lau et al. 2010;  Lau et al. 2013). In 
order to derive quantitative information on the underlying metabolic activities, the 
time-series corresponding to the injected molecule and its metabolites, extracted 
voxel by voxel or within a ROI, are commonly fitted with mathematical models 
(Menichetti et al. 2012). Regardless of the approach chosen for the data fitting, 




extent of the transmural ischemia. Increasing the in-plane resolution by 2 fold, for 
example, results in a 4 fold reduction in SNR. On the other hand, reducing the spatial 
resolution not only enhances the SNR but also increases the partial volume effect 
that prevents the detection of myocardial ischemia characterised by a low degree of 
transmurality.  For this reason the knowledge of the minimum SNRB and in-plane 
resolution necessary for the detection of small percentage of transmural ischemia 
using hyperpolarised 13C MRSI in combination with kinetic modelling would be 




The studies presented in this Chapter were carried out in collaboration with the 
Institute for Biomedical Engineering at ETH Zurich. The aims were to extend non-
selective measurements to imaging of cardiac metabolism in physiological and 
pathophysiological condition (e.g. ischemia) using hyperpolarised 13C MRSI. A 
protocol for the acquisition of MR spectroscopic dynamic images of hyperpolarised 
[1-13C1] pyruvate and its metabolites was developed ex vivo in healthy perfused rat 
hearts (Section 3.4.5) at KCL. Results are presented in Section 7.3.  
Winning the Peter Baker’s fellowship allowed the candidate to join the group headed 
by Prof. Kozerke at ETH Zurich for three months. In this period a series of simulation 
studies were carried out in order to support the translation of the 13C MRSI protocol 
from ex vivo to in vivo. Through Monte Carlo simulations the accuracy in identifying 




modelling was assessed to study the influence of image spatial resolution, SNR and 
the extent of transmural ischemia (Section 7.4).  
 
 
7.3 13C MR Spectroscopic Imaging Ex vivo  
Figure 7.1 shows representative standard 1H cine images in short axis and four 
chamber view acquired at the beginning of each experiment in order to visualise the 




Figure 7.1: (A) Time frame from a short axis 
1
H cine image acquired as reference for the 
13
C 
images. The left ventricle (LV) can be seen in the middle of the image, while the right ventricle 
(RV) on the top left. The white dots outside the heart are incoming (bottom) and outgoing (top) 
perfusion line. (B) Four chamber view of the isolated perfused rat heart form a 
1
H cine scan. 
The LV can be seen on the right while the RV on the left. The closed aortic valve is visible as a 







Time-series of images of [1-13C1] pyruvate, [1-
13C1] lactate and H
13CO3
- from two 
individual experiments are shown in Figure 7.2 A and B overlaid onto a time frame of 
a 1H cine image in short axis view (Figure 7.1 A). The time frame t = 0s was chosen 
to be the last image without 13C signal before the appearance of the hyperpolarised 
signal. Starting with injection of hyperpolarised solution into the perfusion line, the 
signal of pyruvate is visible in the inlet line indicated by the arrow in the pyruvate 
image at t = 5s (top of Figure 7.2 A). Signal in the outflow tube can be found at t = 
30s, indicated by the arrow (bottom of Figure 7.2 A). The metabolic products lactate 
(via LDH) and H13CO3
- (via PDH) are visible in the myocardium from t = 10s. To 
increase the SNR of the images the average of the signal of the images from t = 5s 
to t = 20s was calculated and shown for experiment 1 and 2 in Figure 7.2 C and D, 
respectively. In experiment 1 (Figure 7.2 A and C) the distributions of pyruvate 
perfusion and the production of lactate and H13CO3 are not homogeneous over the 
whole myocardium, while experiment 2 (Figure 7.2 B and D) shows a more 
homogeneous distribution of the metabolic products lactate and H13CO3
-. The 
regions indicated by the arrows 1 and 2 in the lactate and H13CO3 images of 
experiment 1 (Figure 7.2 C) reveal enhanced production of lactate and H13CO3
-, 
respectively.  
Time-series from the regions of experiment 1 characterised by high lactate and 
H13CO3
- production (indicated with arrow 1 and 2 in Figure 7.2 C) were extracted and 
shown in Figure 7.3 A and B, respectively. Figure 7.3 C shows the time-series 
representing the mean of the hyperpolarised signal of the three metabolites over the 





Figure 7.2: (A) and (B) Time-series of 
13
C images from a slice in short axis view of the 
myocardium overlaid onto the 
1
H reference image (Figure 7.1 A) for two different perfused 











respectively. Δt = 5s, where time t = 0s is defined as the last image without 
13
C signal before 
appearance of hyperpolarised [1-
13
C1] pyruvate. The arrows in time frame t = 5s and t= 30s in 
(A) indicates the incoming perfusion line and outgoing tubing, respectively. (C) and (D) Mean 
images of time frames from t = 5s to t = 20s from the image series in (A) and (B), respectively. 










homogeneous ((B) and (D)). The region of high lactate and bicarbonate production in 
experiment 1 is indicated by arrow 1 and 2 respectively. Adapted from reference (Weiss and 









signals from the two experiments 
shown in Figure 7.2. Time-series from the region of high (A) lactate production and (B) 
bicarbonate production for experiment 1 indicated with arrow 1 and 2 in Figure 7.2, 
respectively. (C) time-series of the mean hyperpolarised signal over the whole myocardium 
presented for experiment 2. The solid lines show a fit of the data using a bi-exponential 
equation for interpolation and display purposes only. Adapted from reference (Weiss and 
Mariotti et al. 2012). 
 
 
The early upslope of the H13CO3
- signal in experiment 1 compared to the pyruvate 




signals. In experiment 1 the bicarbonate signal reaches its maximum point about 5s 
earlier in region 2 (between t = 10s and t = 15s) compared to region 1 (between t = 
15s and 25s) suggesting a faster conversion of pyruvate to H13CO3
-, catalysed by 
PDH, in region 2.  
Overall the signals from spectroscopic imaging are clearly limited by SNR as can be 
seen in the images shown in Figure 7.2. For this reason it was not possible to derive 
quantitative information by fitting the time-series with kinetic modelling on a pixel-by-
pixel basis. However the SNR can be improved by summing within a ROI and data 
were interpolated for only display purpose using a bi-exponential function according 
to: 
 
                    7.1 
 
Where S is the observed signal and a, b, c are free fitting parameters. 
The buffer used to perfuse both groups of heart was well oxygenated and therefore 
the heterogeneous distribution of metabolites in the myocardium reported for 
experiment 1 should not be related to the presence of hypoxic or ischemic regions 
but rather to regional variations of the pyruvate perfusion and related differences in 
regional metabolism.  Spatial differences in metabolism may also be caused by 
regional differences in PDH activity, for example partial ischemia due to imperfect 
experimental conditions. Similar metabolic changes would be expected in a true 
ischemic region.  
The methodology presented in this Section are characterised by some limitations 




cardiac function, meaning that we were unable to assess the consistency of our 
heart perfusion protocol after it is inserted into the spectrometer. Moreover, a lack of 
ECG triggering leads to image blurring along the phase encoding direction (left, 
right), due to residual motion as seen in the 13C images in Figure 7.2 A and B.  
 
 
7.4  Exploring Detection Limits of Cardiac Ischemia Using MR 
Dynamic Spectroscopic Imaging of Hyperpolarised 13C Pyruvate 
Combined with Compartmental Modelling 
Firstly, the accuracy and reproducibility of a two-compartment, unidirectional kinetic 
model based on the Bloch-McConnell equations for the conversion of hyperpolarised 
[1-13C1] pyruvate to H
13CO3
- via PDH were assessed using Monte Carlo simulations. 
After its validation, the proposed compartmental model was used to fit simulated 
dynamic 13C images voxel by voxel in order to explore the detection limit of 
hyperpolarised metabolic imaging in identifying local myocardial ischemia depending 
on ischemic transmurality, SNR and image resolution. Usually the lowest SNR 
detected in vivo in small animals is associated with the H13CO3
- peak, for this reason 
in this Chapter the desirable SNR is always presented with reference to this 







7.4.1 Monte Carlo Simulations 
 
7.4.1.1 Hyperpolarised 13C Time-Series  
Datasets were simulated reproducing the characteristics of hyperpolarised 13C time-
activity curves (single voxel) that contain information of the metabolic conversion 
catalysed by PDH. A two-compartment, unidirectional kinetic model (Figure 4.5), 
whose dynamics is described by Equations 4.30 and 4.31 (kAB = 0), was used to 
simulate in vivo 13C dynamic curves of hyperpolarised [1-13C1]
 pyruvate 
(compartment A) and H13CO3
- (compartment B). In this study the input function Cp(t) 
representing the delivery of the hyperpolarised pyruvate to the heart was modelled 
as a γ-variate function (Equation 7.2). 
 
 
                    
       
            




A, alpha and beta are parameters that characterise the shape of the input function 
and tarrival is the time point of arrival of the pyruvate bolus. To obviate further sources 
of variability between one dataset and another, the same Cp(t) was used for all 
simulations. Two in vivo systems characterised by a low a high value of kAB (kAB_low  =  
0.006s-1, kAB_high  =  0.02s
-1) were simulated. The values of the effective relaxation 
rates r1A and r1B were maintained constant (r1A= 0.0179s
-1 and r1B = 0.0293s
-1) and 
chosen in agreement with previous studies (Schroeder et al. 2009;  Atherton et al. 
2011;  Chen et al. 2012;  Santarelli et al. 2012). A representative dataset for each 





To investigate the effect of the random noise, normally exhibited by experimental 
data, hyperpolarised pyruvate and H13CO3
- time-series were simulated for two 
H13CO3
- SNRBs (SNRB_low = 3 and SNRB_high = 12), consistently with the experimental 













(dashed line) for the two different systems simulated (kAB_low = 0.006s
-1
 and kAB_high = 0.02s
-1
). 
The input function Cp(t) used in the simulation is shown in black.   All time-series are 











7.4.1.2 Hyperpolarised 13C Dynamic Images 
A numerical signal model based on a short axis view of the rat heart was used to 
simulate in vivo hyperpolarised 13C dynamic images of pyruvate and bicarbonate 





Figure 7.5: (A) Short axis 
1
H high resolution image from a rat heart in vivo used to derive the 
left ventricle mask used in the Monte Carlo simulations and shown in (B). 
 
 
Images characterised by four SNRBs (3 ≤ SNRB ≤ 12) and six spatial resolutions (2 x 
2 - 0.25 x 0.25 mm2) were simulated. Additionally, to assess which is the minimum 
size of ischemia that can be detected for a chosen SNRB spatial resolution, 
transmural ischemia (18%, 40%, 64% and 100% transmurality) was simulated in the 
myocardial anterior segment in agreement with the left ventricle segmentation 
proposed by the American Heart Association (AHA) (segment 3 in Figure 7.5) 




hyperpolarised 13C dynamic curves, voxel by voxel, were chosen in agreement with 
the study presented by Lau and colleagues where the rate of enzymatic conversion 
of PDH at 45min after reperfusion was reported to be approximately five times 
smaller than the baseline value (Lau et al. 2013) (kAB_baseline = 0.018s
-1, kAB_45min = 
0.0035s-1, r1A= 0.0179s
-1 and r1B = 0.0293s
-1). A Δt = 2s was chosen for all simulated 
time-series. Representative simulated hyperpolarised 13C images are presented in 
Figure 7.6 for the entire range of ischemic transmurality and SNRBs explored at a 
spatial resolution equal to 1 x 1 mm2 and a representative time point (t = 30 s). 
 
 
7.4.2 Data Analysis 
 
7.4.2.1 Hyperpolarised 13C Time-series  
The accuracy and reproducibility of two-compartment, unidirectional kinetic model, 
was assessed by fitting synthetic hyperpolarised 13C time-series of pyruvate and 
H13CO3
- (Figure 7.4) with the proposed compartmental model. The percent bias 
(%BIAS) associate with the estimation of the kinetic rates (kAB, r1A and r1B) was 
calculated as a performance index (Equation 7.3). 
 
 
            
          
     
 
 












Figure 7.6 : Representative synthetic 
13




 presented for 
the entire range of SNRBs and ischemic transmurality studied, 1 x 1 mm
2
 spatial resolution and 




7.4.2.2 Hyperpolarised 13C Dynamic Images 
In order to determine the minimum size of transmural ischemia that is detectable 
using hyperpolarised 13C dynamic imaging for a given SNRB and spatial resolution, 
simulated 13C dynamic images of pyruvate and H13CO3
-  were fitted, voxel by voxel, 
to a two-compartment, unidirectional kinetic model.   
A one way ANOVA with Dunnett’s test was used to compare the values of kAB 
derived through the kinetic model in the anterior segment of the left ventricle 
(ischemic segment) with those in a healthy segment for each simulated image 
(Dunnett 1955). All Monte Carlo simulations and kinetic analysis were performed 





7.4.3.1 Hyperpolarised 13C Time-Series  
Results from Monte Carlo simulations suggested that the chosen two-compartment, 
unidirectional kinetic model is able to accurately estimate the values of kinetic rates 
of the conversion of pyruvate to H13CO3
- (kAB, r1A and r1B) at the rates and SNRB 
values characteristic of in vivo hyperpolarised 13C time-series. 
The mean ± SD of %Bias reported for kAB and for the effective relaxation rates of 
pyruvate and H13CO3
- (r1A and r1B) are presented in Figure 7.7. Regardless the 
SNRBs studied the error in parameter estimation of the proposed kinetic model 
increased with increasing values of kAB. Additionally the performance of the 




%Bias estimated for kAB was 3.4% ± 12.9% at SNRB = 3 and kAB = 0.02s
-1, while the 
minimum value equal to 1.1% ± 13% was reported at SNR = 12 and kAB = 0.006s
-1 
(see Figure 7.7 A). The chosen kinetic model was able to accurately estimate r1A 
with a maximum %Bias equal to - 2.6% ± 26.1% at SNRB = 3 and kAB = 0.02s
-1 and a 
minimum value reported at  SNRB = 12 and kAB = 0.006s
-1 equal to - 0.5% ± 4% (see  
Figure 7.7 B). The values estimated for the %Bias of r1B were comparable to those 
reported for kAB with a maximum value equal to 5% ± 25.1% at SNRB = 3 and kAB = 
0.02s-1 and a minimum value equal to 1.5% ± 12.1% at SNRB = 12 and kAB = 0.006s
-
1 (see Figure 7.7 C). 
 
 
7.4.3.2 Hyperpolarised 13C Dynamic Images 
As expected the ability of detecting myocardial ischemia using hyperpolarised 13C 
imaging combined with kinetic modelling depends on SNRB, in-plane resolution and 
the extent of transmural ischemia. The values of kAB derived by fitting the simulated 
13C dynamic images in Figure 7.6 voxel by voxel with the validated two-
compartment, unidirectional kinetic model are presented in Figure 7.8 for two 
representative in-plane resolutions and all the SNRBs studied. In dynamic 
13C 
images characterised by an in-plane resolution of 1 x 1 mm2 the ischemic segment 
(number 3 in Figure 7.8 A) is well defined only for the highest percentage of 
transmurality simulated (100%) regardless the SNRB assessed (Figure 7.8 B). 
However, in images simulated with 0.25 x 0.25 mm2 in-plane resolution even the 
smallest percentage of transmural ischemia (18%) at the lowest SNRB (SNRB = 3) 






Figure 7.7: Mean ± SD for the %Bias reported for the characteristic kinetic rates of a two-
compartment, unidirectional kinetic model. Values are reported for two values of SNRB and kAB 




The minimum resolutions required to observe significant difference in kAB between 
the ischemic and healthy myocardium for the range of SNRBs simulated are 
summarised in Figure 7.9. Results suggest that to detect 18% of transmural 
ischemia it is necessary to acquire the dynamic images with a minimum in-plane 
resolution of 0.4 x 0.4 mm2 for a SNRB = 3, whereas a resolution of 0.75 x 0.75 mm
2 
is enough at SNRB > 6. A transmurality of 40% in the ischemic segment can be 
discerned with a minimum resolution of 0.75 x 0.75 mm2 at the lowest SNRB studied, 
while 1 x 1 mm2 is sufficient at SNRB > 6. Results also suggest that an in-plane 
resolution of 1 x 1 mm2 is adequate to detect 64% of ischemic transmurality when   3 
< SNRB < 6, whereas for SNRsB > 6 the same degree of ischemia can be detected 
with a minimum resolution of 2 x 2 mm2. Finally, 1 x 1 mm2 resolution is sufficient to 
detect 100% of transmural ischemia at SNRB = 3, whereas an in-plane resolution of 
2 x 2 mm2 is sufficient to discern a 100% transmural ischemic segment from healthy 






Figure 7.8: (A) AHA segmentation of the left ventricle used in the simulation. (B) and (C) kAB  
maps obtained by using a two-compartment, unidirectional kinetic model to fit simulated 
13
C 




 characterised by an in-plane resolution of 1 x 1 mm
2
 





Figure 7.9: Minimum in-plane resolutions necessary to detect the four different percentage of 





The first aim of the study presented in this Section was to assess the accuracy and 
reproducibility in parameter estimation of a kinetic model based on the modified 
Bloch-McConnell equations for the conversion of hyperpolarised 13C pyruvate to 
H13CO3
- via PDH at the rates and SNRB values characteristic of in vivo experiments. 
13C time-series were simulated for a high and a low value of kAB and SNRBs. The 
simulated curves were fitted with the chosen compartmental model and the %BIAS 
associate with the kinetic rates (kAB, r1A and r1B) was calculated as a performance 
index. Results from the Monte Carlo simulations showed that the kinetic model has a 
good accuracy and reproducibility at the values of kAB and SNRBs studied. However, 
its performances are sensitive to the noise level that characterised the 
hyperpolarised pyruvate and H13C  
  time-series. This results in an increase of the 
%Bias associated with the estimation of the kinetic parameters with decreasing 
values of SNRBs. Results also suggested that the error associated with the 
parameter estimation increases with increasing values of kAB. This is due to how the 
synthetic time-series of pyruvate and H13CO3
- were simulated in this study. The 
standard deviation of the noise added to the pyruvate and H13CO3
- curves was 
calculated as the ratio between the maximum value of the H13CO3
- peak and the 
desirable SNRB. Increasing the values of the rate of enzymatic conversion kAB, the 
injected hyperpolarised pyruvate is depleted faster and therefore its peak value is 
diminished compared to that obtained at lower values of kAB, whereas the H
13CO3
- 
maximum value is increased (Figure 7.4). For a given SNRB the resulted SNRA will 





To explore which is the minimum size of transmural ischemia in the left ventricle that 
can be detected using hyperpolarised 13C dynamic imaging, a series of 13C dynamic 
images of pyruvate and bicarbonate were simulated. Different percentages of 
transmural ischemia, in-plane resolutions and SNRBs were simulated and a 
summary of the results obtained from these simulations is shown in Figure 7.9. 
Results suggested that it is possible to discern the lowest percentage of ischemia 
simulated in segment 3 (18%) from the healthy myocardium at SNRB = 3 with a 
minimum in-plane resolution of 0.4 x 0.4 mm2. This means that even if the accuracy 
and reproducibility of a two-compartment, unidirectional kinetic model is affected by 
the presence of the noise, the kAB estimation is accurate enough to allow one to 
discern regions with low values of kAB (ischemic myocardium) from those 
characterised by high values of kAB (healthy myocardium). 
The highest in-plane resolutions that have been reported so far for imaging of 
hyperpolarised compounds are in the order of 1 x 1 mm2 in the rat heart (Weiss et al. 
2013) using a dedicated small animal scanner and 7.5 x 7.5 mm2 in the pig heart 
using a human clinical MRI system (Lau et al. 2010). According to the results just 
presented, at these resolutions the percentage of transmural ischemia that can be 
detected is equal to 40% at SNRB > 6 in the rat heart and SNRB > 3 in the pig heart. 
However, the study presented in this Chapter is characterised by a number of 
limitations that have to be considered. All simulations, for example, assume ideal 
experimental conditions. Variations in coil sensitivities over the field of view, large 
slice thicknesses and motion artefacts, not considered in this study, may 
compromise the quality of the dynamic images and reduce the accuracy in 




The successful completion of the phase I clinical trial using hyperpolarised 13C 
pyruvate as imaging agent for prostate cancer (UCSF, San Francisco, CA) has risen 
expectations for potential other clinical applications such as the early detection of MI. 
The usage of hyperpolarised tracers in cardiology is still at the very early stages and 
many research studies are aimed at the optimisation of the imaging protocol.  The 
simulations presented in this Chapter were aimed to help engineers at ETH Zurich in 
designing an optimal imaging protocol that would allow the detection of small 
degrees of transmural ischemia in the left ventricle in vivo in rat hearts. Similar 
studies could be performed to help the design and optimisation of the imaging 




In this Chapter the feasibility of detecting information on the spatial distribution of 
hyperpolarised [1-13C1]
 pyruvate, [1-13C1]
 lactate and H13CO3
- ex vivo in perfused rat 
hearts using slice selective spectroscopic imaging employing an echo planar readout 
was shown. Spatial distributions of the 13C metabolite signals were measured and 
heterogeneous metabolism within the myocardium was detected. In order to facilitate 
the translation of the developed spectroscopic imaging protocol from ex vivo to in 
vivo experiments it would be desirable to have an a priori knowledge of the minimum 
SNRB and in-plane resolution necessary for the detection of small percentage of 
transmural ischemia using hyperpolarised 13C imaging combined with kinetic 
modelling. Monte Carlo simulations presented in this Chapter showed that a two-




of conversion of pyruvate to H13CO3
- at the values of SNRBs and kAB characteristic of 
in vivo experiments in small animals. Results also suggested that in order to detect 
the smallest percentage of ischemic transmurality simulated (18%) by fitting the 
synthetic 13C dynamic images of pyruvate and H13CO3
- to the validated analysis 
model is necessary to achieve at least a  SNRB equal to 3 and an in-plane resolution 























Chapter 8 : Conclusions  
The aim of this thesis was to develop experimental protocols and analysis methods 
for the real-time assessment of cardiac metabolism. 
 
 
8.1 Major Findings in this Thesis 
The first step towards achieving the aim of this thesis was to set up the HyperSense 
DNP polariser at KCL and validate its performance. Metabolically active molecules 
such as [1-13C1] pyruvate, [1,2-
13C2] pyruvate and [1,4-
13C2] fumarate were 
hyperpolarised and the longitudinal relaxation time constants T1 as well as the 
polarisation enhancements obtained for each molecule was measured in solution 
and compared to the values previously reported in the literature. A hyperpolarised 
MR protocol was developed for the detection of metabolism in vitro in live cells and 
the conversion of hyperpolarised [1-13C1] pyruvate to [1-
13C1] lactate was observed in 
real-time in whole blood cells. Dynamic time courses were analysed using 
quantitative and semi-quantitative methods. A hybrid MEM/NLS algorithm was 
applied to the kinetic analysis of hyperpolarised 13C metabolic data acquired in vitro. 




Monte Carlo simulations and compared to those of compartmental modelling which 
represents the gold standard method for the analysis of hyperpolarised 13C data. 
An MR compatible Langendorff perfused rat heart system was developed together 
with an experimental protocol for 13C MRS and MRSI to measure cardiac metabolism 
in real-time ex vivo. The conversion of hyperpolarised [1-13C1] pyruvate to its 
downstream metabolites was observed in two groups of isolated hearts perfused 
with two Krebs-Henseleit buffers with different compositions. The conversion of [1-
13C1] pyruvate to [1-
13C1] lactate via LDH, [1-
13C1] alanine via ALT and H
13CO3
- via 
PDH was observed in both groups of hearts, whereas the conversion of [1-13C1] 
pyruvate to aspartate C1 and C4 was detected only in the Langendorff hearts 
perfused with glucose only buffer. This last metabolic conversion was detected for 
the first time in perfused hearts in real-time in this thesis. Previous cardiac studies 
employing hyperpolarised pyruvate have suggested that it is possible to estimate 
PDH activity by fitting the hyperpolarised 13C time series of [1-13C1] pyruvate and 
H13CO3
- to a two-compartment, first-order, unidirectional model. This compartmental 
model assumes that the metabolic conversion catalysed by PDH approximates to 
first order kinetics and does not depend on the availability of the enzymatic cofactors 
NAD+ and CoA. The validity of this assumption was explored for hyperpolarised 
experiments carried out ex vivo by fitting the 13C time-series of [1-13C1] pyruvate and 
H13CO3
- with both first and second-order compartmental models. Results suggested 
that the metabolic conversion in perfused hearts follows second-order rather than 
first-order kinetics and therefore depends on the availability of the enzymatic 
cofactors. This result has been supported by a preliminary study carried out by Dr. 




measured using fluorescence during the injection of a 50mM pyruvate solution 
mimicking that used for the hyperpolarised experiments at KCL. This study 
suggested for the first time that the injection of a hyperpolarised pyruvate solution 
into a perfused heart may perturb the biological kinetics assessed.  
 
Information on the local distribution of hyperpolarised [1-13C1] pyruvate and its 
metabolites was obtained using 13C MRSI techniques developed in collaboration with 
Dr. Kilian Weiss. In these experiments a heterogeneous distribution of [1-13C1] 
pyruvate, [1-13C1] lactate and H
13CO3
- were detected in the myocardium. In order to 
support the translation of the 13C MRSI protocol from ex vivo to in vivo, 
compartmental modelling was used to explore the detection limits of transmural 
myocardial ischemia in vivo in small rodents using hyperpolarised 13C MRSI 
depending on SNR, spatial resolution and extent of ischemia. Results suggested that 
in order to detect the smallest percentage of ischemic transmurality simulated (18%) 
by fitting the synthetic 13C dynamic images of pyruvate and H13CO3
- with a two-
compartment, first-order kinetic model it is necessary to achieve at least a SNR 
equal to 3 and an in-plane resolution equal to 4 x 4 mm2.  
 
A study was carried out to develop and validate quantitative and semi-quantitative 
analysis methods for time-activity curves of PET tracers acquired ex vivo. PET 
dynamic data were acquired by Dr. Richard Southworth and Dr. Rodolfo Medina as 
part of a study aimed at the characterisation of the uptake in the perfused heart of 
two PET tracers, namely [18F]-FDG and [18F]-FMISO, in normoxia and hypoxia. The 




characterising the kinetics of these two PET tracers was assessed using both Monte 
Carlo simulations and experimental time-activity curves. The results showed that 
none of the analysis methods proposed is able to identify the number of the non-
trapped kinetic components due to the heterogeneity of the measurement. However, 
NLSA is adequate to identify the presence of the trapping. Once identified, the 
trapped component can be estimated using either NLSA or the semi-quantitative 
index NA.  
 
 
8.2 Future Work 
In this thesis ex vivo dynamic data were acquired during the development and 
optimisation of the Langendorff perfused heart system and 13C MR experimental 
protocols. This has resulted in high variability between measurements and the 
unavailability of cardiac contractility for some of the perfused hearts. In future all the 
Langendorff perfused heart experiments will be carried out under the same 
experimental conditions and the cardiac contractility will be monitored throughout the 
experiments in order to correlate the metabolic changes with cardiac function.  
 
The possibility of injecting Langendorff perfused hearts with hyperpolarised 13C urea, 
or another non metabolically active molecule, at the same time as [1-13C1] pyruvate 
will be explored in the future. The 13C time-series of urea contains information on the 
perfusion of the hyperpolarised solution and will be used as input function in the 




for the kinetic analysis of ex vivo and in vivo hyperpolarised data will also be 
explored by deconvoluting the experimental dynamic data with the input function. 
 
The hypothesis that the metabolic conversion of hyperpolarised [1-13C1] pyruvate to 
H13CO3
- via PDH in perfused hearts is limited by the availability of the coenzyme 
NAD+ will be further investigated. An experimental set up will be developed at KCL in 
order to investigate the dynamics of the cofactor NAD+ using NADH fluorescence.  
 
The analysis methods for characterising the conversion of hyperpolarised [1-13C] 
pyruvate to H13CO3
- will be extended using a second-order compartmental model 
including the non-hyperpolarised 13C pools of [1-13C1] pyruvate and H
13CO3
-, which 
are not detectable but are subject to metabolic conversion, together with the 
hyperpolarised 13C pools.  
 
In future work a compartmental model including the metabolic conversion of pyruvate 
to all its metabolites identified in the hyperpolarised 13C MR spectrum (Figure 5.7 
and Figure 5.8) will be implemented. This will allow obtaining a more complete 
overview of pyruvate metabolism in Langendorff perfused rat hearts. However, to 
describe such a complex metabolic pathway a large number of unknown parameters 
are necessary and the accuracy of compartmental model parameters estimates may 
be affected.  
 
 A PET insert is available for the 9.4T MR spectrometer used in this thesis. In future 




will allow a more complete picture of the metabolic and functional state of the heart 
in physiological and pathophysiological conditions. A series of PET/MR experiments 
will be, for example, performed in order to investigate whether the injection of a 
hyperpolarised 13C pyruvate solution at non-tracer concentration saturates the 
uptake of pyruvate across the mitochondria membrane making the metabolic 
conversion of pyruvate to H13CO3
- transport-limited rather than limited by the rate of 
enzymatic conversion.  In order to do so the distribution of the uptake of radioactive 
11C pyruvate (PET), injected at tracer concentration, and that of hyperpolarised 13C 
pyruvate (MR) will be detected in one or more axial slices during the same 
experiment. Anatomical 1H MR reference acquired for the same Langendorff 
perfused rat heart will be used to register the pyruvate uptake acquired with the two 
imaging modalities. This type of experiment will be performed both in normoxic and 
in hypoxic or ischemic perfused hearts to investigate whether the effect of the 
hyperpolarised solution on the pyruvate uptake depends on the level of oxygenation 
of the hearts.  Additionally, cardiac metabolism and perfusion will be assessed in the 
same Langendorff heart using hyperpolarised 13C pyruvate and radioactive 11C 
ammonia, respectively. Metabolic and perfusion information will be integrated with 
the anatomical information of the same heart acquired using 1H MR imaging.  
 
The ex vivo imaging experimental protocol developed in this thesis at St. Thomas’ 
hospital is being translated to in vivo studies in small animal (rats) at ETH Zurich 
were a MR scanner adequate to this type of experiments is installed next to a DNP 
polariser. Many efforts have been done by this group in the last five years in order to 




pyruvate to its metabolites in vivo in real time (Weiss et al. 2013;  Sigfridsson et al. 
2014).  An experimental protocol for the injection of a hyperpolarised solution into a 
living animal has been also developed and optimised in the same group. The next 
step towards the translation to in vivo MRSI studies will be to acquire hyperpolarise 
images of pyruvate and its metabolites in healthy animals using different spatial 
resolutions and measuring the SNRb obtained. Results will be compared with those 
obtained from the Monte Carlo simulation performed in this thesis (Section 7.4) to 
evaluate the effects of the variations in coil sensitivities over the field of view, large 
slice thicknesses and motion artefacts, not considered in this thesis, may have on 
the quality of the dynamic images on the accuracy in parameter estimation of the 
proposed kinetic model.  Subsequently an experimental protocol for inducing 
different level of transmural myocardial ischemia through the ligation of the left 
descending coronary artery will be developed and validated. Finally a number of 
experiments aimed at the detection of myocardial ischemia using hyperpolarised 13C 
MR combined with kinetic modelling will be performed.  
After optimising the hyperpolarised imaging for cardiac metabolic studies Professor 
Kozerke’s group aims to translate the experimental protocol validate for small 
animals to humans. They have recently bought a DNP polariser able to produce 
hyperpolarised sample for human studies. This machine is able to check, soon after 
the dissolution, the PH, purity and temperature of the hyperpolarised solution and 
releases only those samples suitable for injection. The aim for the future it is 
obtained the approval to start a clinical trial using hyperpolarised 13C pyruvate as 
imaging agent for MI. Metabolic images of the human hearts will be acquired using 




located.  Before starting the clinical trial it will be necessary to develop and optimise 
an experimental protocol for the safe injection of the hyperpolarised solution into 
humans as well as fast MR sequences for the detection of the hyperpolarised 13C 
pyruvate metabolism in to the heart as previously done for the in vivo experiments 
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Natural abundance 13C MR spectra of the main metabolites involved in cardiac 
metabolism used to assign the peaks in the hyperpolarised 13C spectra acquired 
from Langendorff perfused rat hearts and shown in Figure 5.7and Figure 5.8. 128 
spectra were acquired for each compound using a flip angle θ = 30°, TR = 21s (total 
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